CTRP Agent Terminology

Preferred Label : CTRP Agent Terminology;

NCIt synonyms : Clinical Trials Reporting Program Agent Terminology;

NCIt definition : A subset of terminology about pharmacologic substances and formulations that are currently being used or tested in clinical trials for the treatment of cancer, cancer-related conditions and chemo/radiotherapy-related side effects.;

Details

Origin ID

C116978;

UMLS CUI

C3899744;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- 1,2-Carbon C 13-labeled Glucose [NCIt concept]
- 12-Lipoxygenase Inhibitor VLX-1005 [NCIt concept]
- 16,16-Dimethyl Prostaglandin E2 [NCIt concept]
- 18-F-fluoroacetate [NCIt concept]
- 18F-FHBG [NCIt concept]
- 18F-Fluoromisonidazole [NCIt concept]
- 18F-labeled Mini-PEG Spacered RGD Dimer [NCIt concept]
- 2'-F-ara-deoxyuridine [NCIt concept]
- 2-Deoxy-D-glucose [NCIt concept]
- 2-Fluorofucose [NCIt concept]
- 2-Fluoropropionyl-labeled Pegylated Dimeric RGD Peptide [NCIt concept]
- 2-Methoxyestradiol [NCIt concept]
- 2-Methoxyestradiol Nanocrystal Colloidal Dispersion [NCIt concept]
- 2H-labeled Acetate [NCIt concept]
- 3'-Aminomethyl Nicotine-P. aeruginosa r-Exoprotein A Conjugate Vaccine [NCIt concept]
- 3'-C-ethynylcytidine [NCIt concept]
- 3D-expanded Placenta-derived Cells PLX-R18 [NCIt concept]
- 4'-Iodo-4'-Deoxydoxorubicin [NCIt concept]
- 4-Peptide Melanoma Vaccine [NCIt concept]
- 4-Thio-2-deoxycytidine [NCIt concept]
- 4H11-28z/fIL-12/EGFRt-expressing Autologous T-lymphocytes [NCIt concept]
- 5-Aza-4'-thio-2'-deoxycytidine [NCIt concept]
- 5-Carbon C 13-labeled Glutamine [NCIt concept]
- 5-Fluoro-2-Deoxycytidine [NCIt concept]
- 5-HT3 Receptor Antagonist [NCIt concept]
- 6 Melanoma Helper Peptide Vaccine [NCIt concept]
- 7-Hydroxystaurosporine [NCIt concept]
- 8-Chloroadenosine [NCIt concept]
- 99mTc-based PSMA Imaging and Surgery Agent [NCIt concept]
- A2A/A2B Adenosine Receptor Antagonist INCB106385 [NCIt concept]
- ABCG2 Substrate [NCIt concept]
- ABVD Regimen [NCIt concept]
- AC Regimen [NCIt concept]
- ADH-1 [NCIt concept]
- AE37 Peptide/GM-CSF Vaccine [NCIt concept]
- AKR1C3-activated Prodrug AST-3424 [NCIt concept]
- AKT 1/2 Inhibitor BAY1125976 [NCIt concept]
- AKT Inhibitor [NCIt concept]
- AKT/RSK/S6K Inhibitor TAS0612 [NCIt concept]
- AKT1 E17K Inhibitor ALTA2618 [NCIt concept]
- ALC1 Inhibitor EIS-12656 [NCIt concept]
- ALDH2 Activator FP-045 [NCIt concept]
- ALK Inhibitor ASP3026 [NCIt concept]
- ALK-FAK Inhibitor CEP-37440 [NCIt concept]
- ALVAC gp100 Vaccine [NCIt concept]
- ALVAC(2) Melanoma Multi-antigen Vaccine [NCIt concept]
- ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine [NCIt concept]
- ALVAC-hB7.1 [NCIt concept]
- AMP KRAS Vaccine ELI-002 [NCIt concept]
- APC8015F [NCIt concept]
- APE1/Ref-1 Redox Inhibitor APX3330 [NCIt concept]
- APIM-containing Peptide ATX-101 [NCIt concept]
- AR Antagonist BMS-641988 [NCIt concept]
- ARC Fusion Protein SL-279252 [NCIt concept]
- ATM Inhibitor M 3541 [NCIt concept]
- ATM Kinase Inhibitor AZD1390 [NCIt concept]
- ATM Kinase Inhibitor WSD-0628 [NCIt concept]
- ATM Kinase/DNA-PK Inhibitor XRD-0394 [NCIt concept]
- ATR Inhibitor [NCIt concept]
- ATR Inhibitor ART0380 [NCIt concept]
- ATR Inhibitor ATRN-119 [NCIt concept]
- ATR Inhibitor IMP9064 [NCIt concept]
- AXL Inhibitor [NCIt concept]
- AXL Inhibitor AB801 [NCIt concept]
- AXL Inhibitor DS-1205c [NCIt concept]
- AXL Inhibitor SLC-391 [NCIt concept]
- Abagovomab [NCIt concept]
- Abarelix [NCIt concept]
- Abatacept [NCIt concept]
- Abelacimab [NCIt concept]
- Abexinostat [NCIt concept]
- Abexinostat Tosylate [NCIt concept]
- Abipapogene Suvaplasmid [NCIt concept]
- Abiraterone [NCIt concept]
- Abiraterone Acetate [NCIt concept]
- Abiraterone Acetate/Niraparib [NCIt concept]
- Abiraterone Decanoate Depot [NCIt concept]
- Abituzumab [NCIt concept]
- Abivertinib [NCIt concept]
- Absorbable Fibrin Sealant Patch [NCIt concept]
- Absorbable Gelatin Sponge [NCIt concept]
- Acalabrutinib [NCIt concept]
- Acasunlimab [NCIt concept]
- Acazicolcept [NCIt concept]
- Acellular Cadaveric Dermal Matrix [NCIt concept]
- Acellular Dermal Matrix [NCIt concept]
- Acetaminophen [NCIt concept]
- Acetazolamide [NCIt concept]
- Acetazolamide Sodium [NCIt concept]
- Acetyl-L-Carnitine Hydrochloride [NCIt concept]
- Acetylcysteine [NCIt concept]
- Acimtamig [NCIt concept]
- Acolbifene Hydrochloride [NCIt concept]
- Acoramidis [NCIt concept]
- Actinium Ac 225 FPI-2059 [NCIt concept]
- Actinium Ac 225 FPI-2068 [NCIt concept]
- Actinium Ac 225 PSMA-I&T [NCIt concept]
- Actinium Ac 225 Rosopatamab Tetraxetan [NCIt concept]
- Actinium Ac 225 Vofatamab [NCIt concept]
- Actinium Ac 225-DOTA-Daratumumab [NCIt concept]
- Actinium Ac 225-DOTA-MTI-201 [NCIt concept]
- Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Actinium Ac 225-DOTA-h11B6 JNJ-69086420 [NCIt concept]
- Actinium Ac 225-FPI-1434 [NCIt concept]
- Activated Charcoal [NCIt concept]
- Activated Marrow Infiltrating Lymphocytes [NCIt concept]
- Activated Polyethylene Glycol/Polyethyleneimine-based Surgical Sealant [NCIt concept]
- Active Comparator Drug [NCIt concept]
- Activin Type 2B Receptor Fc Fusion Protein STM 434 [NCIt concept]
- Acyclovir [NCIt concept]
- Acyclovir Sodium [NCIt concept]
- Acylfulvene-derived Prodrug LP-184 [NCIt concept]
- Ad-RTS-hIL-12 [NCIt concept]
- Ad-hCMV-Flt3L [NCIt concept]
- Ad-hCMV-TK [NCIt concept]
- Ad5-CMV-NIS [NCIt concept]
- Ad5-SGE-REIC/Dkk-3 MTG-201 [NCIt concept]
- Ad5-survivin-transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Ad5-yCD/mutTK(SR39)rep-ADP [NCIt concept]
- Ad5.SSTR/TK.RGD [NCIt concept]
- AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992 [NCIt concept]
- AdGMCAIX-transduced Autologous Dendritic Cells [NCIt concept]
- AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine [NCIt concept]
- Adagloxad Simolenin [NCIt concept]
- Adagrasib [NCIt concept]
- Adakitug [NCIt concept]
- Adalimumab [NCIt concept]
- Adavosertib [NCIt concept]
- Adenosine A2A Receptor Antagonist [NCIt concept]
- Adenosine A2A Receptor Antagonist DZD2269 [NCIt concept]
- Adenosine A2A Receptor Antagonist JNJ-86974680 [NCIt concept]
- Adenosine A2A Receptor Antagonist NIR178 [NCIt concept]
- Adenosine A2A Receptor Antagonist TT-10 [NCIt concept]
- Adenosine A2B Receptor Antagonist PBF-1129 [NCIt concept]
- Adenosine Axis Inhibitor [NCIt concept]
- Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 [NCIt concept]
- Adenoviral Brachyury Vaccine ETBX-051 [NCIt concept]
- Adenoviral Cancer Vaccine PF-06936308 [NCIt concept]
- Adenoviral MUC1 Vaccine ETBX-061 [NCIt concept]
- Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001 [NCIt concept]
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP [NCIt concept]
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901 [NCIt concept]
- Adenoviral Vector Ad5-CEA(6D) Vaccine [NCIt concept]
- Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine [NCIt concept]
- Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE [NCIt concept]
- Adenovirus Encoding Human Aquaporin-1 [NCIt concept]
- Adenovirus Encoding Recombinant Human Endostatin [NCIt concept]
- Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Adenovirus Expressing Mutant HPV E6/E7 [NCIt concept]
- Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine [NCIt concept]
- Adenovirus RSV-TK [NCIt concept]
- Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918 [NCIt concept]
- Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 [NCIt concept]
- Adenovirus Serotype 5-based Therapeutic Agent [NCIt concept]
- Adenovirus-Encoding E.coli PNP [NCIt concept]
- Adenovirus-PSA Prostate Cancer Vaccine [NCIt concept]
- Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001 [NCIt concept]
- Adenovirus-p53 Transduced Dendritic Cell Vaccine [NCIt concept]
- Adenovirus/Cytomegalovirus/Epstein-Barr Virus-specific Allogeneic Cytotoxic T Lymphocytes [NCIt concept]
- Aderbasib [NCIt concept]
- Adoptive Cell Therapy Agent [NCIt concept]
- Aerosol Gemcitabine [NCIt concept]
- Aerosol Sargramostim [NCIt concept]
- Aerosolized Aldesleukin [NCIt concept]
- Afamitresgene Autoleucel [NCIt concept]
- Afatinib [NCIt concept]
- Afatinib Dimaleate [NCIt concept]
- Afimoxifene [NCIt concept]
- Afuresertib [NCIt concept]
- Agatolimod Sodium [NCIt concept]
- Agerafenib [NCIt concept]
- Aglatimagene Besadenovec [NCIt concept]
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 [NCIt concept]
- Akt Inhibitor MK2206 [NCIt concept]
- Akt Inhibitor SR13668 [NCIt concept]
- Akt-1/2 Inhibitor-treated Tumor Infiltrating Lymphocytes [NCIt concept]
- Alanylglutamine [NCIt concept]
- Albumin [NCIt concept]
- Albumin-binding Cisplatin Prodrug BTP-114 [NCIt concept]
- Albuterol [NCIt concept]
- Albuterol Sulfate [NCIt concept]
- Alcohol [NCIt concept]
- Aldastotug [NCIt concept]
- Aldesleukin [NCIt concept]
- Aldoxorubicin [NCIt concept]
- Alectinib [NCIt concept]
- Alefacept [NCIt concept]
- Alemtuzumab [NCIt concept]
- Alextatug [NCIt concept]
- Algenpantucel-L [NCIt concept]
- Alintegimod [NCIt concept]
- Alirocumab [NCIt concept]
- Alisertib [NCIt concept]
- Alisertib Sodium [NCIt concept]
- Alkaline Water [NCIt concept]
- Alloantigen-specific Allogeneic Type 1 Regulatory T Cells T-allo10 [NCIt concept]
- Allodepleted Haploidentical T Cells-expressing Inducible Caspase 9 [NCIt concept]
- Allodepleted T Cell Immunotherapeutic ATIR101 [NCIt concept]
- Allogeneic AML Antigen-expressing Dendritic Cell Vaccine [NCIt concept]
- Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes [NCIt concept]
- Allogeneic Adipose-derived Mesenchymal Stem Cells [NCIt concept]
- Allogeneic Anti-BCMA CAR T Cells ALLO-605 [NCIt concept]
- Allogeneic Anti-BCMA CAR T Cells P-BCMA-ALLO1 [NCIt concept]
- Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715 [NCIt concept]
- Allogeneic Anti-BCMA-CAR T-cells PBCAR269A [NCIt concept]
- Allogeneic Anti-CD19 CAR T-cells ATA3219 [NCIt concept]
- Allogeneic Anti-CD19 CAR T-cells PBCAR19B [NCIt concept]
- Allogeneic Anti-CD19-CAR-CD28-IL-15-expressing Natural Killer T-cells [NCIt concept]
- Allogeneic Anti-CD19/CD22 CAR-BBz T-cells [NCIt concept]
- Allogeneic Anti-CD20-CAR T-cells PBCAR20A [NCIt concept]
- Allogeneic Anti-CD20/CD22 Universal CAR-expressing T-lymphocytes UCART20x22 [NCIt concept]
- Allogeneic Anti-CD30 CAR-Epstein-Barr Virus-specific T-lymphocytes [NCIt concept]
- Allogeneic Anti-CD33 CAR T-cells VCAR33 [NCIt concept]
- Allogeneic Anti-CD38 DAR-T Cells STI-1492 [NCIt concept]
- Allogeneic Anti-CD5 CAR-CD28zeta T-lymphocytes [NCIt concept]
- Allogeneic Anti-CD6 CAR T-regulatory Cells [NCIt concept]
- Allogeneic Anti-CD7 CAR-T Cells BEAM-201 [NCIt concept]
- Allogeneic Anti-CD7 CAR-T Cells WU-CART-007 [NCIt concept]
- Allogeneic Anti-CD70-CAR T-cells ALLO-316 [NCIt concept]
- Allogeneic Anti-CD70-CAR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Allogeneic Anti-HA-1 TCR-engineered T-cells TSC-100 [NCIt concept]
- Allogeneic Anti-HA-2 TCR-engineered T-cells TSC-101 [NCIt concept]
- Allogeneic Anti-NY-ESO-1-TCR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Allogeneic Autophagosome-enriched Vaccine DPV-001 [NCIt concept]
- Allogeneic BK-specific Cytotoxic T-lymphocytes [NCIt concept]
- Allogeneic CAR-T Cells [NCIt concept]
- Allogeneic CD123-specific Universal CAR123-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD16-expressing Natural Killer Cells CYNK-101 [NCIt concept]
- Allogeneic CD19-CAR CD45RA-negative T-cells [NCIt concept]
- Allogeneic CD19-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX019 [NCIt concept]
- Allogeneic CD19-specific Universal CAR19-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD19/CD20-specific CAR-T Cells P-CD19CD20-ALLO1 [NCIt concept]
- Allogeneic CD20 CAR-grafted Gamma Delta T-cells ADI-001 [NCIt concept]
- Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22 [NCIt concept]
- Allogeneic CD25/Treg-depleted Donor Lymphocytes [NCIt concept]
- Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100 [NCIt concept]
- Allogeneic CD3- CD19- Selected Natural Killer Cells [NCIt concept]
- Allogeneic CD33CAR-CD3zeta-4-1BB-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD34+-enriched and CD45RA-depleted PBSCs [NCIt concept]
- Allogeneic CD34-positive E-rosetted T-cell Depleted Peripheral Blood Stem Cells [NCIt concept]
- Allogeneic CD34-positive Enriched Peripheral Blood Stem Cells [NCIt concept]
- Allogeneic CD56-positive CD3-negative Natural Killer Cells [NCIt concept]
- Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001 [NCIt concept]
- Allogeneic CD8+ Memory T-cells [NCIt concept]
- Allogeneic CMV Antigen-specific CD4+/CD8+ T-lymphocytes [NCIt concept]
- Allogeneic CMV/AdV-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD19 CAR T Cells CTX110 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD19 CAR T-cells CTX112 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX131 [NCIt concept]
- Allogeneic CRISPR-edited Anti-BCMA CAR-T Cells CB-011 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CD19 CAR-T Cells CB-010 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CLL-1 CAR-T Cells CB-012 [NCIt concept]
- Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A [NCIt concept]
- Allogeneic Calibrated Release IL-15-expressing Logic-Gated Gene Circuit Anti-CD33/FLT3 CAR-NK Cells SENTI-202 [NCIt concept]
- Allogeneic Cellular Vaccine 1650-G [NCIt concept]
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes [NCIt concept]
- Allogeneic Epstein-Barr Virus-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Allogeneic GM-CSF-Based Myeloma Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-Secreting Breast Cancer Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Myeloma Vaccine [NCIt concept]
- Allogeneic Gamma-delta T-lymphocytes KB-GDT-01 [NCIt concept]
- Allogeneic Gene-edited CD33-knockout Hematopoietic Stem and Progenitor Cells [NCIt concept]
- Allogeneic Gene-modified Gamma Delta T-cells [NCIt concept]
- Allogeneic HAdV Antigen-specific T-lymphocytes [NCIt concept]
- Allogeneic Human Stem Cell-derived Pancreatic Islet Cells VX-880 [NCIt concept]
- Allogeneic Human T Cell Progenitors SMART 101 [NCIt concept]
- Allogeneic Hypoimmune Anti-CD19 CAR T-cells SC291 [NCIt concept]
- Allogeneic Hypoimmune Anti-CD22 CAR T-cells SC262 [NCIt concept]
- Allogeneic Invariant Natural Killer T-cells agenT-797 [NCIt concept]
- Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine [NCIt concept]
- Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 [NCIt concept]
- Allogeneic Most Closely HLA-matched Adenovirus-specific Cytotoxic T Lymphocytes [NCIt concept]
- Allogeneic Multipotent Adult Progenitor Cells [NCIt concept]
- Allogeneic NKG2D-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX101 [NCIt concept]
- Allogeneic Natural Killer Cell Line NK-92 [NCIt concept]
- Allogeneic Natural Killer Cells CHM 0201 [NCIt concept]
- Allogeneic Natural Killer Cells DVX201 [NCIt concept]
- Allogeneic Natural Killer Cells IDP-023 [NCIt concept]
- Allogeneic Natural Killer Cells SAR445419 [NCIt concept]
- Allogeneic Nicotinamide-expanded Natural Killer Cells [NCIt concept]
- Allogeneic PD-L1 Tumor-targeted High-affinity Natural Killer Cells [NCIt concept]
- Allogeneic Polymer-encapsulated IL-2-secreting Retinal Pigmented Epithelial Cells AVB-001 [NCIt concept]
- Allogeneic Regulatory T-cells TRX103 [NCIt concept]
- Allogeneic Rituximab Conjugated Gamma Delta T-cells ACE1831 [NCIt concept]
- Allogeneic SARS-CoV-2 Specific T Cells [NCIt concept]
- Allogeneic Skin-derived ABCB5-positive MSCs allo-APZ2-OTS [NCIt concept]
- Allogeneic TCR-CD3 complex/CD16/IL-15-expressing Natural Killer Cells [NCIt concept]
- Allogeneic Tumor Cell Vaccine [NCIt concept]
- Allogeneic Umbilical Cord Blood-derived CXCR4-enriched T-regulatory Cells CK0804 [NCIt concept]
- Allogeneic Variable Delta 1 Gamma-delta T-lymphocytes GDX012 [NCIt concept]
- Allogeneic Virus-specific T-lymphocytes R-MVST [NCIt concept]
- Allogeneic iC9/CD19-CAR-CD28-zeta-2A-IL15-transduced Cord Blood-derived Natural Killer Cells TAK-007 [NCIt concept]
- Allogeneic iPSC-derived Anti-CD19-CAR/IL-15-expressing NK Cells CNTY-101 [NCIt concept]
- Allogeneic iPSC-derived Anti-MICA/B CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT536 [NCIt concept]
- Allogeneic shRNA-based Anti-BCMA CAR T-cells CYAD-211 [NCIt concept]
- Allopurinol [NCIt concept]
- Allovectin-7 [NCIt concept]
- Almond Oil [NCIt concept]
- Alnuctamab [NCIt concept]
- Alobresib [NCIt concept]
- Alomfilimab [NCIt concept]
- Alpelisib [NCIt concept]
- Alpha Fetoprotein Adenoviral Vector Vaccine [NCIt concept]
- Alpha Galactosylceramide [NCIt concept]
- Alpha V Beta 8 Antagonist PF-06940434 [NCIt concept]
- Alpha-1-Antitrypsin [NCIt concept]
- Alpha-1-Proteinase Inhibitor Human [NCIt concept]
- Alpha-Lipoic Acid [NCIt concept]
- Alpha-lactalbumin Breast Cancer Vaccine [NCIt concept]
- Alpha-type-1 Polarized Dendritic Cells [NCIt concept]
- Alpha/beta T-cell/CD19+ B-cell-depleted Unrelated or Partially Matched Donor-derived Allogeneic Peripheral Blood Stem Cells [NCIt concept]
- AlphaVbeta1/8 Inhibitor PLN-101095 [NCIt concept]
- Alprostadil [NCIt concept]
- Alsevalimab [NCIt concept]
- Alvelestat [NCIt concept]
- Alvespimycin Hydrochloride [NCIt concept]
- Alvimopan [NCIt concept]
- Alvocidib [NCIt concept]
- Alvocidib Hydrochloride [NCIt concept]
- Alvocidib Prodrug TP-1287 [NCIt concept]
- Amantadine Hydrochloride [NCIt concept]
- Amatuximab [NCIt concept]
- Amcasertib [NCIt concept]
- Amcenestrant [NCIt concept]
- Amdizalisib [NCIt concept]
- American Ginseng [NCIt concept]
- Amifampridine [NCIt concept]
- Amifostine [NCIt concept]
- Amikacin Inhalation Solution [NCIt concept]
- Amino Acid/Electrolyte Mixture-based Dietary Supplement [NCIt concept]
- Aminoflavone Prodrug AFP464 [NCIt concept]
- Aminolevulinic Acid Hydrochloride [NCIt concept]
- Aminolevulinic Acid Intravenous Formulation SONALA-001 [NCIt concept]
- Aminophylline [NCIt concept]
- Amivantamab [NCIt concept]
- Amivantamab and Recombinant Human Hyaluronidase [NCIt concept]
- Ammonia N-13 [NCIt concept]
- Amolimogene Bepiplasmid [NCIt concept]
- Amonafide L-Malate [NCIt concept]
- Amredobresib [NCIt concept]
- Amrubicin [NCIt concept]
- Amrubicin Hydrochloride [NCIt concept]
- Amuvatinib [NCIt concept]
- Anagrelide [NCIt concept]
- Anakinra [NCIt concept]
- Anamorelin Hydrochloride [NCIt concept]
- Anastrozole [NCIt concept]
- Anbenitamab [NCIt concept]
- Andecaliximab [NCIt concept]
- Androgen Antagonist APC-100 [NCIt concept]
- Androgen Receptor Antagonist TRC253 [NCIt concept]
- Androgen Receptor Antisense Oligonucleotide AZD5312 [NCIt concept]
- Androgen Receptor Degrader [NCIt concept]
- Androgen Receptor Degrader AC176 [NCIt concept]
- Androgen Receptor Degrader RO7656594 [NCIt concept]
- Androgen Receptor Downregulator AZD3514 [NCIt concept]
- Androgen Receptor Inhibitor [NCIt concept]
- Androgen Receptor Inhibitor ONCT-534 [NCIt concept]
- Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10 [NCIt concept]
- Androstane Steroid HE3235 [NCIt concept]
- Anesthetic Agent [NCIt concept]
- Anetumab Ravtansine [NCIt concept]
- Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241 [NCIt concept]
- Angiogenesis Inhibitor [NCIt concept]
- Angiogenesis Inhibitor JI-101 [NCIt concept]
- Angiopoietin-2-specific Fusion Protein PF-04856884 [NCIt concept]
- Anhydrous Enol-oxaloacetate [NCIt concept]
- Anidulafungin [NCIt concept]
- Annamycin Liposomal [NCIt concept]
- Anthracycline Antineoplastic Antibiotic [NCIt concept]
- Anti-4-1BB/5T4 Bispecific Antibody ALG.APV-527 [NCIt concept]
- Anti-4-1BB/PD-L1 Bispecific Antibody BH3120 [NCIt concept]
- Anti-5T4 Antibody-Drug Conjugate PF-06263507 [NCIt concept]
- Anti-5T4 Antibody-drug Conjugate ASN004 [NCIt concept]
- Anti-A33 Monoclonal Antibody KRN330 [NCIt concept]
- Anti-A5B1 Integrin Monoclonal Antibody PF-04605412 [NCIt concept]
- Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 [NCIt concept]
- Anti-AG7 Antibody Drug Conjugate AbGn-107 [NCIt concept]
- Anti-AGS-16 Monoclonal Antibody AGS-16M18 [NCIt concept]
- Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME [NCIt concept]
- Anti-AGS-8 Monoclonal Antibody AGS-8M4 [NCIt concept]
- Anti-ALK-1 Monoclonal Antibody GT90001 [NCIt concept]
- Anti-ALPP/ALPPL2/MMAE ADC SGN-ALPV [NCIt concept]
- Anti-ANG2 Monoclonal Antibody MEDI-3617 [NCIt concept]
- Anti-ASCT2 Antibody-drug Conjugate MEDI7247 [NCIt concept]
- Anti-Androgen [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate DB-1311 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate MGC026 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate YL201 [NCIt concept]
- Anti-B7-H3 CAR T-cells [NCIt concept]
- Anti-B7-H3/CD28 Bispecific Antibody XmAb808 [NCIt concept]
- Anti-B7-H3/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BGB-C354 [NCIt concept]
- Anti-B7-H4 Antibody Drug Conjugate BG-C9074 [NCIt concept]
- Anti-B7-H4 Antibody-drug Conjugate SGN-B7H4V [NCIt concept]
- Anti-B7-H4 Monoclonal Antibody [NCIt concept]
- Anti-B7-H4 Monoclonal Antibody NC762 [NCIt concept]
- Anti-B7-H4/ TOP1i Antibody-drug Conjugate AZD8205 [NCIt concept]
- Anti-B7-H4/Anti-4-1BB Bispecific Antibody CLN-418 [NCIt concept]
- Anti-B7-H4/Anti-CD3 Bispecific Antibody GEN1047 [NCIt concept]
- Anti-B7-H4/Anti-CD3 Bispecific Antibody PF-07260437 [NCIt concept]
- Anti-B7-H4/TOP1i Antibody-drug Conjugate GSK5733584 [NCIt concept]
- Anti-B7-H6/Anti-CD3 Bispecific Antibody BI 765049 [NCIt concept]
- Anti-B7H7 Monoclonal Antibody [NCIt concept]
- Anti-BCMA Antibody SEA-BCMA [NCIt concept]
- Anti-BCMA Antibody-drug Conjugate AMG 224 [NCIt concept]
- Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA [NCIt concept]
- Anti-BCMA/Alpha-amanitin Antibody-drug Conjugate HDP-101 [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody WVT078 [NCIt concept]
- Anti-BCMA/Anti-GPRC5D CAR-T Cells BMS-986453 [NCIt concept]
- Anti-BCMA/CD38/CD3 Trispecific Antibody ISB 2001 [NCIt concept]
- Anti-BCMA/PBD ADC MEDI2228 [NCIt concept]
- Anti-BTLA Monoclonal Antibody HFB200603 [NCIt concept]
- Anti-BTN3A Agonistic Monoclonal Antibody ICT01 [NCIt concept]
- Anti-CA19-9 Antibody hu5B1/TCO Immunoconjugate [NCIt concept]
- Anti-CA19-9 Monoclonal Antibody BNT321 [NCIt concept]
- Anti-CALRmut/Anti-CD3 Bispecific Antibody JNJ-88549968 [NCIt concept]
- Anti-CCR7 Antibody-drug Conjugate JBH492 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody AMG 355 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody BGB-A3055 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody RO7502175 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody S-531011 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody ZL-1218 [NCIt concept]
- Anti-CD117/Amanitin Antibody-drug Conjugate MGTA-117 [NCIt concept]
- Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1 [NCIt concept]
- Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A [NCIt concept]
- Anti-CD123/CD3 BiTE Antibody SAR440234 [NCIt concept]
- Anti-CD123/CD3 Bispecific Antibody JNJ-63709178 [NCIt concept]
- Anti-CD123/Kinesin Spindle Protein Inhibitor Antibody-drug Conjugate VIP943 [NCIt concept]
- Anti-CD123/TOP1i Antibody-drug Conjugate AZD9829 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody ADG106 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody AGEN2373 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody CTX-471 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody EU101 [NCIt concept]
- Anti-CD137 Monoclonal Antibody [NCIt concept]
- Anti-CD137/Anti-FAP Bispecific Antibody BI 765179 [NCIt concept]
- Anti-CD138 Antibody-IFNalpha Fusion Protein QXL138AM [NCIt concept]
- Anti-CD19 Antibody-drug Conjugate IKS03 [NCIt concept]
- Anti-CD19 Antibody-drug Conjugate SGN-CD19B [NCIt concept]
- Anti-CD19 CAR T Cells Preparation [NCIt concept]
- Anti-CD19 CAR-IL-18-expressing Autologous T-lymphocytes [NCIt concept]
- Anti-CD19 Monoclonal Antibody MDX-1342 [NCIt concept]
- Anti-CD19-CAR CMV-specific T-lymphocytes [NCIt concept]
- Anti-CD19-CAR FMC63-28Z Retroviral Vector-transduced Allogeneic T-lymphocytes [NCIt concept]
- Anti-CD19-CAR Retroviral Vector-Transduced Autologous T Cells [NCIt concept]
- Anti-CD19-CAR-CD28/CD20-CAR-4-1BB-expressing Autologous T-lymphocytes Hu1928-Hu20BB [NCIt concept]
- Anti-CD19-Glucosteroid Receptor Modulator ADC ABBV-31 [NCIt concept]
- Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL [NCIt concept]
- Anti-CD19/Anti-CD3/Anti-CD2 Trispecific Antibody PIT565 [NCIt concept]
- Anti-CD19/CD20 Bicistronic CAR T-cells [NCIt concept]
- Anti-CD19/CD20/CD22 CAR T-Cells [NCIt concept]
- Anti-CD19/CD28 Bispecific Antibody RO7443904 [NCIt concept]
- Anti-CD19/CD3 BiTE Antibody AMG 562 [NCIt concept]
- Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978 [NCIt concept]
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein [NCIt concept]
- Anti-CD20 Monoclonal Antibody PRO131921 [NCIt concept]
- Anti-CD20-engineered Toxin Body MT-3724 [NCIt concept]
- Anti-CD20/Anti-CD3 Bispecific Antibody [NCIt concept]
- Anti-CD20/Anti-CD3/Anti-CD8 Trispecific Antibody AZD5492 [NCIt concept]
- Anti-CD20/CD37 Monoclonal Antibody Combination PSB202 [NCIt concept]
- Anti-CD205 Antibody-drug Conjugate OBT076 [NCIt concept]
- Anti-CD22 ADC TRPH-222 [NCIt concept]
- Anti-CD22 CAR T Cells Preparation [NCIt concept]
- Anti-CD22 CAR-expressing T Lymphocytes [NCIt concept]
- Anti-CD22 scFv TCRz:41BB-CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-CD22-CAR m971-BBz Lentiviral Vector-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-CD22/Anti-CD28 Bispecific Antibody REGN5837 [NCIt concept]
- Anti-CD226 Agonist Antibody LY3435151 [NCIt concept]
- Anti-CD228/4-1BB Bispecific Agent SGN-BB228 [NCIt concept]
- Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A [NCIt concept]
- Anti-CD24 Monoclonal Antibody ATG-031 [NCIt concept]
- Anti-CD27 Monoclonal Antibody [NCIt concept]
- Anti-CD27 Monoclonal Antibody GEN1053/BNT313 [NCIt concept]
- Anti-CD27L Antibody-Drug Conjugate AMG 172 [NCIt concept]
- Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1) [NCIt concept]
- Anti-CD3 Monoclonal Antibody [NCIt concept]
- Anti-CD3 OKT3/Anti-EGFR Bispecific Antibody Armed Activated T Lymphocytes [NCIt concept]
- Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells [NCIt concept]
- Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044 [NCIt concept]
- Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119 [NCIt concept]
- Anti-CD3/CD19/CD20 Trispecific Antibody 1A46 [NCIt concept]
- Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424 [NCIt concept]
- Anti-CD3/CD38 Bispecific Monoclonal Antibody IGM-2644 [NCIt concept]
- Anti-CD3/CD7-Ricin Toxin A Immunotoxin [NCIt concept]
- Anti-CD30 Antibody-drug Conjugate SGN-35C [NCIt concept]
- Anti-CD30 Antibody-drug Conjugate SGN-35T [NCIt concept]
- Anti-CD30 Monoclonal Antibody MDX-1401 [NCIt concept]
- Anti-CD30 Monoclonal Antibody XmAb2513 [NCIt concept]
- Anti-CD30/CD3 Bispecific Antibody GEN3017 [NCIt concept]
- Anti-CD32B Monoclonal Antibody BI-1206 [NCIt concept]
- Anti-CD33 Antibody-drug Conjugate IMGN779 [NCIt concept]
- Anti-CD33 CAR T Cells Preparation [NCIt concept]
- Anti-CD33 CAR T-cells [NCIt concept]
- Anti-CD33 GSPT1 Degrader BMS-986497 [NCIt concept]
- Anti-CD33 Monoclonal Antibody [NCIt concept]
- Anti-CD33 Monoclonal Antibody BI 836858 [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 [NCIt concept]
- Anti-CD352 Antibody-drug Conjugate SGN-CD352A [NCIt concept]
- Anti-CD37 MMAE Antibody-drug Conjugate AGS67E [NCIt concept]
- Anti-CD37 Monoclonal Antibody BI 836826 [NCIt concept]
- Anti-CD37-CAR-expressing T-lymphocytes [NCIt concept]
- Anti-CD38 Antibody-drug Conjugate STI-6129 [NCIt concept]
- Anti-CD38 Monoclonal Antibody [NCIt concept]
- Anti-CD38 Monoclonal Antibody SAR442085 [NCIt concept]
- Anti-CD38-CAR-TCRz/4-1BB-expressing T-lymphocytes [NCIt concept]
- Anti-CD38/Anti-CD47 Bispecific Antibody ISB 1442 [NCIt concept]
- Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257 [NCIt concept]
- Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342 [NCIt concept]
- Anti-CD38/CD3 Bispecific Monoclonal Antibody XmAb18968 [NCIt concept]
- Anti-CD39 Monoclonal Antibody AB598 [NCIt concept]
- Anti-CD39 Monoclonal Antibody IPH5201 [NCIt concept]
- Anti-CD39 Monoclonal Antibody PUR001 [NCIt concept]
- Anti-CD4 CAR T-cells [NCIt concept]
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140 [NCIt concept]
- Anti-CD40/Anti-mesothelin Bispecific Antibody ABBV-428 [NCIt concept]
- Anti-CD44 Monoclonal Antibody RO5429083 [NCIt concept]
- Anti-CD45 Monoclonal Antibody [NCIt concept]
- Anti-CD45 Monoclonal Antibody AHN-12 [NCIt concept]
- Anti-CD46 Antibody-drug Conjugate FOR46 [NCIt concept]
- Anti-CD46 Monoclonal Antibody YS5 [NCIt concept]
- Anti-CD47 ADC SGN-CD47M [NCIt concept]
- Anti-CD47 Monoclonal Antibody AO-176 [NCIt concept]
- Anti-CD47 Monoclonal Antibody CC-90002 [NCIt concept]
- Anti-CD47 Monoclonal Antibody IMC-002 [NCIt concept]
- Anti-CD47 Monoclonal Antibody ZL-1201 [NCIt concept]
- Anti-CD47/Anti-HER2 Bispecific Antibody D3L-001 [NCIt concept]
- Anti-CD47/Anti-PD-L1 Bispecific Antibody PF-07257876 [NCIt concept]
- Anti-CD47/CD20 Bispecific Antibody CC-96673 [NCIt concept]
- Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A [NCIt concept]
- Anti-CD52 Monoclonal Antibody ALLO-647 [NCIt concept]
- Anti-CD7 CAR T Cells Preparation [NCIt concept]
- Anti-CD70 Antibody-Drug Conjugate MDX-1203 [NCIt concept]
- Anti-CD70 CAR-expressing T Lymphocytes [NCIt concept]
- Anti-CD70 Monoclonal Antibody MDX-1411 [NCIt concept]
- Anti-CD70 Monoclonal Antibody SEA-CD70 [NCIt concept]
- Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 [NCIt concept]
- Anti-CD73 Monoclonal Antibody BMS-986179 [NCIt concept]
- Anti-CD73 Monoclonal Antibody HB0045 [NCIt concept]
- Anti-CD73 Monoclonal Antibody NZV930 [NCIt concept]
- Anti-CD73 Monoclonal Antibody PT199 [NCIt concept]
- Anti-CD73 Monoclonal Antibody Sym024 [NCIt concept]
- Anti-CD74 Antibody-drug Conjugate STRO-001 [NCIt concept]
- Anti-CD79b CAR T Cells [NCIt concept]
- Anti-CD93 Monoclonal Antibody DCBY02 [NCIt concept]
- Anti-CD93 Monoclonal Antibody DCSZ11 [NCIt concept]
- Anti-CDH17 Monoclonal Antibody [NCIt concept]
- Anti-CDH3/MMAE Antibody-drug Conjugate BC3195 [NCIt concept]
- Anti-CDH3/MSLN BiTE Antibody AMG 305 [NCIt concept]
- Anti-CDH6 Antibody-drug Conjugate HKT288 [NCIt concept]
- Anti-CDH6/Exatecan ADC CUSP06 [NCIt concept]
- Anti-CEA BiTE Monoclonal Antibody AMG211 [NCIt concept]
- Anti-CEA-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody BGB-B167 [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody LM-24C5 [NCIt concept]
- Anti-CEA/Anti-CEACAM6 Antibody-drug Conjugate EBC-129 [NCIt concept]
- Anti-CEACAM1 Monoclonal Antibody CM-24 [NCIt concept]
- Anti-CEACAM5 ADC SGN-CEACAM5C [NCIt concept]
- Anti-CEACAM5 Antibody-drug Conjugate M9140 [NCIt concept]
- Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47 [NCIt concept]
- Anti-CFH Monoclonal Antibody GT103 [NCIt concept]
- Anti-CLDN18.2 Monoclonal Antibody ZL-1211 [NCIt concept]
- Anti-CLDN18.2/Anti-CD3 Bispecific Antibody ASP2138 [NCIt concept]
- Anti-CLDN4/Anti-CD137 Bispecific Antibody ASP1002 [NCIt concept]
- Anti-CLDN6 Antibody-drug Conjugate DS-9606a [NCIt concept]
- Anti-CLDN6 Antibody-drug Conjugate TORL-1-23 [NCIt concept]
- Anti-CLDN6 Monoclonal Antibody ASP1650 [NCIt concept]
- Anti-CLDN6/9 Antibody-drug Conjugate SC-004 [NCIt concept]
- Anti-CLDN6/CD3 Bispecific Antibody XmAb541 [NCIt concept]
- Anti-CLL1-PBD ADC DCLL9718S [NCIt concept]
- Anti-CSF1 Monoclonal Antibody PD-0360324 [NCIt concept]
- Anti-CSF1R Monoclonal Antibody AMB-05X [NCIt concept]
- Anti-CSF1R Monoclonal Antibody IMC-CS4 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody REGN4659 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody XTX101 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody YH001 [NCIt concept]
- Anti-CTLA-4 Probody BMS-986288 [NCIt concept]
- Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine [NCIt concept]
- Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine [NCIt concept]
- Anti-CTLA4 Monoclonal Antibody BMS-986218 [NCIt concept]
- Anti-CXCR4 Monoclonal Antibody PF-06747143 [NCIt concept]
- Anti-Caprin-1 Monoclonal Antibody TRK-950 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate EO-3021 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SHR-A1904 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SKB315 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SOT102 [NCIt concept]
- Anti-Claudin-18.2 Monoclonal Antibody SPX-101 [NCIt concept]
- Anti-Claudin18.2 ADC AZD0901 [NCIt concept]
- Anti-Claudin18.2 Monoclonal Antibody TORL-2-307-MAB [NCIt concept]
- Anti-Claudin18.2/Anti-CD3 Bispecific Antibody AZD5863 [NCIt concept]
- Anti-Claudin18.2/Anti-CD47 Bispecific Antibody PT886 [NCIt concept]
- Anti-DDR1 Monoclonal Antibody PRTH-101 [NCIt concept]
- Anti-DKK1 Monoclonal Antibody [NCIt concept]
- Anti-DKK1 Monoclonal Antibody BHQ880 [NCIt concept]
- Anti-DLK-1 Antibody-drug Conjugate ADCT-701 [NCIt concept]
- Anti-DLK-1/MMAE Antibody-drug Conjugate TORL-4-500 [NCIt concept]
- Anti-DLL3 ADC ZL-1310 [NCIt concept]
- Anti-DLL3 Antibody-drug Conjugate SC-002 [NCIt concept]
- Anti-DLL4 Monoclonal Antibody MEDI0639 [NCIt concept]
- Anti-DLL4/Anti-VEGF-A Bispecific Antibody CTX-009 [NCIt concept]
- Anti-DR5 Agonistic Antibody DS-8273a [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate ABBV-637 [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate CPO301 [NCIt concept]
- Anti-EGFR Gamma Delta T-cell Engaging Bispecific Antibody SGN-EGFRd2 [NCIt concept]
- Anti-EGFR Monoclonal Antibody Mixture MM-151 [NCIt concept]
- Anti-EGFR Monoclonal Antibody SYN004 [NCIt concept]
- Anti-EGFR Monoclonal Antibody ZZ06 [NCIt concept]
- Anti-EGFR/Anti-c-Met Monoclonal Antibody FPI-2053 [NCIt concept]
- Anti-EGFR/CD16A Bispecific Antibody AFM24 [NCIt concept]
- Anti-EGFR/DM1 Antibody-drug Conjugate AVID100 [NCIt concept]
- Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013 [NCIt concept]
- Anti-EGFR/anti-CD3 Tumor Protease-activated T-cell Engager JANX008 [NCIt concept]
- Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1 [NCIt concept]
- Anti-EGFRvIII Antibody Drug Conjugate AMG 595 [NCIt concept]
- Anti-EGFRvIII CAR-transduced Allogeneic T-lymphocytes [NCIt concept]
- Anti-EGFRvIII Immunotoxin MR1-1 [NCIt concept]
- Anti-EGFRvIII-CAR-CD3/EGFR BiTE-transduced Autologous T-lymphocytes CARv3-TEAM-E [NCIt concept]
- Anti-EGFRvIII/CD3 Bispecific Antibody RO7428731 [NCIt concept]
- Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F [NCIt concept]
- Anti-ENPP3/Anti-CD3 Bispecific Antibody XmAb819 [NCIt concept]
- Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F [NCIt concept]
- Anti-ENTPD2 Monoclonal Antibody KAZ954 [NCIt concept]
- Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A [NCIt concept]
- Anti-EpCAM/Anti-4-1BB Bispecific Antibody BNT314 [NCIt concept]
- Anti-EpCAM/Anti-CD3 Bispecific Antibody BA3182 [NCIt concept]
- Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310 [NCIt concept]
- Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547 [NCIt concept]
- Anti-EphA5/MMAE Antibody-drug Conjugate MBRC-101 [NCIt concept]
- Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody AV-203 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody CDX-3379 [NCIt concept]
- Anti-FAP Antibody-drug Conjugate OMTX705 [NCIt concept]
- Anti-FGFR2b/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BG-C137 [NCIt concept]
- Anti-FGFR3 Antibody-drug Conjugate LY3076226 [NCIt concept]
- Anti-FL(FITC-E2) CAR T Cells [NCIt concept]
- Anti-FLT3 Antibody-drug Conjugate AGS62P1 [NCIt concept]
- Anti-FLT3 Monoclonal Antibody IMC-EB10 [NCIt concept]
- Anti-FLT3/CD3 Bispecific Antibody CLN-049 [NCIt concept]
- Anti-FOLR1 Antibody-drug Conjugate [NCIt concept]
- Anti-FOLR1 CAR T-cells [NCIt concept]
- Anti-FOLR1 CoStAR-expressing Autologous Tumor-infiltrating Lymphocytes ITIL-306 [NCIt concept]
- Anti-FOXP3 Antisense Oligonucleotide AZD8701 [NCIt concept]
- Anti-FRa Antibody-drug Conjugate AZD5335 [NCIt concept]
- Anti-FRalpha/Exatecan ADC LY4170156 [NCIt concept]
- Anti-FRalpha/Exatecan ADC PRO1184 [NCIt concept]
- Anti-FcRH5 Antibody-drug Conjugate DFRF4539A [NCIt concept]
- Anti-GARP Monoclonal Antibody DS-1055a [NCIt concept]
- Anti-GCC Antibody-Drug Conjugate TAK-164 [NCIt concept]
- Anti-GD2 Monoclonal Antibody hu14.18K322A [NCIt concept]
- Anti-GD2 scFv/Anti-DOTA scFv Fusion Protein GD2-SADA [NCIt concept]
- Anti-GD3 Antibody-drug Conjugate PF-06688992 [NCIt concept]
- Anti-GDF-15 Monoclonal Antibody AZD8853 [NCIt concept]
- Anti-GFRAL Monoclonal Antibody NGM120 [NCIt concept]
- Anti-GITR Agonistic Monoclonal Antibody ASP1951 [NCIt concept]
- Anti-GITR Agonistic Monoclonal Antibody BMS-986156 [NCIt concept]
- Anti-GITR Monoclonal Antibody GWN 323 [NCIt concept]
- Anti-GPC3-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-GPC3/Anti-4-1BB Bispecific Antibody BGB-B2033 [NCIt concept]
- Anti-GPC3/TCR Nanobody SAR444200 [NCIt concept]
- Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a [NCIt concept]
- Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962 [NCIt concept]
- Anti-Globo H Monoclonal Antibody OBI-888 [NCIt concept]
- Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999 [NCIt concept]
- Anti-Glypican 3-scFvGC33-CAR-expressing T Lymphocytes [NCIt concept]
- Anti-Glypican 3/CD3 Bispecific Antibody ERY974 [NCIt concept]
- Anti-HA Epitope Monoclonal Antibody MEDI8852 [NCIt concept]
- Anti-HB-EGF Monoclonal Antibody KHK2866 [NCIt concept]
- Anti-HBEGF Monoclonal Antibody U3-1565 [NCIt concept]
- Anti-HER2 ADC BB-1701 [NCIt concept]
- Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate BL-M07D1 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate DB-1303 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate MEDI4276 [NCIt concept]
- Anti-HER2 Bispecific Antibody-drug Conjugate ZW49 [NCIt concept]
- Anti-HER2 Dendritic Cell Vaccine [NCIt concept]
- Anti-HER2 GSPT1 Degrader ORM-5029 [NCIt concept]
- Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 [NCIt concept]
- Anti-HER2 Monoclonal Antibody [NCIt concept]
- Anti-HER2 Monoclonal Antibody BAY2701438 [NCIt concept]
- Anti-HER2-CAR Autologous CMV-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 [NCIt concept]
- Anti-HER2-vc0101 ADC PF-06804103 [NCIt concept]
- Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302 [NCIt concept]
- Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522 [NCIt concept]
- Anti-HER2/CD3/CD28 Tri-specific Antibody SAR443216 [NCIt concept]
- Anti-HER2/HER3 Dendritic Cell Vaccine [NCIt concept]
- Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A [NCIt concept]
- Anti-HER3 Antibody-drug Conjugate YL202 [NCIt concept]
- Anti-HER3 Dendritic Cell Vaccine [NCIt concept]
- Anti-HER3 Monoclonal Antibody GSK2849330 [NCIt concept]
- Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate [NCIt concept]
- Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate DB-1310 [NCIt concept]
- Anti-HHLA2 Monoclonal Antibody NPX887 [NCIt concept]
- Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968 [NCIt concept]
- Anti-HJV Monoclonal Antibody DISC-0974 [NCIt concept]
- Anti-HLA-A2-MAGE-A4/Anti-CD3 Bispecific Antibody RO7444973 [NCIt concept]
- Anti-HLA-A2-WT1/Anti-CD3 T-cell Engaging Bispecific Antibody RO7283420 [NCIt concept]
- Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-HLA-DR Monoclonal Antibody IMMU-114 [NCIt concept]
- Anti-HLA-G Antibody TTX-080 [NCIt concept]
- Anti-HLA-G Monoclonal Antibody [NCIt concept]
- Anti-HLA-G/CD3 Bispecific Antibody RO7515629 [NCIt concept]
- Anti-ICOS Agonist Monoclonal Antibody BMS-986226 [NCIt concept]
- Anti-ICOS Monoclonal Antibody MEDI-570 [NCIt concept]
- Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022 [NCIt concept]
- Anti-IL-4/IL-13 Combination Agent QBX258 [NCIt concept]
- Anti-IL17A Monoclonal Antibody CJM112 [NCIt concept]
- Anti-ILT2 Monoclonal Antibody [NCIt concept]
- Anti-ILT2 Monoclonal Antibody AGEN1571 [NCIt concept]
- Anti-ILT2 Monoclonal Antibody SAR444881 [NCIt concept]
- Anti-ILT2/Anti-ILT4 Bispecific Antibody PF-07826390 [NCIt concept]
- Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707 [NCIt concept]
- Anti-ILT4 Monoclonal Antibody [NCIt concept]
- Anti-ILT4 Monoclonal Antibody MK-4830 [NCIt concept]
- Anti-ILT4/Anti-PD-L1 Bispecific Antibody SPX-303 [NCIt concept]
- Anti-Inhibitor Coagulant Complex [NCIt concept]
- Anti-K-RAS G12D mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-K-RAS G12V mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-KIR Monoclonal Antibody IPH 2101 [NCIt concept]
- Anti-KIR3DL3 Monoclonal Antibody NPX267 [NCIt concept]
- Anti-KLRG1 Monoclonal Antibody ABC008 [NCIt concept]
- Anti-KSP/Anti-VEGF siRNAs ALN-VSP02 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody LBL-007 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody Sym022 [NCIt concept]
- Anti-LAG-3/PD-1 Bispecific Antibody INCA32459 [NCIt concept]
- Anti-LAG-3/PD-L1 Bispecific Antibody FS118 [NCIt concept]
- Anti-LAIR1 Monoclonal Antibody NC525 [NCIt concept]
- Anti-LAIR1 Monoclonal Antibody NGM438 [NCIt concept]
- Anti-LILRB Monoclonal Antibody ADA-011 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody BMS-986406 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody IO-108 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody BND-35 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody IO-202 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody MK-0482 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody NGM831 [NCIt concept]
- Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102 [NCIt concept]
- Anti-Ly6E Antibody-Drug Conjugate RG 7841 [NCIt concept]
- Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C [NCIt concept]
- Anti-MART-1 TCR Retroviral Vector-Transduced Autologous TIL [NCIt concept]
- Anti-MICA/MICB Monoclonal Antibody CLN-619 [NCIt concept]
- Anti-MSLN/Anti-CD3 Bispecific Antibody ZW171 [NCIt concept]
- Anti-MUC1/EGFR Bispecific Antibody Drug Conjugate M1231 [NCIt concept]
- Anti-MUC16 CAR T-cells 27T51 [NCIt concept]
- Anti-MUC16/CD28 Bispecific Antibody REGN5668 [NCIt concept]
- Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A [NCIt concept]
- Anti-Met Monoclonal Antibody Mixture Sym015 [NCIt concept]
- Anti-NKG2A Monoclonal Antibody Sym025 [NCIt concept]
- Anti-NRP1 Antibody ASP1948 [NCIt concept]
- Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A [NCIt concept]
- Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso [NCIt concept]
- Anti-NaPi2b Antibody-drug Conjugate XMT-1592 [NCIt concept]
- Anti-Notch1 Monoclonal Antibody [NCIt concept]
- Anti-Nucleolin Aptamer AS1411 [NCIt concept]
- Anti-OFA Immunotherapeutic BB-MPI-03 [NCIt concept]
- Anti-OX40 Agonist Monoclonal Antibody HFB301001 [NCIt concept]
- Anti-OX40 Antibody BMS 986178 [NCIt concept]
- Anti-OX40 Hexavalent Agonist Antibody INBRX-106 [NCIt concept]
- Anti-OX40 Monoclonal Antibody GSK3174998 [NCIt concept]
- Anti-OX40/CD137 Bispecific Antibody FS120 [NCIt concept]
- Anti-PD-1 Fusion Protein AMP-224 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody MEDI0680 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody Sym021 [NCIt concept]
- Anti-PD-1/Anti-CD3 Bispecific Antibody ONO-4685 [NCIt concept]
- Anti-PD-1/Anti-ILT4 Bispecific Antibody CDX-585 [NCIt concept]
- Anti-PD-1/Anti-PD-L1 Bispecific Antibody CTX-8371 [NCIt concept]
- Anti-PD-1/Anti-TGFbRII Bispecific Antibody INCA33890 [NCIt concept]
- Anti-PD-1/Anti-TIM-3 Bispecific Antibody AZD7789 [NCIt concept]
- Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363 [NCIt concept]
- Anti-PD-1/IL-2 Fusion Protein TEV-56278 [NCIt concept]
- Anti-PD-1/IL-2Ra/IL-2 Fusion Protein REGN10597 [NCIt concept]
- Anti-PD-L1 Antibody-drug Conjugate SGN-PDL1V [NCIt concept]
- Anti-PD-L1 Antibody/IL-15 Fusion Protein IGM-7354 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody FAZ053 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody MDX-1105 [NCIt concept]
- Anti-PD-L1/Anti-4-1BB Bispecific Antibody ABL503 [NCIt concept]
- Anti-PD-L1/Anti-CD47 Bispecific Monoclonal Antibody LB101 [NCIt concept]
- Anti-PD-L1/Anti-VEGF-A Bispecific Antibody BNT327 [NCIt concept]
- Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 [NCIt concept]
- Anti-PD-L1/CD27 Bispecific Antibody CDX-527 [NCIt concept]
- Anti-PD-L1/IL-15 Fusion Protein KD033 [NCIt concept]
- Anti-PD-L1/PD-L2 Bispecific Antibody IMGS-001 [NCIt concept]
- Anti-PD-L1/TGFbetaRII Fusion Protein BJ-005 [NCIt concept]
- Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244 [NCIt concept]
- Anti-PD-L2 Monoclonal Antibody [NCIt concept]
- Anti-PD1/IL-15 Fusion Protein SAR445877 [NCIt concept]
- Anti-PLVAP CSR02-Fab-Tissue Factor [NCIt concept]
- Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4 [NCIt concept]
- Anti-PRAME Immunotherapeutic GSK2302032A [NCIt concept]
- Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C [NCIt concept]
- Anti-PSCA Monoclonal Antibody AGS-1C4D4 [NCIt concept]
- Anti-PSMA Antibody-drug Conjugate ABBV-969 [NCIt concept]
- Anti-PSMA Gamma Delta T-cell Engaging Bispecific Antibody LAVA-1207 [NCIt concept]
- Anti-PSMA Monoclonal Antibody-MMAE Conjugate [NCIt concept]
- Anti-PSMA/Anti-CD28 Bispecific Antibody JNJ-87189401 [NCIt concept]
- Anti-PSMA/CD3 Bispecific Antibody CCW702 [NCIt concept]
- Anti-PSMA/CD3 Bispecific Antibody REGN4336 [NCIt concept]
- Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414 [NCIt concept]
- Anti-PSMA/CD3 Protease-activated T-cell Engager JANX007 [NCIt concept]
- Anti-PSMA/PBD ADC MEDI3726 [NCIt concept]
- Anti-PTK7/MMAE ADC PRO1107 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody COM701 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody GSK4381562 [NCIt concept]
- Anti-Progranulin Monoclonal Antibody AG01 [NCIt concept]
- Anti-RNF43 Antibody-drug Conjugate SC-006 [NCIt concept]
- Anti-ROR1/Anti-CD3/Anti-HSA Trispecific Antibody NM32-2668 [NCIt concept]
- Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002 [NCIt concept]
- Anti-S15 Monoclonal Antibody NC318 [NCIt concept]
- Anti-SARS-CoV-2 Monoclonal Antibodies AZD5156 [NCIt concept]
- Anti-SEZ6 Antibody-drug Conjugate ABBV-011 [NCIt concept]
- Anti-SIRP Monoclonal Antibody ELA026 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody ADU-1805 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody BI 765063 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody BI 770371 [NCIt concept]
- Anti-STEAP1 CAR T-cells [NCIt concept]
- Anti-STn Antibody-drug Conjugate SGN-STNV [NCIt concept]
- Anti-TA-MUC1/DXd Antibody-drug Conjugate DS-3939a [NCIt concept]
- Anti-TAA Monoclonal Antibody-chelator Conjugate BAY3547922 [NCIt concept]
- Anti-TAAs/Anti-CD3/Anti-CD28 Tetra-specific Antibody MDX2001 [NCIt concept]
- Anti-TCR Vb6/Vb10/IL-2 Antibody Fusion Protein STAR0602 [NCIt concept]
- Anti-TF Monoclonal Antibody ALT-836 [NCIt concept]
- Anti-TGF-beta 1/Anti-COX-2 siRNAs STP707 [NCIt concept]
- Anti-TGF-beta Monoclonal Antibody SAR-439459 [NCIt concept]
- Anti-TGF-beta RII Monoclonal Antibody IMC-TR1 [NCIt concept]
- Anti-TIGIT Bispecific Antibody BMS-986442 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody ASP8374 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody COM902 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody SGN-TGT [NCIt concept]
- Anti-TIGIT Monoclonal Antibody TAB006 [NCIt concept]
- Anti-TIM-3 Antibody BMS-986258 [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody Sym023 [NCIt concept]
- Anti-TIM3 Monoclonal Antibody LY3321367 [NCIt concept]
- Anti-TMEFF2/Anti-CD3 Bispecific Antibody JNJ-70218902 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody BI-1910 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody SIM1811-03 [NCIt concept]
- Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711 [NCIt concept]
- Anti-TREM1 Agonistic Monoclonal Antibody PY159 [NCIt concept]
- Anti-TREM2 Monoclonal Antibody PY314 [NCIt concept]
- Anti-TROP-2 Antibody-drug Conjugate DB-1305 [NCIt concept]
- Anti-TROP-2 Antibody-drug Conjugate PBI-410 [NCIt concept]
- Anti-TROP-2 Antibody-drug Conjugate PF-06664178 [NCIt concept]
- Anti-TROP-2/MMAE Antibody-drug Conjugate LCB84 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate BIO-106 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate OBI-992 [NCIt concept]
- Anti-TROP2-CAR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Anti-TSPAN8/Anti-CD3 Bispecific Antibody ASP2074 [NCIt concept]
- Anti-TYRP1/CD3 T-cell Engager RO7293583 [NCIt concept]
- Anti-Thymocyte Globulin [NCIt concept]
- Anti-Tissue Factor Monoclonal Antibody MORAb-066 [NCIt concept]
- Anti-VEGF/ANG2 Nanobody BI 836880 [NCIt concept]
- Anti-VEGFC Monoclonal Antibody VGX-100 [NCIt concept]
- Anti-VEGFR2-CAR Retroviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- Anti-VEGFR3 Monoclonal Antibody IMC-3C5 [NCIt concept]
- Anti-VISTA Monoclonal Antibody HMBD-002 [NCIt concept]
- Anti-VISTA Monoclonal Antibody KVA12123 [NCIt concept]
- Anti-alpha5beta1 Integrin Antibody MINT1526A [NCIt concept]
- Anti-angiopoietin Monoclonal Antibody AMG 780 [NCIt concept]
- Anti-c-KIT Monoclonal Antibody CDX 0158 [NCIt concept]
- Anti-c-Met ADC ABBV-400 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate HTI-1066 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate TR1801 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate YL211 [NCIt concept]
- Anti-c-Met/EGFR/VEGF Trispecific Antibody TAVO412 [NCIt concept]
- Anti-c-Met/MMAE ADC MYTX-011 [NCIt concept]
- Anti-dectin-2 Agonist Monoclonal Antibody BDC-3042 [NCIt concept]
- Anti-galectin-9 Monoclonal Antibody LYT-200 [NCIt concept]
- Anti-gpA33/CD3 Monoclonal Antibody MGD007 [NCIt concept]
- Anti-gremlin-1 Monoclonal Antibody TST003 [NCIt concept]
- Anti-hCD70-CAR Retroviral Vector-transduced Autologous PBLs [NCIt concept]
- Anti-hepcidin Monoclonal Antibody LY2787106 [NCIt concept]
- Anti-human Cytomegalovirus Monoclonal Antibody Combination CSJ-148 [NCIt concept]
- Anti-human GITR Monoclonal Antibody AMG 228 [NCIt concept]
- Anti-human GITR Monoclonal Antibody TRX518 [NCIt concept]
- Anti-integrin Beta-1 Monoclonal Antibody OS2966 [NCIt concept]
- Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A [NCIt concept]
- Anti-interleukin-1 Beta Monoclonal Antibody [NCIt concept]
- Anti-interleukin-2 Receptor Subunit Gamma Monoclonal Antibody REGN7257 [NCIt concept]
- Anti-latent TGFb1 Monoclonal Antibody RO7496353 [NCIt concept]
- Anti-mesothelin Antibody-drug Conjugate BMS-986148 [NCIt concept]
- Anti-mesothelin Antibody-drug Conjugate SGN-MesoC2 [NCIt concept]
- Anti-mesothelin CAR Vector-transduced T-lymphocytes [NCIt concept]
- Anti-mesothelin CIR mRNA-electroporated Autologous T Cells [NCIt concept]
- Anti-mesothelin iCasp9M28z CAR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100 [NCIt concept]
- Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A [NCIt concept]
- Anti-mutant Calreticulin Monoclonal Antibody INCA033989 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate ADRX-0706 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate LY4052031 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate LY4101174 [NCIt concept]
- Anti-nectin-4/MMAE Antibody-drug Conjugate CRB-701 [NCIt concept]
- Anti-prolactin Receptor Antibody LFA102 [NCIt concept]
- Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes [NCIt concept]
- Anti-von Willebrand Factor Nanobody [NCIt concept]
- Antibiotic [NCIt concept]
- Antibody ROSE12 [NCIt concept]
- Antibody STING Drug Conjugate TAK-500 [NCIt concept]
- Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014 [NCIt concept]
- Antibody-drug Conjugate PF-06647263 [NCIt concept]
- Antibody-drug Conjugate PHN-010 [NCIt concept]
- Antibody-drug Conjugate SC-007 [NCIt concept]
- Antibody-drug Conjugate TORL-2-307-ADC [NCIt concept]
- Anticoagulant Agent [NCIt concept]
- Anticonvulsant Agent [NCIt concept]
- Antiestrogen [NCIt concept]
- Antifungal Agent VL-2397 [NCIt concept]
- Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV [NCIt concept]
- Antigen-presenting Cells-expressing HPV16 E6/E7/CD86/mbIL-2/mbIL-12 SQZ-eAPC-HPV [NCIt concept]
- Antihemophilic Factor, Human Recombinant [NCIt concept]
- Antileukemic Agent [NCIt concept]
- Antimetabolite FF-10502 [NCIt concept]
- Antineoplastic Biological Agent [NCIt concept]
- Antineoplastic Immunomodulating Agent [NCIt concept]
- Antineoplastic Radiopharmaceutical Agent [NCIt concept]
- Antisense Oligonucleotide GTI-2040 [NCIt concept]
- Antisense Oligonucleotide QR-313 [NCIt concept]
- Antiviral Agent TGN-S11 [NCIt concept]
- Antroquinonol Capsule [NCIt concept]
- Anvatabart Opadotin [NCIt concept]
- Anzurstobart [NCIt concept]
- Apadamtase Alfa [NCIt concept]
- Apalutamide [NCIt concept]
- Apatorsen [NCIt concept]
- Apaziquone [NCIt concept]
- Apilimod Dimesylate Capsule [NCIt concept]
- Apitolisib [NCIt concept]
- Apixaban [NCIt concept]
- Aplitabart [NCIt concept]
- Apolizumab [NCIt concept]
- Apomab [NCIt concept]
- Apoptosis Inducer BZL101 [NCIt concept]
- Apoptosis Inducer GCS-100 [NCIt concept]
- Apple Juice [NCIt concept]
- Apraglutide [NCIt concept]
- Apremilast [NCIt concept]
- Aprepitant [NCIt concept]
- Apricoxib [NCIt concept]
- Aprotinin [NCIt concept]
- Aprutumab Ixadotin [NCIt concept]
- Arfolitixorin [NCIt concept]
- Argatroban [NCIt concept]
- Arginine Butyrate [NCIt concept]
- Arlocabtagene Autoleucel [NCIt concept]
- Armodafinil [NCIt concept]
- Arnebia Indigo Jade Pearl Topical Cream [NCIt concept]
- Aromatase Inhibitor [NCIt concept]
- Arsenic Trioxide [NCIt concept]
- Arsenic Trioxide Capsule Formulation ORH 2014 [NCIt concept]
- Artemisia annua Decaffeinated Coffee [NCIt concept]
- Artesunate [NCIt concept]
- Aryl Hydrocarbon Receptor Inhibitor IK-175 [NCIt concept]
- Ascorbic Acid [NCIt concept]
- Ascrinvacumab [NCIt concept]
- Aspacytarabine [NCIt concept]
- Asparaginase [NCIt concept]
- Asparaginase Erwinia chrysanthemi [NCIt concept]
- Aspirin [NCIt concept]
- Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10 [NCIt concept]
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 [NCIt concept]
- Astrovirus-derived Peptide RLS-0071 [NCIt concept]
- Astuprotimut-R [NCIt concept]
- Atamparib [NCIt concept]
- Atazanavir/Ritonavir [NCIt concept]
- Atenolol [NCIt concept]
- Atezolizumab [NCIt concept]
- Atezolizumab and Recombinant Human Hyaluronidase [NCIt concept]
- Atibuclimab [NCIt concept]
- Atigotatug [NCIt concept]
- Atiprimod [NCIt concept]
- Atirmociclib [NCIt concept]
- Atorvastatin Calcium [NCIt concept]
- Atrasentan Hydrochloride [NCIt concept]
- Attenuated Live Listeria monocytogenes Encoding KRAS G12D [NCIt concept]
- Atuveciclib [NCIt concept]
- Aumolertinib [NCIt concept]
- Auranofin [NCIt concept]
- Aurora A Kinase Inhibitor JAB-2485 [NCIt concept]
- Aurora A Kinase Inhibitor LY3295668 [NCIt concept]
- Aurora A Kinase Inhibitor LY3295668 Erbumine [NCIt concept]
- Aurora A Kinase Inhibitor MK5108 [NCIt concept]
- Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076 [NCIt concept]
- Aurora B Serine/Threonine Kinase Inhibitor TAK-901 [NCIt concept]
- Aurora B/VEGFR/FGFR Inhibitor AL8326 [NCIt concept]
- Aurora Kinase A Inhibitor [NCIt concept]
- Aurora Kinase Inhibitor AMG 900 [NCIt concept]
- Aurora Kinase Inhibitor SNS-314 [NCIt concept]
- Aurora Kinase/VEGFR2 Inhibitor CYC116 [NCIt concept]
- Autogene Cevumeran [NCIt concept]
- Autologous 19-28z/IL-18 CAR T-lymphocytes [NCIt concept]
- Autologous 4-1BB Selected Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 [NCIt concept]
- Autologous ALPG/ALPP-targeted Anti-MSLN CAR-Fas/PTPN2 shRNA-miR-expressing T-lymphocytes AB-1015 [NCIt concept]
- Autologous AML/Dendritic Cell Fusion Vaccine [NCIt concept]
- Autologous Active IL-7 Receptor Co-expressing GD2-specific CAR T-cells [NCIt concept]
- Autologous Ad-CD154-Transduced CLL B Cells [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 and CD19-specific Adapter Molecule SWI019 [NCIt concept]
- Autologous Anti-B7-H3 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-B7-H3/CD19 CAR T-cells SCRI-CARB7H3(s)x19 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells MCARH125 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells PHE885 [NCIt concept]
- Autologous Anti-BCMA CAR-transduced T-cells KITE-585 [NCIt concept]
- Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 [NCIt concept]
- Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-expressing T-cells NXC-201 [NCIt concept]
- Autologous Anti-BCMA-CAR-TCRz/4-1BB-expressing T-lymphocytes CART-BCMA [NCIt concept]
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 [NCIt concept]
- Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes [NCIt concept]
- Autologous Anti-BCMA/CS1 Bispecific CAR-T Cells [NCIt concept]
- Autologous Anti-CD123 CAR TCR/4-1BB-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-CD123 CAR-T Cells [NCIt concept]
- Autologous Anti-CD19 AbTCR-expressing T-lymphocytes EB103 [NCIt concept]
- Autologous Anti-CD19 CAR T Cells KITE-197 [NCIt concept]
- Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx [NCIt concept]
- Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 [NCIt concept]
- Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-CD19 CAR-CD8alpha-CD28-CD3zeta T Cells KYV 101 [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells CABA-201 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes UF-KURE19 [NCIt concept]
- Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor Fusion Construct T-cells TC-110 [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor T cells ET190L1 [NCIt concept]
- Autologous Anti-CD19/Anti-CD20-CAR-CD28-4-1BB-CD3zeta-EGFRt+-expressing Tn/mem Cells [NCIt concept]
- Autologous Anti-CD19/Anti-CD79b CAR-expressing Bispecific T-cells [NCIt concept]
- Autologous Anti-CD19/CD20 Bispecific CAR-T Cells IMPT-314 [NCIt concept]
- Autologous Anti-CD19/CD20 CAR-T Cells KITE-363 [NCIt concept]
- Autologous Anti-CD19/CD22 CAR T-cells AUTO3 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T-lymphocytes SCRI-huCAR19v2 [NCIt concept]
- Autologous Anti-CD19CAR-CD28tm/4-1BB/CD3zeta-HER2tG-expressing CD4+/CD8+ T-lymphocytes SCRI-huCAR19v1 [NCIt concept]
- Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-CD20 CAR T-cells C-CAR066 [NCIt concept]
- Autologous Anti-CD20CAR-CD28-4-1BB-CD3zeta T-lymphocytes MB-106 [NCIt concept]
- Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s [NCIt concept]
- Autologous Anti-CD22 CAR-expressing T-cells SCRI-CAR22v2 [NCIt concept]
- Autologous Anti-CD3/Anti-EGFR Bispecific Antibody Armed Peripheral Blood Mononuclear Cells [NCIt concept]
- Autologous Anti-CD3/Anti-SLAMF7 Bispecific Antibody-armed Activated T-lymphocytes [NCIt concept]
- Autologous Anti-CD33 CAR-mbIL15-Safety Switch T-cells PRGN-3006 [NCIt concept]
- Autologous Anti-CD38 A2 CAR2-expressing T-cells [NCIt concept]
- Autologous Anti-CD4 CAR T-cells LB1901 [NCIt concept]
- Autologous Anti-CD5 CAR Monocytes MT-101 [NCIt concept]
- Autologous Anti-CD7-CAR-CD28zeta T-cells [NCIt concept]
- Autologous Anti-CD79a/anti-CD20 CAR T-cells bbT369 [NCIt concept]
- Autologous Anti-CEA CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B530 [NCIt concept]
- Autologous Anti-CLDN18.2 TAC T-cells TAC01-CLDN18.2 [NCIt concept]
- Autologous Anti-CLL-1-CAR T-lymphocytes KITE-222 [NCIt concept]
- Autologous Anti-CSPG4 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-Claudin18.2 CAR T-cells LB1908 [NCIt concept]
- Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells [NCIt concept]
- Autologous Anti-EGFRvIII synNotch Receptor-induced Anti-EphA2/IL-13Ralpha2 CAR-T Cells [NCIt concept]
- Autologous Anti-FSHR CER-4-1BB/CD3zeta-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-GD2-CAR-BBz-iCasp9 Retroviral Vector-transduced T Lymphocytes [NCIt concept]
- Autologous Anti-GD2CAR-CD28-CD3zeta-IL-15-expressing Natural Killer T-cells [NCIt concept]
- Autologous Anti-GFRa4 CAR-TCR-zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-GPC2-CAR T-cells [NCIt concept]
- Autologous Anti-GPRC5D CAR-T Cells OriCAR-017 [NCIt concept]
- Autologous Anti-GPRC5D-CAR-4-1BB-expressing T-cells MCARH109 [NCIt concept]
- Autologous Anti-H3.3K27M TCR-expressing T-cells [NCIt concept]
- Autologous Anti-HER2 CAR Macrophages CT-0508 [NCIt concept]
- Autologous Anti-HER2 CAR Monocytes CT-0525 [NCIt concept]
- Autologous Anti-HER2 CAR-CD28 T Cells [NCIt concept]
- Autologous Anti-HER2 CAR-T Cells [NCIt concept]
- Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 [NCIt concept]
- Autologous Anti-HLA-G CAR-T Cells IVS-3001 [NCIt concept]
- Autologous Anti-HPV-16 E6 T-cell Receptor Gene-engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 [NCIt concept]
- Autologous Anti-KK-LC-1 TCR-expressing T-cells [NCIt concept]
- Autologous Anti-L1CAM-CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-A0201 [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-C0702 [NCIt concept]
- Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-MART-1 F5 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-MSLN CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B694 [NCIt concept]
- Autologous Anti-MUC1*-CAR-4-1BB-CD3zeta-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-MUC16 CAR-mbIL15-Safety Switch T-cells PRGN-3005 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/dnTGF-BRII-expressing T-cells GSK3845097 [NCIt concept]
- Autologous Anti-NY-ESO-1 mTCR Retroviral Vector Transduced PBLs [NCIt concept]
- Autologous Anti-PRAME TCR/CD8alphabeta-expressing T-cells IMA203CD8 [NCIt concept]
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-PSMA CAR-T Cells P-PSMA-101 [NCIt concept]
- Autologous Anti-PSMA Gene-Modified T-Lymphocytes [NCIt concept]
- Autologous Anti-ROR1 CAR T-cells LYL797 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells BMS-986403 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells ONCT-808 [NCIt concept]
- Autologous Anti-ROR1 CAR-mbIL15-Safety Switch/Intrinsic PD-1 Blockade T-cells PRGN-3007 [NCIt concept]
- Autologous Anti-SLAMF7 CAR-expressing T-cells [NCIt concept]
- Autologous Anti-glypican-3 CAR-IL-15-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-mesothelin CAR-CD3zeta-4-1-BB-expressing T-cells [NCIt concept]
- Autologous Anti-mesothelin KIR-CAR-transduced T-cells SynKIR-110 [NCIt concept]
- Autologous Anti-mesothelin M28z1XXPD1DNR CAR-expressing T-cells [NCIt concept]
- Autologous Anti-mesothelin TCR-expressing T-cells FH-TCR TMSLN [NCIt concept]
- Autologous BAFF-expressing CAR T Cells LMY-920 [NCIt concept]
- Autologous BAFFR-targeting CAR T Cells [NCIt concept]
- Autologous BCL11A-disrupted Human Hematopoietic Stem and Progenitor Cells HIX763 [NCIt concept]
- Autologous BCMA-targeted CAR T Cells CC-98633 [NCIt concept]
- Autologous Base Edited CD34+ HSPCs BEAM-101 [NCIt concept]
- Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F [NCIt concept]
- Autologous Bladder Cell Carcinoma RNAs/CD40L RNA Electroporated Autologous Matured Dendritic Cells [NCIt concept]
- Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 [NCIt concept]
- Autologous CAR-engineered Regulatory T-cells SBT777101 [NCIt concept]
- Autologous CCR4-CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes [NCIt concept]
- Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes MB-102 [NCIt concept]
- Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Autologous CD171-specific CAR-CD28 zeta-4-1-BB-EGFRt-expressing T Lymphocytes [NCIt concept]
- Autologous CD19 CAR+ EGFRt + CD4+ and CD8+ T Cells [NCIt concept]
- Autologous CD19-28z Chimeric Antigen Receptor-expressing T-lymphocytes [NCIt concept]
- Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells [NCIt concept]
- Autologous CD19-targeted CAR T Cells CC-97540 [NCIt concept]
- Autologous CD19/CD22 Chimeric Antigen Receptor T-cells CT120 [NCIt concept]
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T Cells [NCIt concept]
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes [NCIt concept]
- Autologous CD30CAR-CD28-CD3zeta-expressing T-Lymphocytes [NCIt concept]
- Autologous CD34+ enriched Alpha-L-iduronidase-expressing Hematopoietic Stem Cells OTL-203 [NCIt concept]
- Autologous CD34+-enriched HSPCs Transduced with LV Vector Carrying TCIRG1 Gene RP-L401 [NCIt concept]
- Autologous CD34-positive BCL11A-disrupted Hematopoietic Progenitor Cells BIVV003 [NCIt concept]
- Autologous CD34-positive BCL11A-disrupted Hematopoietic Progenitor Cells ST-400 [NCIt concept]
- Autologous CD34-positive Peripheral Blood Stem Cells [NCIt concept]
- Autologous CD4 and CD8 Positive Truncated CD19-expressing Antigen Presenting T-cells [NCIt concept]
- Autologous CD4+/CD8+ 4-1BB-CD3zeta-EGFR806-CAR-EGFRt/4-1BB-CD3zeta-CD19-CAR-HER2tG-expressing CARs T Cells [NCIt concept]
- Autologous CD4+/CD8+ EGFR806 Specific 4-1BB-CD3zeta-EGFRt-expressing CAR T Cells [NCIt concept]
- Autologous CD40L-expressing B-CLL Vaccine [NCIt concept]
- Autologous CD5-specific CAR-28 zeta CAR T-cells [NCIt concept]
- Autologous CD5KO Anti-CD5 CAR 4-1BB-expressing T-lymphocytes and Autologous CD5KO T-lymphocytes [NCIt concept]
- Autologous CD8 Positive PBL Sensitized to Drosophila Cell-Presented Melanoma Peptides [NCIt concept]
- Autologous CD8+ SLC45A2-specific T Lymphocytes [NCIt concept]
- Autologous CISH-inactivated TILs [NCIt concept]
- Autologous CLTX-targeted CAR T-lymphocytes CHM 1101 [NCIt concept]
- Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine [NCIt concept]
- Autologous CMV-pp65-shLAMP-1 mRNA Loaded Dendritic Cell Vaccine [NCIt concept]
- Autologous CRISPR-Cas9 Engineered Regnase-1/SOCS1 Dual-edited Tumor Infiltrating Lymphocytes KSQ-004EX [NCIt concept]
- Autologous CRISPR-Cas9 Engineered Tumor Infiltrating Lymphocytes KSQ-001EX [NCIt concept]
- Autologous CRISPR-Cas9 Modified/BCL11A Gene-disrupted Human Hematopoietic Stem and Progenitor Cells OTQ923 [NCIt concept]
- Autologous CT-RCC-1 HERV-E-TCR-transduced-HLA-A11-restricted CD8+/CD34t+ T-cells [NCIt concept]
- Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells [NCIt concept]
- Autologous Cultured Acute Myeloid Leukemia-specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous Cytokine-induced Killer Cells/Vaccinia Virus DD-CDSR CRX100 [NCIt concept]
- Autologous Cytomegalovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous Deep IL-15 Primed T-cells TRQ15-01 [NCIt concept]
- Autologous Dendritic Cell-Adenovirus CCL21 Vaccine [NCIt concept]
- Autologous Dendritic Cell-Adenovirus P53 Vaccine [NCIt concept]
- Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine [NCIt concept]
- Autologous Dendritic Cell-Tumor Fusion Vaccine [NCIt concept]
- Autologous Dendritic Cell/Myeloma Fusion Vaccine [NCIt concept]
- Autologous Dendritic Cells Pulsed with MART-1 (26-35) Peptide [NCIt concept]
- Autologous Dendritic Cells Transduced with Wild-type p53 Adenovirus Vaccine [NCIt concept]
- Autologous Desmoglein-3 Chimeric Autoantibody Receptor T-cells DSG3-CAART [NCIt concept]
- Autologous E6 T Cell Receptor Genetically-modified T Cells [NCIt concept]
- Autologous EBV-CTL CD19CAR zeta [NCIt concept]
- Autologous EGFRt/19-28z/4-1BBL CAR T-Lymphocytes [NCIt concept]
- Autologous Enhanced NY-ESO-1 TCR Engineered T-cells GSK4427296 [NCIt concept]
- Autologous Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous Follicular Lymphoma-Derived Idiotype Vaccine [NCIt concept]
- Autologous GCC-targeting CAR T Cells GCC19CART [NCIt concept]
- Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine [NCIt concept]
- Autologous GM-CSF-secreting Lethally Irradiated Leukemia Cell Vaccine [NCIt concept]
- Autologous GM-CSF-secreting Lethally Irradiated Pancreatic Cancer Vaccine [NCIt concept]
- Autologous Gamma Delta T-cell Receptor-expressing T-cells TEG002 [NCIt concept]
- Autologous Gamma-retroviral MSGV1 139 scFv EGFRvIII CAR Gene-modified T Cells [NCIt concept]
- Autologous Gene-modified Gamma Delta T-cells [NCIt concept]
- Autologous HBV-specific TCR-expressing T-lymphocytes SCG101 [NCIt concept]
- Autologous HER2-CAR-modified Adenovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous HER2-targeted Dual-switch CAR-T Cells BPX-603 [NCIt concept]
- Autologous HIV Gag-specific CD4+ T-cells AGT103-T [NCIt concept]
- Autologous HLA-A*11:01 KRASG12V-specific TCR-expressing CD8- and CD4-positive T-lymphocytes AFNT-211 [NCIt concept]
- Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 [NCIt concept]
- Autologous IL-12/Multi-targeted Primed T-cells RPTR 168 [NCIt concept]
- Autologous IL-15-expanded HER2-specific CD4+ T-cells [NCIt concept]
- Autologous IL-15/IL-21-armored Anti-glypican-3 CAR T-cells [NCIt concept]
- Autologous IL-2-expressing B-CLL Vaccine [NCIt concept]
- Autologous IL-7-expanded HER2-specific CD4+ T-cells [NCIt concept]
- Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine [NCIt concept]
- Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR Gene Engineered T-lymphocytes NT-112 [NCIt concept]
- Autologous KRAS Mutant-specific TCRs Gene Engineered PBLs [NCIt concept]
- Autologous LMP1-/LMP2- Specific Cytotoxic T-Lymphocytes [NCIt concept]
- Autologous Lymphocyte [NCIt concept]
- Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine [NCIt concept]
- Autologous MAGE-A10-specific HLA-A2-restricted TCR c796 Gene-engineered Lymphocytes [NCIt concept]
- Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 [NCIt concept]
- Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR [NCIt concept]
- Autologous MGMTP140K Lentiviral Vector-transduced HSCs [NCIt concept]
- Autologous MUC1-activated T-cells [NCIt concept]
- Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Autologous Memory Cytokine-enriched Natural Killer Cells [NCIt concept]
- Autologous Mesothelin-specific CAR-T Cells [NCIt concept]
- Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 [NCIt concept]
- Autologous Monocytes [NCIt concept]
- Autologous Muscle-derived Cells for Gastrointestinal Repair [NCIt concept]
- Autologous NKG2D CAR T-cells CYAD-02 [NCIt concept]
- Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 [NCIt concept]
- Autologous NY-ESO-1 TCR-targeted T Lymphocytes [NCIt concept]
- Autologous NY-ESO-1-Melanoma-Specific CD8+ T-lymphocytes [NCIt concept]
- Autologous NY-ESO-1-specific CD8-positive T Lymphocytes [NCIt concept]
- Autologous Natural Killer Cell-like CTLs [NCIt concept]
- Autologous Natural Killer Cells SNK01 [NCIt concept]
- Autologous Neoantigen-specific T-lymphocytes GEN-011 [NCIt concept]
- Autologous Neuroblastoma Lysate/KLH-pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous Orthogonal IL-2Rbeta-expressing Anti-CD19 CAR T-cells SYNCAR-001 [NCIt concept]
- Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous PBLs Retrovirally-transduced with TCRs Targeting Neoantigens [NCIt concept]
- Autologous PBMCs in GM-CSF [NCIt concept]
- Autologous PBTL CD19CAR-28 zeta [NCIt concept]
- Autologous PD-1-knockout Tumor-infiltrating Lymphocytes IOV-4001 [NCIt concept]
- Autologous PRAME-targeting TCR-engineered T-cells IMA203 [NCIt concept]
- Autologous PSMA-inducible Anti-CA9 CAR T-cells AB-2100 [NCIt concept]
- Autologous Peripheral Blood Lymphocytes Cotransduced with Retroviral Vectors Encoding Inducible IL-12 and Anti-NY-ESO-1 TCR [NCIt concept]
- Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 [NCIt concept]
- Autologous Peripheral Blood Mononuclear Cells [NCIt concept]
- Autologous Pluripotent ALDHbr Stem Cells ALD-451 [NCIt concept]
- Autologous Polyclonal Tumor Infiltrating Lymphocytes LYL845 [NCIt concept]
- Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 [NCIt concept]
- Autologous Retroviral Vector MSGV1-transduced Anti-PSCA-8T28Z CAR Gamma Delta T-cells [NCIt concept]
- Autologous SIRPa-depleted Activated Macrophages SI-101 [NCIt concept]
- Autologous Sarcoma Cell Lysate [NCIt concept]
- Autologous TBX-4000-treated Peripheral Blood Mononuclear Cells TBX-3400 [NCIt concept]
- Autologous TCR-engineered T-cells IMA201 [NCIt concept]
- Autologous TCR-engineered T-cells IMA202 [NCIt concept]
- Autologous TCRm-expressing T-cells ET140203 [NCIt concept]
- Autologous TGFbeta-Resistant HER2/EBV-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Autologous TNS9.3.55-transduced CD34-positive Cells [NCIt concept]
- Autologous TP53 R175H Mutant-specific HLA-A*02:01-restricted TCR Gene Engineered T-lymphocytes NT-175 [NCIt concept]
- Autologous Tn-MUC1-specific CAR T-lymphocytes [NCIt concept]
- Autologous Tolerogenic Proinsulin Peptide-loaded Dendritic Cells PIpepTolDC [NCIt concept]
- Autologous Total Tumor mRNA Loaded Liposome Vaccine [NCIt concept]
- Autologous Tumor Cell Vaccine [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes C-TIL051 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes ITIL-168 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145-S1 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes TBio-4101 [NCIt concept]
- Autologous Tumor Membrane Vesicles Vaccine [NCIt concept]
- Autologous UCD19 CAR T Cells [NCIt concept]
- Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes [NCIt concept]
- Autologous WT1-directed CRISPR/Cas9-engineered TCR-T Cells NTLA-5001 [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-GPC3 CAR T-cells AZD5851 [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-STEAP2 CAR T-cells AZD0754 [NCIt concept]
- Autologous gamma-globinG16D/sh RNA734 Gene-transduced CD34-positive Cells CSL200 [NCIt concept]
- Autologous iC9-GD2-CAR-expressing VZV-specific T Lymphocytes [NCIt concept]
- Autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T-lymphocytes [NCIt concept]
- Autologous iC9-deltaNGFR-CD19CAR-CD3zeta-4-1BB-expressing T-lymphocytes [NCIt concept]
- Autologous iCASP9-CD19-expressing T-Lymphocytes [NCIt concept]
- Autologous iCasp9-deltaNGFR-CD19CAR-expressing T Cells [NCIt concept]
- Autologous mDC3 Vaccine [NCIt concept]
- Autologous mDC3/8-KRAS Vaccine [NCIt concept]
- Avadomide [NCIt concept]
- Avadomide Hydrochloride [NCIt concept]
- Avanafil [NCIt concept]
- Avapritinib [NCIt concept]
- Avdoralimab [NCIt concept]
- Avelumab [NCIt concept]
- Avena sativa [NCIt concept]
- Aviptadil [NCIt concept]
- Avutometinib [NCIt concept]
- Axalimogene Filolisbac [NCIt concept]
- Axatilimab [NCIt concept]
- Axicabtagene Ciloleucel [NCIt concept]
- Axitinib [NCIt concept]
- Axl/Mer Inhibitor INCB081776 [NCIt concept]
- Axl/Mer Inhibitor PF-07265807 [NCIt concept]
- Axl/Mer/CSF1R Inhibitor Q702 [NCIt concept]
- Azacitidine [NCIt concept]
- Azadirachta indica [NCIt concept]
- Azeliragon [NCIt concept]
- Azenosertib [NCIt concept]
- Azercabtagene Zapreleucel [NCIt concept]
- Azerutamig [NCIt concept]
- Azintuxizumab Vedotin [NCIt concept]
- Azithromycin [NCIt concept]
- Azithromycin Monohydrate [NCIt concept]
- Aztreonam [NCIt concept]
- Azurin:50-77 Cell Penetrating Peptide p28 [NCIt concept]
- B-Raf/VEGFR-2 Inhibitor RAF265 [NCIt concept]
- B. infantis-based Formulation PBCLN-014 [NCIt concept]
- B16alphaGal Melanoma Vaccine [NCIt concept]
- B7-DC Crosslinking Antibody rHIgM12B7 [NCIt concept]
- B7-H3-targeting Agent [NCIt concept]
- B7-H4-targeting Agent [NCIt concept]
- B7H3/CD3-targeting T-cell Engaging Molecule TAK-280 [NCIt concept]
- BCG Solution [NCIt concept]
- BCG Tokyo-172 Strain Solution [NCIt concept]
- BCG Tokyo-172 Strain Vaccine [NCIt concept]
- BCG Vaccine [NCIt concept]
- BCL-XL Inhibitor [NCIt concept]
- BCL2 Inhibitor VOB560 [NCIt concept]
- BCL6 Degrader ARV-393 [NCIt concept]
- BCL6 Degrader BMS-986458 [NCIt concept]
- BCR Signaling Pathway Inhibitor DZD8586 [NCIt concept]
- BCR-ABL Inhibitor [NCIt concept]
- BCR-ABL Inhibitor ELVN-001 [NCIt concept]
- BCR-ABL Inhibitor HS-10382 [NCIt concept]
- BCR-ABL Inhibitor TGRX-678 [NCIt concept]
- BEACOPP Regimen [NCIt concept]
- BET Bromodomain Inhibitor ZEN-3694 [NCIt concept]
- BET Inhibitor [NCIt concept]
- BET Inhibitor ABBV-744 [NCIt concept]
- BET Inhibitor BAY1238097 [NCIt concept]
- BET Inhibitor FT-1101 [NCIt concept]
- BET Inhibitor GSK2820151 [NCIt concept]
- BET Inhibitor INCB054329 [NCIt concept]
- BET Inhibitor INCB057643 [NCIt concept]
- BET Inhibitor RO6870810 [NCIt concept]
- BET/CBP/p300 Inhibitor EP31670 [NCIt concept]
- BMS-214662 [NCIt concept]
- BMX Inhibitor [NCIt concept]
- BRAF Inhibitor [NCIt concept]
- BRAF Inhibitor ARQ 736 [NCIt concept]
- BRAF Inhibitor LUT014 [NCIt concept]
- BRAF V600E Degrader CFT1946 [NCIt concept]
- BRAF(V600E) Kinase Inhibitor ABM-1310 [NCIt concept]
- BRAF585-614 (V600E) Peptide [NCIt concept]
- BRAFV600/PI3K Inhibitor ASN003 [NCIt concept]
- BRD4 Inhibitor PLX2853 [NCIt concept]
- BRD4 Inhibitor PLX51107 [NCIt concept]
- BRD4 Protein Degrader RNK05047 [NCIt concept]
- BRD9 Degrader FHD-609 [NCIt concept]
- BTK Degrader [NCIt concept]
- BTK Degrader ABBV-101 [NCIt concept]
- BTK Degrader AC0676 [NCIt concept]
- BTK Degrader BGB-16673 [NCIt concept]
- BTK Degrader NX-5948 [NCIt concept]
- BTK Inhibitor DTRMWXHS-12 [NCIt concept]
- BTK Inhibitor GB5121 [NCIt concept]
- BTK Inhibitor HMPL-760 [NCIt concept]
- BTK Inhibitor JNJ-64264681 [NCIt concept]
- BTK Inhibitor TL-895 [NCIt concept]
- BTK Inhibitor TT-01488 [NCIt concept]
- BXQ-350 Nanovesicle Formulation [NCIt concept]
- Bacteriophage phi X 174 Vaccine [NCIt concept]
- Bafetinib [NCIt concept]
- Bafisontamab [NCIt concept]
- Balixafortide [NCIt concept]
- Baloramotide [NCIt concept]
- Baloxavir Marboxil [NCIt concept]
- Balstilimab [NCIt concept]
- Baltaleucel-T [NCIt concept]
- Banoxantrone [NCIt concept]
- Bapotulimab [NCIt concept]
- Barasertib [NCIt concept]
- Bardoxolone Methyl [NCIt concept]
- Baricitinib [NCIt concept]
- Basiliximab [NCIt concept]
- Basiliximab-IR700 RM-1995 [NCIt concept]
- Basroparib [NCIt concept]
- Batiraxcept [NCIt concept]
- Batoprotafib [NCIt concept]
- Bavdegalutamide [NCIt concept]
- Bavituximab [NCIt concept]
- Bazedoxifene [NCIt concept]
- Bcl-2 Family Protein Inhibitor [NCIt concept]
- Bcl-2 Inhibitor BCL201 [NCIt concept]
- Bcl-2 Inhibitor LOXO-338 [NCIt concept]
- Bcl-2/Bcl-XL Inhibitor LP-118 [NCIt concept]
- Bcl-XL Proteolysis Targeting Chimera DT2216 [NCIt concept]
- Bcr-Abl (b2a2)-Derived Peptide Vaccine [NCIt concept]
- Bcr-Abl (b3a2)-Derived Peptide Vaccine [NCIt concept]
- Becatecarin [NCIt concept]
- Beclomethasone Dipropionate [NCIt concept]
- Bedaquiline [NCIt concept]
- Begelomab [NCIt concept]
- Belagenpumatucel-L [NCIt concept]
- Belantamab Mafodotin [NCIt concept]
- Belapectin [NCIt concept]
- Belimumab [NCIt concept]
- Belinostat [NCIt concept]
- Belumosudil [NCIt concept]
- Belumosudil Mesylate [NCIt concept]
- Belzupacap Sarotalocan [NCIt concept]
- Belzutifan [NCIt concept]
- Bemarituzumab [NCIt concept]
- Bemcentinib [NCIt concept]
- Bempegaldesleukin [NCIt concept]
- Benazepril Hydrochloride [NCIt concept]
- Bendamustine Hydrochloride [NCIt concept]
- Bendamustine-containing Nanoparticle-based Formulation RXDX-107 [NCIt concept]
- Benralizumab [NCIt concept]
- Benzaldehyde Dimethane Sulfonate [NCIt concept]
- Benzoylphenylurea [NCIt concept]
- Bermekimab [NCIt concept]
- Beroterkib Anhydrous [NCIt concept]
- Bersanlimab [NCIt concept]
- Berubicin Hydrochloride [NCIt concept]
- Berzosertib [NCIt concept]
- Beta-Glucan [NCIt concept]
- Beta-Glucan MM-10-001 [NCIt concept]
- Beta-catenin Antagonist ST316 [NCIt concept]
- Beta-catenin Inhibitor [NCIt concept]
- Beta-catenin Inhibitor FOG-001 [NCIt concept]
- Beta-glucan/Dexpanthenol/Glutamine in Mucoadhesive Polymer Hydrogel [NCIt concept]
- Beta-lapachone Prodrug ARQ 761 [NCIt concept]
- Bethanechol [NCIt concept]
- Bethanechol Chloride [NCIt concept]
- Betibeglogene Autotemcel [NCIt concept]
- Betifisolimab [NCIt concept]
- Betrixaban [NCIt concept]
- Betulinic Acid [NCIt concept]
- Bevacizumab [NCIt concept]
- Bevifimod [NCIt concept]
- Bevonescein [NCIt concept]
- Bexarotene [NCIt concept]
- Bexirestrant [NCIt concept]
- Bezlotoxumab [NCIt concept]
- Bezuclastinib [NCIt concept]
- Bi-Sialidase Fusion Protein E-602 [NCIt concept]
- Bicalutamide [NCIt concept]
- Bictegravir [NCIt concept]
- Bifunctional Expression Vector Plasmid DNA-bi-shRNA EWS/FLI1 Type 1 Lipoplex [NCIt concept]
- Bimagrumab [NCIt concept]
- Bimatoprost Ophthalmic Solution [NCIt concept]
- Binimetinib [NCIt concept]
- Bintrafusp Alfa [NCIt concept]
- Bio-enhanced Curcumin Extract Formulation [NCIt concept]
- Bioadhesive Nanoparticles-encapsulating Avobenzone/Octocrylene Plus Diosmin/Ferulic Acid/Cytisine/Trans-resveratrol Sunscreen [NCIt concept]
- Birabresib [NCIt concept]
- Birinapant [NCIt concept]
- Biropepimut-S [NCIt concept]
- Birtamimab [NCIt concept]
- Bispecific Antibody AGEN1223 [NCIt concept]
- Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102 [NCIt concept]
- Bispecific Monoclonal Antibody [NCIt concept]
- Bivalent BRD4 Inhibitor AZD5153 [NCIt concept]
- Bizalimogene Ralaplasmid [NCIt concept]
- Black Seed Oil Extract Supplement [NCIt concept]
- Black Tea [NCIt concept]
- Bleomycin [NCIt concept]
- Bleomycin Sulfate [NCIt concept]
- Bleximenib [NCIt concept]
- Blinatumomab [NCIt concept]
- Blueberry Powder Supplement [NCIt concept]
- Boceprevir [NCIt concept]
- Bocodepsin Besylate [NCIt concept]
- Bomedemstat [NCIt concept]
- Bone Cement without Medicinal Substance [NCIt concept]
- Bone Metastasis Targeting Peptide-11 [NCIt concept]
- Boron-dipyrromethene-modified Olaparib Fluorescent Imaging Agent [NCIt concept]
- Bortezomib [NCIt concept]
- Bosentan [NCIt concept]
- Boserolimab [NCIt concept]
- Bosutinib [NCIt concept]
- Bosutinib Monohydrate [NCIt concept]
- Boswellia serrata Extract [NCIt concept]
- Botanical Extracts Rinse IZN-6N4 [NCIt concept]
- Botanical-based Agent NBT-NM108 [NCIt concept]
- Botanically-derived Agent RH324 [NCIt concept]
- Botensilimab [NCIt concept]
- Botulinum Toxin E EB-001 [NCIt concept]
- Botulinum Toxin Type A [NCIt concept]
- Bovine Lactoferrin Supplement [NCIt concept]
- Bowman-Birk Inhibitor Concentrate [NCIt concept]
- Brachyury-expressing Yeast Vaccine GI-6301 [NCIt concept]
- Brain Tumor Initiating Cell Vaccine [NCIt concept]
- Brentuximab [NCIt concept]
- Brentuximab Vedotin [NCIt concept]
- Brepocitinib [NCIt concept]
- Brexucabtagene Autoleucel [NCIt concept]
- Briciclib Sodium [NCIt concept]
- Brigatinib [NCIt concept]
- Brigimadlin [NCIt concept]
- Brilacidin Oral Rinse [NCIt concept]
- Brilanestrant [NCIt concept]
- Brimarafenib [NCIt concept]
- Brimonidine Tartrate [NCIt concept]
- Brimonidine Tartrate Nanoemulsion OCU-300 [NCIt concept]
- Brincidofovir [NCIt concept]
- Briquilimab [NCIt concept]
- Brivanib Alaninate [NCIt concept]
- Brivaracetam [NCIt concept]
- Brivudine [NCIt concept]
- Broad-Spectrum Human Papillomavirus Vaccine V505 [NCIt concept]
- Broccoli Sprout Extract [NCIt concept]
- Broccoli Sprout/Broccoli Seed Extract Supplement [NCIt concept]
- Brontictuzumab [NCIt concept]
- Brostallicin [NCIt concept]
- Broxuridine [NCIt concept]
- Bryostatin 1 [NCIt concept]
- Budesonide [NCIt concept]
- Budigalimab [NCIt concept]
- Bumetanide [NCIt concept]
- Buparlisib [NCIt concept]
- Bupivacaine [NCIt concept]
- Bupivacaine Hydrochloride [NCIt concept]
- Buprenorphine [NCIt concept]
- Buprenorphine Transdermal Matrix Patch [NCIt concept]
- Bupropion [NCIt concept]
- Bupropion Hydrochloride [NCIt concept]
- Bupropion Hydrochloride Controlled-release [NCIt concept]
- Burixafor Hydrobromide [NCIt concept]
- Burosumab [NCIt concept]
- Buserelin [NCIt concept]
- Buspirone Hydrochloride [NCIt concept]
- Busulfan [NCIt concept]
- Buthionine Sulfoximine [NCIt concept]
- C-VISA BikDD:Liposome [NCIt concept]
- C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs [NCIt concept]
- C7R-expressing EBVSTs [NCIt concept]
- CA9-targeting Agent [NCIt concept]
- CAR T-Cells AMG 119 [NCIt concept]
- CARD11-BCL10-MALT1 Complex Inhibitor XL114 [NCIt concept]
- CBL-B Inhibitor HST-1011 [NCIt concept]
- CBL-B Inhibitor-treated Autologous Tumor-infiltrating Lymphocytes DeTIL-0255 [NCIt concept]
- CBP/beta-catenin Modulator E7386 [NCIt concept]
- CBP/p300 Bromodomain Inhibitor OPN-6602 [NCIt concept]
- CCL21-expressing H1944 Cell Vaccine [NCIt concept]
- CCR2 Antagonist CCX872-B [NCIt concept]
- CCR2 Antagonist PF-04136309 [NCIt concept]
- CCR2/CCR5 Antagonist BMS-813160 [NCIt concept]
- CCR8 Inhibitor [NCIt concept]
- CD-expressing Bifidobacterium APS001F [NCIt concept]
- CD11b Agonist GB1275 [NCIt concept]
- CD123-Specific Adapter SPRX002 [NCIt concept]
- CD123-targeting Agent [NCIt concept]
- CD137 Agonist [NCIt concept]
- CD137/Nectin-4 Bispecific-targeting Agent BT7480 [NCIt concept]
- CD137/PSMA/HSA Trispecific-targeting Agent CB 307 [NCIt concept]
- CD138CAR-CD137/TCRzeta-expressing T Lymphocytes [NCIt concept]
- CD16-based ROR1-targeted NK Cell Engager PBA-0405 [NCIt concept]
- CD19-CD34tagged Metabolically Programmed CAR T-cells [NCIt concept]
- CD19-expressing Oncolytic Virus CF33 [NCIt concept]
- CD19-specific Adapter Molecule SWI019 [NCIt concept]
- CD19-targeting Agent [NCIt concept]
- CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes [NCIt concept]
- CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes [NCIt concept]
- CD19CAR-CD28zeta-4-1BB-expressing Allogeneic T Lymphocytes [NCIt concept]
- CD19CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocyte Cells [NCIt concept]
- CD19R(EQ)-CD28-CD3zeta-EGFRt-expressing T-lymphocytes [NCIt concept]
- CD19x22 Bicistronic CAR T-cells [NCIt concept]
- CD20/CD47 Bispecific Fusion Protein CPO107 [NCIt concept]
- CD200 Activation Receptor Ligand hP1A8 [NCIt concept]
- CD228-targeting Agent [NCIt concept]
- CD27-targeting Agent [NCIt concept]
- CD3+/CD19+ Cell-depleted Autologous Hematopoietic Stem Cells [NCIt concept]
- CD3+/CD19+ Cell-depleted Unrelated or Partially Matched Donor-derived Allogeneic Peripheral Blood Stem Cells [NCIt concept]
- CD3/CD28 Costimulated Autologous T-Cells [NCIt concept]
- CD30 CAR-expressing Autologous T Lymphocytes [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Allogeneic T-lymphocytes [NCIt concept]
- CD33-specific CAR Lentiviral Vector-transduced Autologous T-lymphocytes [NCIt concept]
- CD34/TK75 Retroviral Vector-Transduced Donor Lymphocytes [NCIt concept]
- CD37-targeting Agent [NCIt concept]
- CD371-specific/YSNVz/IL-18 CAR T Cells [NCIt concept]
- CD4+ CD25+ Regulatory T Cells [NCIt concept]
- CD40 Agonist [NCIt concept]
- CD40L-Fc Fusion Protein MEDI5083 [NCIt concept]
- CD40L-augmented Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- CD44 Targeted Agent SPL-108 [NCIt concept]
- CD45RA-depleted Donor T-lymphocytes [NCIt concept]
- CD47-targeting Agent [NCIt concept]
- CD70-targeting Agent [NCIt concept]
- CD73 Inhibitor LY3475070 [NCIt concept]
- CD73 Inhibitor ORIC-533 [NCIt concept]
- CD73-targeting Agent [NCIt concept]
- CD8 Enriched Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR [NCIt concept]
- CDC7 Inhibitor SGR-2921 [NCIt concept]
- CDC7 Kinase Inhibitor BMS-863233 [NCIt concept]
- CDC7 Kinase Inhibitor NMS-1116354 [NCIt concept]
- CDK Inhibitor AT7519 [NCIt concept]
- CDK2 Inhibitor AVZO-021 [NCIt concept]
- CDK2 Inhibitor AZD8421 [NCIt concept]
- CDK2 Inhibitor INX-315 [NCIt concept]
- CDK2 Inhibitor NKT3447 [NCIt concept]
- CDK2/4/6 Inhibitor RGT-419B [NCIt concept]
- CDK2/4/6/FLT3 Inhibitor FN-1501 [NCIt concept]
- CDK4 Inhibitor BGB-43395 [NCIt concept]
- CDK4 Inhibitor P1446A-05 [NCIt concept]
- CDK4/6 Degrader BTX-9341 [NCIt concept]
- CDK4/6 Inhibitor FCN-437 [NCIt concept]
- CDK4/6 Inhibitor GLR2007 [NCIt concept]
- CDK4/6 Inhibitor PRT3645 [NCIt concept]
- CDK4/6 Inhibitor UCT-03-008 [NCIt concept]
- CDK7 Inhibitor LY3405105 [NCIt concept]
- CDK7 Inhibitor LY3405105 Besylate [NCIt concept]
- CDK7 Inhibitor Q901 [NCIt concept]
- CDK7 Inhibitor SY-5609 [NCIt concept]
- CDK8/19 Inhibitor RVU120 [NCIt concept]
- CDK9 Inhibitor GFH009 [NCIt concept]
- CEA-MUC-1-TRICOM Vaccine CV301 [NCIt concept]
- CEA-targeting Agent [NCIt concept]
- CEA-targeting Agent RG6123 [NCIt concept]
- CEBPA-targeting saRNA MTL-CEBPA Liposome [NCIt concept]
- CENP-E Inhibitor GSK-923295A [NCIt concept]
- CHK1 Inhibitor MK-8776 [NCIt concept]
- CHK1 Inhibitor PF-477736 [NCIt concept]
- CHOP Regimen [NCIt concept]
- CHP-NY-ESO-1 Peptide Vaccine IMF-001 [NCIt concept]
- CK1 Alpha Degrader CC-91633 [NCIt concept]
- CK1 Alpha Degrader GLB-001 [NCIt concept]
- CK1alpha/CDK7/CDK9 Inhibitor BTX-A51 [NCIt concept]
- CLDN18.2-targeting Agent [NCIt concept]
- CLEC12A-targeting CCR/Anti-ADGRE2 CAR T Cells ADCLEC.syn1 [NCIt concept]
- CLK Inhibitor BH-30236 [NCIt concept]
- CLK Inhibitor CTX-712 [NCIt concept]
- CMV Pentamer Complex Proteins/gB-encoding mRNA Vaccine mRNA-1647 [NCIt concept]
- CMV pp65 Peptide-loaded Alpha-type-1 Polarized Dendritic Cell Vaccine [NCIt concept]
- CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- CMVpp65/gB Plasmid Vaccine ASP0113 [NCIt concept]
- CNDO-109-activated Allogeneic Natural Killer Cells [NCIt concept]
- CNGRC Peptide-TNF Alpha Conjugate [NCIt concept]
- COVID-19 Convalescent Plasma [NCIt concept]
- COVID-19 Vaccine Ad26.COV2.S [NCIt concept]
- CR2-fH Fusion Protein TT30 [NCIt concept]
- CRL4-CRBN Modulator KPG-818 [NCIt concept]
- CSF1-targeting Agent [NCIt concept]
- CSF1R Inhibitor PLX73086 [NCIt concept]
- CSF1R-targeting Agent [NCIt concept]
- CTLA-4-targeting Agent [NCIt concept]
- CTPS1 Inhibitor STP938 [NCIt concept]
- CXC Chemokine Receptor 2 Antagonist AZD5069 [NCIt concept]
- CXCR2 Agonist MGTA-145 [NCIt concept]
- CXCR2 Antagonist QBM076 [NCIt concept]
- CXCR2-transduced Autologous Tumor Infiltrating Lymphocytes [NCIt concept]
- CXCR3/IL-12/TGFb1 Inhibitor Engineered Oncolytic Vaccinia Virus VET3-TGI [NCIt concept]
- CXCR4 Antagonist USL311 [NCIt concept]
- CXCR4 Inhibitor GPC-100 [NCIt concept]
- CXCR4 Inhibitor Q-122 [NCIt concept]
- CXCR4 Peptide Antagonist LY2510924 [NCIt concept]
- CXCR4/E-selectin Antagonist GMI-1359 [NCIt concept]
- CYP17 Lyase Inhibitor ASN001 [NCIt concept]
- CYP17/CYP11B2 Inhibitor LAE001 [NCIt concept]
- CYP3A4 Substrate [NCIt concept]
- Cabazitaxel [NCIt concept]
- Cabergoline [NCIt concept]
- Cabiralizumab [NCIt concept]
- Cabotegravir [NCIt concept]
- Cabozantinib [NCIt concept]
- Cabozantinib S-malate [NCIt concept]
- Cadazolid [NCIt concept]
- Cafelkibart [NCIt concept]
- Caffeine [NCIt concept]
- Caffeine-based Cream [NCIt concept]
- Calaspargase Pegol [NCIt concept]
- Calcineurin Inhibitor [NCIt concept]
- Calcipotriene [NCIt concept]
- Calcitriol [NCIt concept]
- Calcium Aluminosilicate Anti-Diarrheal [NCIt concept]
- Calcium Carbonate [NCIt concept]
- Calcium Citrate [NCIt concept]
- Calcium Gluconate [NCIt concept]
- Calcium Release-activated Channels Inhibitor RP4010 [NCIt concept]
- Calcium Saccharate [NCIt concept]
- Calendula Ointment [NCIt concept]
- Camibirstat [NCIt concept]
- Camidanlumab Tesirine [NCIt concept]
- Camizestrant [NCIt concept]
- Camonsertib [NCIt concept]
- Camoteskimab [NCIt concept]
- Camphor/Herbal Formulation-based Topical Plaster [NCIt concept]
- Camptothecin Analogue TLC388 [NCIt concept]
- Camptothecin-20(S)-O-Propionate Hydrate [NCIt concept]
- Camrelizumab [NCIt concept]
- Camsirubicin [NCIt concept]
- Canagliflozin [NCIt concept]
- Canakinumab [NCIt concept]
- Canerpaturev [NCIt concept]
- Canertinib Dihydrochloride [NCIt concept]
- Canfosfamide Hydrochloride [NCIt concept]
- Cannabidiol [NCIt concept]
- Cannabis sativa Extract [NCIt concept]
- Cantrixil [NCIt concept]
- Cantuzumab Ravtansine [NCIt concept]
- Capecitabine [NCIt concept]
- Capivasertib [NCIt concept]
- Caplacizumab [NCIt concept]
- Capmatinib [NCIt concept]
- Capmatinib Hydrochloride [NCIt concept]
- Carbomer/Polycarbophil-based Vaginal Gel [NCIt concept]
- Carbon C 11 AZ14193391 [NCIt concept]
- Carbon C 11 Alpha-methyltryptophan [NCIt concept]
- Carbon C 11 Choline [NCIt concept]
- Carbon C 11 Erlotinib Hydrochloride [NCIt concept]
- Carbon C 11 Glutamine [NCIt concept]
- Carbon C 11 Pittsburgh Compound B [NCIt concept]
- Carbon C 11 Sarcosine [NCIt concept]
- Carbon C 11 YJH08 [NCIt concept]
- Carbon C 13 Hyperpolarized Bicarbonate [NCIt concept]
- Carbon C 13 Lycopene [NCIt concept]
- Carbon C 13 Phytoene [NCIt concept]
- Carbon C 13 Phytofluene [NCIt concept]
- Carbon C 14 Gilteritinib [NCIt concept]
- Carbon C 14 Oxaliplatin [NCIt concept]
- Carbon C 14-labeled Ixazomib [NCIt concept]
- Carbon C11 Nicotine [NCIt concept]
- Carbon C11 Temozolomide [NCIt concept]
- Carbon C14 EGFR Inhibitor ASP8273 [NCIt concept]
- Carbon C14-labeled Carboplatin [NCIt concept]
- Carbon-11 Acetate [NCIt concept]
- Carboplatin [NCIt concept]
- Carboplatin/Paclitaxel Regimen [NCIt concept]
- Carboxyamidotriazole [NCIt concept]
- Carboxyamidotriazole Orotate [NCIt concept]
- Carboxylesterase-expressing Allogeneic Neural Stem Cells [NCIt concept]
- Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine [NCIt concept]
- Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine [NCIt concept]
- Carcinoembryonic Antigen-Expressing Measles Virus [NCIt concept]
- Carfilzomib [NCIt concept]
- Carlumab [NCIt concept]
- Carmustine [NCIt concept]
- Carmustine Implant [NCIt concept]
- Carotuximab [NCIt concept]
- Carrot Juice [NCIt concept]
- Carvedilol [NCIt concept]
- Carvedilol Phosphate [NCIt concept]
- Carvedilol Phosphate Extended-Release Capsule [NCIt concept]
- Casdatifan [NCIt concept]
- Casdozokitug [NCIt concept]
- Casirivimab [NCIt concept]
- Casirivimab/Imdevimab [NCIt concept]
- Caspofungin Acetate [NCIt concept]
- Catequentinib Hydrochloride [NCIt concept]
- Cathepsin-cleavable NIR Substrate Probe 6QC-ICG [NCIt concept]
- Cathepsin-cleavable NIR Substrate Probe 6QC-NIR [NCIt concept]
- Cathepsin-targeted Fluorescent Imaging Probe VGT-309 [NCIt concept]
- Cationic Peptide Cream Cypep-1 [NCIt concept]
- Catumaxomab [NCIt concept]
- Cavrotolimod [NCIt concept]
- Cedazuridine [NCIt concept]
- Cedazuridine/Azacitidine Combination Agent ASTX030 [NCIt concept]
- Cediranib [NCIt concept]
- Cediranib Maleate [NCIt concept]
- Cefazolin [NCIt concept]
- Cefepime Hydrochloride [NCIt concept]
- Cefixime [NCIt concept]
- Cefoxitin Sodium [NCIt concept]
- Cefpodoxime Proxetil [NCIt concept]
- Ceftaroline Fosamil [NCIt concept]
- Ceftazidime/Avibactam Sodium [NCIt concept]
- Ceftolozane [NCIt concept]
- Celecoxib [NCIt concept]
- Cell Cycle Checkpoint/DNA Repair Antagonist IC83 [NCIt concept]
- Cell Membrane-anchored/CSV-targeted IL-12-expressing T-lymphocytes [NCIt concept]
- Cell Therapy Agent [NCIt concept]
- Cellulose, Microcrystalline [NCIt concept]
- Cemacabtagene Ansegedleucel [NCIt concept]
- Cemiplimab [NCIt concept]
- Cemsidomide [NCIt concept]
- Cenersen [NCIt concept]
- Cenisertib [NCIt concept]
- Cephalexin [NCIt concept]
- Ceralasertib [NCIt concept]
- Ceramide [NCIt concept]
- Ceramide Nanoliposome [NCIt concept]
- Ceramide/CLA/Cholesterol Controlled-release Skin Barrier Emulsion [NCIt concept]
- Cerdulatinib [NCIt concept]
- Cereblon Modulator BTX-1188 [NCIt concept]
- Cergutuzumab Amunaleukin [NCIt concept]
- Ceritinib [NCIt concept]
- Certociclib [NCIt concept]
- Cesium Cs-131 [NCIt concept]
- Cetrelimab [NCIt concept]
- Cetuximab [NCIt concept]
- Cetuximab Sarotalocan Sodium [NCIt concept]
- Cetuximab-IRDye 800CW [NCIt concept]
- Cevidoplenib Dimesylate [NCIt concept]
- Cevimeline Hydrochloride [NCIt concept]
- Cevostamab [NCIt concept]
- ChAdOx1-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine ChAdOx1-PCAQ [NCIt concept]
- Checkpoint Kinase Inhibitor AZD7762 [NCIt concept]
- Checkpoint Kinase Inhibitor XL844 [NCIt concept]
- Cherry Juice [NCIt concept]
- Chimeric Antigen Receptor T-cells [NCIt concept]
- Chinese Herbal Formulation PHY906 [NCIt concept]
- Chk1 Inhibitor [NCIt concept]
- Chk1 Inhibitor BBI-355 [NCIt concept]
- Chk1 Inhibitor GDC-0425 [NCIt concept]
- Chk1 Inhibitor GDC-0575 [NCIt concept]
- Chk1 Inhibitor LY2880070 [NCIt concept]
- Chlorambucil [NCIt concept]
- Chlorhexidine [NCIt concept]
- Chlorhexidine Gluconate [NCIt concept]
- Chlorhexidine Gluconate Skin Cleanser [NCIt concept]
- Chloroquine [NCIt concept]
- Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes [NCIt concept]
- Cholecalciferol [NCIt concept]
- Cholestyramine [NCIt concept]
- Cholic Acid-24-13C [NCIt concept]
- Cholic-2,2,4,4-D4 Acid [NCIt concept]
- Choline Kinase Alpha Inhibitor TCD-717 [NCIt concept]
- Choline Magnesium Trisalicylate [NCIt concept]
- Cibisatamab [NCIt concept]
- Cidofovir [NCIt concept]
- Ciforadenant [NCIt concept]
- Cifurtilimab [NCIt concept]
- Cilengitide [NCIt concept]
- Cilgavimab/Tixagevimab [NCIt concept]
- Cilostazol [NCIt concept]
- Ciltacabtagene Autoleucel [NCIt concept]
- Cimdelirsen [NCIt concept]
- Cimetidine [NCIt concept]
- Cinacalcet Hydrochloride [NCIt concept]
- Cinrebafusp Alfa [NCIt concept]
- Cintirorgon [NCIt concept]
- Cintredekin Besudotox [NCIt concept]
- Cipepofol [NCIt concept]
- Cisplatin [NCIt concept]
- Cisplatin Nano-engineered Intraoperative System PRV211 [NCIt concept]
- Cisplatin Transmucosal Patch [NCIt concept]
- Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 [NCIt concept]
- Citalopram Hydrobromide [NCIt concept]
- Citarinostat [NCIt concept]
- Citric Acid Monohydrate [NCIt concept]
- Cixutumumab [NCIt concept]
- Cladribine [NCIt concept]
- Clarithromycin [NCIt concept]
- Claturafenib [NCIt concept]
- Clavulanic Acid [NCIt concept]
- Clazakizumab [NCIt concept]
- Clearing Agent [NCIt concept]
- Clobetasol [NCIt concept]
- Clobetasol Propionate [NCIt concept]
- Clodronate Disodium [NCIt concept]
- Clofarabine [NCIt concept]
- Clofazimine [NCIt concept]
- Clonidine-containing Mucoadhesive Buccal Tablet [NCIt concept]
- Clopidogrel [NCIt concept]
- Clopidogrel Bisulfate [NCIt concept]
- Clostridia Strain Formulation VE303 [NCIt concept]
- Clostridium Novyi-NT Spores [NCIt concept]
- Clostridium butyricum CBM 588 Probiotic Strain [NCIt concept]
- Clostridium butyricum-containing Probiotic [NCIt concept]
- Cloxacillin [NCIt concept]
- CoREST Inhibitor TNG260 [NCIt concept]
- Cobalamin [NCIt concept]
- Cobicistat [NCIt concept]
- Cobimetinib [NCIt concept]
- Cobiprostone [NCIt concept]
- Cobolimab [NCIt concept]
- Cobomarsen [NCIt concept]
- Codrituzumab [NCIt concept]
- Coenzyme Q10 [NCIt concept]
- Cofetuzumab Pelidotin [NCIt concept]
- Colchicine-Site Binding Agent ABT-751 [NCIt concept]
- Cold Contaminant-free Iobenguane I-131 [NCIt concept]
- Colesevelam Hydrochloride [NCIt concept]
- Colestipol [NCIt concept]
- Coltuximab Ravtansine [NCIt concept]
- Commensal Bacterial Strain Formulation VE800 [NCIt concept]
- Complement Inhibitor [NCIt concept]
- Complete Estrogen Receptor Antagonist [NCIt concept]
- Conatumumab [NCIt concept]
- Conditionally Replicative Adenovirus 5/3-delta24 [NCIt concept]
- Conditionally-activated Anti-EpCAM Antibody-drug Conjugate CX-2051 [NCIt concept]
- Conjugated Estrogens/Bazedoxifene [NCIt concept]
- Conjugated Linoleic Acid [NCIt concept]
- Contrast Agent [NCIt concept]
- Contusugene Ladenovec [NCIt concept]
- Convalescent Plasma [NCIt concept]
- Copanlisib [NCIt concept]
- Copanlisib Hydrochloride [NCIt concept]
- Copper 64 Cu-DOTA-daratumumab [NCIt concept]
- Copper 64 Cu-labeled Macrophage-targeted Nanoparticle [NCIt concept]
- Copper Cu 62 Ethylglyoxal Bis(thiosemicarbazone) [NCIt concept]
- Copper Cu 62-ATSM [NCIt concept]
- Copper Cu 62-PTSM [NCIt concept]
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Copper Cu 64 Dotatate [NCIt concept]
- Copper Cu 64 FAP-2286 [NCIt concept]
- Copper Cu 64 FBP8 [NCIt concept]
- Copper Cu 64 GRIP B [NCIt concept]
- Copper Cu 64 NODAGA-TTX-MC138 [NCIt concept]
- Copper Cu 64 NOTA-PSMAi-PEG-Cy5.5-C' Dots [NCIt concept]
- Copper Cu 64 SAR-Bombesin [NCIt concept]
- Copper Cu 64 TP3805 [NCIt concept]
- Copper Cu 64 Ucasareotide Dasaroxetan [NCIt concept]
- Copper Cu 64-ATSM [NCIt concept]
- Copper Cu 64-CB-TE1A1P-PEG4-LLP2A [NCIt concept]
- Copper Cu 64-DOTA B-Fab [NCIt concept]
- Copper Cu 64-DOTA-Anti-HER3 Monoclonal Antibody U3-1287 [NCIt concept]
- Copper Cu 64-DOTA-ECL1i [NCIt concept]
- Copper Cu 64-DOTA-Rituximab [NCIt concept]
- Copper Cu 64-DOTA-Trastuzumab [NCIt concept]
- Copper Cu 64-DOTA-pembrolizumab [NCIt concept]
- Copper Cu 64-GRIP B [NCIt concept]
- Copper Cu 64-PSMA-I&T [NCIt concept]
- Copper Cu 64-Tz-SarAr [NCIt concept]
- Copper Cu 67 SAR-bisPSMA [NCIt concept]
- Copper Cu 67 SAR-bombesin [NCIt concept]
- Copper Cu 67 Ucasareotide Dasaroxetan [NCIt concept]
- Copper Cu-64-DOTA-alendronate [NCIt concept]
- Copper Gluconate [NCIt concept]
- Cord Blood-derived CMV/AdV/EBV/BKV-specific Cytotoxic T-lymphocytes [NCIt concept]
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells [NCIt concept]
- Cordycepin [NCIt concept]
- Coriolus Versicolor Extract [NCIt concept]
- Corticorelin Acetate [NCIt concept]
- Corticosteroid-containing Eye Drop [NCIt concept]
- Cosibelimab [NCIt concept]
- Cositecan [NCIt concept]
- Cotsiranib [NCIt concept]
- CpG Oligodeoxynucleotide GNKG168 [NCIt concept]
- CpG-28 Oligodeoxynucleotide [NCIt concept]
- CpG-STAT3 siRNA CAS3/SS3 [NCIt concept]
- Creatine Monohydrate [NCIt concept]
- Crelosidenib [NCIt concept]
- Crenigacestat [NCIt concept]
- Crenolanib Besylate [NCIt concept]
- Crizanlizumab [NCIt concept]
- Crizotinib [NCIt concept]
- Crofelemer [NCIt concept]
- Crolibulin [NCIt concept]
- Crovalimab [NCIt concept]
- Cryopreserved Umbilical Cord Allograft [NCIt concept]
- Cudarolimab [NCIt concept]
- Cultured Lentinula edodes Mycelia Extract [NCIt concept]
- Curcumin [NCIt concept]
- Curcumin-based Gel [NCIt concept]
- Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-containing Supplement [NCIt concept]
- Curcumin/Polyphenols-containing Botanical Agent APG-157 [NCIt concept]
- Cusatuzumab [NCIt concept]
- Custirsen Sodium [NCIt concept]
- Cyclin A/B RxL Inhibitor CID-078 [NCIt concept]
- Cyclin-Dependent Kinase 2 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 4 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 6 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase 9 Inhibitor [NCIt concept]
- Cyclin-Dependent Kinase Inhibitor [NCIt concept]
- Cyclobenzaprine Hydrochloride [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Cyclosporine [NCIt concept]
- Cyclosporine Ophthalmic Emulsion [NCIt concept]
- Cyproheptadine Hydrochloride [NCIt concept]
- Cytarabine [NCIt concept]
- Cytarabine Hydrochloride [NCIt concept]
- Cytokine-Induced Killer Cells [NCIt concept]
- Cytokine-treated Veto Cells [NCIt concept]
- Cytomegalovirus pp65-Specific Cytotoxic T Lymphocytes [NCIt concept]
- Cytotoxic Agent-LAT1 Substrate QBS10072S [NCIt concept]
- D Vitamin [NCIt concept]
- D1/3-Mage-3-His Fusion Protein [NCIt concept]
- DCEP Regimen [NCIt concept]
- DDR1-2/VEGFR2-3/PDGFRalpha-beta Inhibitor ICP-033 [NCIt concept]
- DDX5 Degrader FL118 [NCIt concept]
- DGK-alpha Inhibitor GS-9911 [NCIt concept]
- DHA-Paclitaxel [NCIt concept]
- DI-Leu16-IL2 Immunocytokine [NCIt concept]
- DL-Selenomethionine [NCIt concept]
- DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine [NCIt concept]
- DLL3-targeting Agent [NCIt concept]
- DNA Minor Groove Binding Agent SG2000 [NCIt concept]
- DNA Plasmid Vaccine ITI-1001 [NCIt concept]
- DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151 [NCIt concept]
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457 [NCIt concept]
- DNA Polymerase Theta Inhibitor [NCIt concept]
- DNA Polymerase Theta Inhibitor ART6043 [NCIt concept]
- DNA Polymerase Theta Inhibitor GSK4524101 [NCIt concept]
- DNA Polymerase Theta Inhibitor RP-3467 [NCIt concept]
- DNA Vector pPRA-PSM Vaccine [NCIt concept]
- DNA-PK inhibitor AZD7648 [NCIt concept]
- DNA-PK/TOR Kinase Inhibitor CC-115 [NCIt concept]
- DNA-dependent Protein Kinase Inhibitor [NCIt concept]
- DNA-dependent Protein Kinase Inhibitor VX-984 [NCIt concept]
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine [NCIt concept]
- DNMT1 Inhibitor NTX-301 [NCIt concept]
- DNR-expressing Nasopharyngeal Carcinoma-specific Cytotoxic T-Lymphocytes [NCIt concept]
- DPACE Regimen [NCIt concept]
- DPX-E7 HPV Vaccine [NCIt concept]
- DR5-targeting Tetrameric Nanobody Agonist TAS266 [NCIt concept]
- DRD2 Antagonist/ClpP Agonist ONC206 [NCIt concept]
- DTA-H19 Plasmid [NCIt concept]
- DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 [NCIt concept]
- Dabigatran [NCIt concept]
- Dabrafenib [NCIt concept]
- Dabrafenib Mesylate [NCIt concept]
- Dacarbazine [NCIt concept]
- Dacetuzumab [NCIt concept]
- Daclizumab [NCIt concept]
- Dacomitinib [NCIt concept]
- Dactinomycin [NCIt concept]
- Dactolisib [NCIt concept]
- Dalantercept [NCIt concept]
- Dalbavancin [NCIt concept]
- Dalmitamig [NCIt concept]
- Dalnicastobart [NCIt concept]
- Dalotuzumab [NCIt concept]
- Dalteparin [NCIt concept]
- Dalutrafusp Alfa [NCIt concept]
- Danaparoid Sodium [NCIt concept]
- Danazol [NCIt concept]
- Danburstotug [NCIt concept]
- Danicopan [NCIt concept]
- Daniquidone [NCIt concept]
- Danusertib [NCIt concept]
- Danvatirsen [NCIt concept]
- Dapagliflozin [NCIt concept]
- Dapagliflozin Propanediol [NCIt concept]
- Dapansutrile [NCIt concept]
- Dapatifagene Navolactibac [NCIt concept]
- Dapolsertib [NCIt concept]
- Dapsone Gel [NCIt concept]
- Daptomycin [NCIt concept]
- Daratumumab [NCIt concept]
- Daratumumab and Recombinant Human Hyaluronidase [NCIt concept]
- Darbepoetin Alfa [NCIt concept]
- Dargistotug [NCIt concept]
- Darinaparsin [NCIt concept]
- Daromun [NCIt concept]
- Darovasertib [NCIt concept]
- Darunavir/Ritonavir [NCIt concept]
- Dasabuvir [NCIt concept]
- Dasatinib [NCIt concept]
- Dasatinib Anhydrous [NCIt concept]
- Dasminapant [NCIt concept]
- Datopotamab Deruxtecan [NCIt concept]
- Daunorubicin [NCIt concept]
- Daunorubicin Hydrochloride [NCIt concept]
- Davamotecan Pegadexamer [NCIt concept]
- Davoceticept [NCIt concept]
- Davutamig [NCIt concept]
- Dazostinag Disodium [NCIt concept]
- Decitabine [NCIt concept]
- Decitabine and Cedazuridine [NCIt concept]
- Defactinib [NCIt concept]
- Defactinib Hydrochloride [NCIt concept]
- Deferasirox [NCIt concept]
- Deferoxamine [NCIt concept]
- Deferoxamine Mesylate [NCIt concept]
- Defibrotide Sodium [NCIt concept]
- Defosbarasertib [NCIt concept]
- Degarelix [NCIt concept]
- Degarelix Acetate [NCIt concept]
- Deglycosylated Ricin A Chain-Conjugated Anti-CD19/Anti-CD22 Immunotoxins [NCIt concept]
- Delamanid [NCIt concept]
- Delanzomib [NCIt concept]
- Delolimogene Mupadenorepvec [NCIt concept]
- Delta-Tocotrienol [NCIt concept]
- Demcizumab [NCIt concept]
- Demeclocycline Hydrochloride [NCIt concept]
- Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466 [NCIt concept]
- Dendritic Cell Tumor Peptide Vaccine [NCIt concept]
- Dendritic Cell-MART-1 Peptide Vaccine [NCIt concept]
- Denenicokin [NCIt concept]
- Denfivontinib Hydrochloride [NCIt concept]
- Denibulin Hydrochloride [NCIt concept]
- Denifanstat [NCIt concept]
- Denileukin Diftitox [NCIt concept]
- Denintuzumab Mafodotin [NCIt concept]
- Denosumab [NCIt concept]
- Deoxycholic Acid [NCIt concept]
- Deoxycytidine Kinase Inhibitor TRE-515 [NCIt concept]
- Depatuxizumab [NCIt concept]
- Depatuxizumab Mafodotin [NCIt concept]
- Derazantinib [NCIt concept]
- Dersimelagon [NCIt concept]
- Desipramine Hydrochloride [NCIt concept]
- Deslorelin [NCIt concept]
- Deupirfenidone [NCIt concept]
- Deutenzalutamide [NCIt concept]
- Deuterated Glucose [NCIt concept]
- Deuterated Phenanthrene [NCIt concept]
- Deuterium Oxide [NCIt concept]
- Devimistat [NCIt concept]
- Dexamethasone [NCIt concept]
- Dexamethasone Acetate, Unspecified [NCIt concept]
- Dexamethasone Sodium Phosphate [NCIt concept]
- Dexanabinol [NCIt concept]
- Dexmedetomidine Hydrochloride [NCIt concept]
- Dexrazoxane [NCIt concept]
- Dexrazoxane Hydrochloride [NCIt concept]
- Dextran 1 Subfraction-based Cryoprotective Agent [NCIt concept]
- Dextromethorphan Hydrobromide [NCIt concept]
- Dextromethorphan/Bupropion Tablet AXS-05 [NCIt concept]
- Dezamizumab [NCIt concept]
- Dezapelisib [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor ASP1570 [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor BGB-30813 [NCIt concept]
- Dianhydrogalactitol [NCIt concept]
- Dianicline [NCIt concept]
- Diazepam [NCIt concept]
- Diazepinomicin [NCIt concept]
- Dibotatug [NCIt concept]
- Diclofenac Epolamine [NCIt concept]
- Diclofenac Sodium Gel [NCIt concept]
- Dietary Fiber [NCIt concept]
- Dietary Supplement [NCIt concept]
- Diflunisal [NCIt concept]
- Digestible Starch [NCIt concept]
- Digoxin [NCIt concept]
- Dihydro-5-Azacytidine [NCIt concept]
- Dihydroorotate Dehydrogenase Inhibitor AG-636 [NCIt concept]
- Diindolylmethane [NCIt concept]
- Dilanubicel [NCIt concept]
- Dilpacimab [NCIt concept]
- Dimerizing Agent Regulated Immunoreceptor Complex-expressing CD33-specific Autologous CAR T Cells SC-DARIC33 [NCIt concept]
- Dimesna [NCIt concept]
- Dimethicone/Polymer Barrier Cream [NCIt concept]
- Dimethyl Fumarate [NCIt concept]
- Dimethyl Sulfoxide [NCIt concept]
- Dinaciclib [NCIt concept]
- Dinitrophenyl [NCIt concept]
- Dinutuximab [NCIt concept]
- Diphenhydramine [NCIt concept]
- Diphenhydramine Hydrochloride [NCIt concept]
- Diphenhydramine/Lidocaine/Antacid Mouthwash [NCIt concept]
- Diphenoxylate Hydrochloride/Atropine Sulfate [NCIt concept]
- Diphtheria Toxoid/Tetanus Toxoid Vaccine Adsorbed [NCIt concept]
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed [NCIt concept]
- Diphtheria Toxoid/Tetanus Toxoid/Inactivated Pertussis Vaccine [NCIt concept]
- Direct Oral Anticoagulant [NCIt concept]
- Disaccharide Tripeptide Glycerol Dipalmitoyl [NCIt concept]
- Disitamab Vedotin [NCIt concept]
- Disufenton Sodium [NCIt concept]
- Disulfiram [NCIt concept]
- Divarasib [NCIt concept]
- Docetaxel [NCIt concept]
- Docetaxel Emulsion ANX-514 [NCIt concept]
- Docetaxel-loaded Nanopharmaceutical CRLX301 [NCIt concept]
- Docetaxel/Ritonavir [NCIt concept]
- Dociparstat sodium [NCIt concept]
- Docosahexaenoic Acid [NCIt concept]
- Dodecyl Maltoside [NCIt concept]
- Dolasetron Mesylate [NCIt concept]
- Dolastatin 10 [NCIt concept]
- Dolcanatide [NCIt concept]
- Dolutegravir [NCIt concept]
- Domatinostat [NCIt concept]
- Domperidone [NCIt concept]
- Domvanalimab [NCIt concept]
- Donepezil [NCIt concept]
- Donepezil Hydrochloride [NCIt concept]
- Donepezil Hydrochloride/Memantine Hydrochloride Extended Release [NCIt concept]
- Donor Derived HIV-Specific T-cells with Non-escaped Epitope Targets [NCIt concept]
- Donor Lymphocytes [NCIt concept]
- Donor Regulatory T-lymphocytes [NCIt concept]
- Donor-derived Cytokine-induced Memory-like Natural Killer Cells [NCIt concept]
- Donor-derived Haploidentical IL-21-Expanded Natural Killer Cells [NCIt concept]
- Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes [NCIt concept]
- Doravirine [NCIt concept]
- Dornase Alfa Inhalation Solution [NCIt concept]
- Dostarlimab [NCIt concept]
- Dovitinib [NCIt concept]
- Dovitinib Lactate [NCIt concept]
- Doxepin Hydrochloride [NCIt concept]
- Doxercalciferol [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370 [NCIt concept]
- Doxorubicin-Eluting Beads [NCIt concept]
- Doxorubicin-loaded EGFR-targeting Nanocells [NCIt concept]
- Doxycycline [NCIt concept]
- Doxycycline Hyclate [NCIt concept]
- Doxycycline Hyclate Matrix Formulation [NCIt concept]
- Dronabinol [NCIt concept]
- Dronedarone Hydrochloride [NCIt concept]
- Drozitumab [NCIt concept]
- Drug-drug Conjugate NUV-1511 [NCIt concept]
- Dual IGF-1R/InsR Inhibitor BMS-754807 [NCIt concept]
- Dual IRAK1/4 Inhibitor R906289 Monosodium [NCIt concept]
- Dual-activating Polyvalent STING Agonist ONM-501 [NCIt concept]
- Dubermatinib [NCIt concept]
- Dulanermin [NCIt concept]
- Duligotuzumab [NCIt concept]
- Duloxetine Hydrochloride [NCIt concept]
- Dupilumab [NCIt concept]
- Dural Polyethylene Glycol-based Surgical Sealant [NCIt concept]
- Durvalumab [NCIt concept]
- Dusigitumab [NCIt concept]
- Dusquetide [NCIt concept]
- Dutasteride [NCIt concept]
- Duvelisib [NCIt concept]
- Duvortuxizumab [NCIt concept]
- Dye [NCIt concept]
- E-101 Solution [NCIt concept]
- E. coli CD-expressing Genetically Modified Neural Stem Cells [NCIt concept]
- E1A Lipid Complex [NCIt concept]
- E1M(184V) Peptide Vaccine [NCIt concept]
- EBNA-1 inhibitor VK-2019 [NCIt concept]
- EBP Inhibitor DSP-0390 [NCIt concept]
- ECT-001 Expanded Cord Blood [NCIt concept]
- EDB-FN-targeting Gadolinium-based Contrast Agent MT218 [NCIt concept]
- EED Inhibitor MAK683 [NCIt concept]
- EF5 [NCIt concept]
- EGFR Antisense DNA [NCIt concept]
- EGFR Exon 20 Inhibitor [NCIt concept]
- EGFR Inhibitor ERAS-801 [NCIt concept]
- EGFR Inhibitor NRC-2694 Hydrochloride [NCIt concept]
- EGFR Mutant-selective Inhibitor BLU-701 [NCIt concept]
- EGFR Mutant-selective Inhibitor FWD1509 MsOH [NCIt concept]
- EGFR Mutant-selective Inhibitor PLB1004 [NCIt concept]
- EGFR Mutant-selective Inhibitor WZ4002 [NCIt concept]
- EGFR Mutant-specific Inhibitor CK-101 [NCIt concept]
- EGFR Mutant-specific Inhibitor ZN-e4 [NCIt concept]
- EGFR-targeted IL-2/IL-10 Dual Cytokine Fusion Protein DK210 (EGFR) [NCIt concept]
- EGFR-targeting Agent [NCIt concept]
- EGFR/CD3-targeting T-cell Engaging Molecule TAK-186 [NCIt concept]
- EGFR/EGFRvIII Inhibitor WSD0922-FU [NCIt concept]
- EGFR/HER2 Inhibitor AV-412 [NCIt concept]
- EGFR/HER2 Inhibitor ORIC-114 [NCIt concept]
- EGFR/HER2 Inhibitor TAS2940 [NCIt concept]
- EGFR/HER2 Kinase Inhibitor TAK-285 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor BAY2927088 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor STX-721 [NCIt concept]
- EGFRBi-Armed Autologous T Cells [NCIt concept]
- EGFRt/19-28z/IL-12 CAR T-lymphocytes [NCIt concept]
- EGFRvIII-specific CAR-transduced Autologous T Lymphocytes [NCIt concept]
- EGb761 [NCIt concept]
- EP2/EP4 Antagonist TPST-1495 [NCIt concept]
- EP4 Antagonist INV-1120 [NCIt concept]
- EP4 Antagonist ONO-4578 [NCIt concept]
- EPOCH Regimen [NCIt concept]
- ER Alpha-targeting Chimeric Protein Degrader AC682 [NCIt concept]
- ER-targeting Agent [NCIt concept]
- ERK Inhibitor [NCIt concept]
- ERK Inhibitor CC-90003 [NCIt concept]
- ERK Inhibitor MK-8353 [NCIt concept]
- ERK1/2 Inhibitor D3S-002 [NCIt concept]
- ERK1/2 Inhibitor ERAS-007 [NCIt concept]
- ERK1/2 Inhibitor HH2710 [NCIt concept]
- ERK1/2 Inhibitor JSI-1187 [NCIt concept]
- ERK1/2 Inhibitor KO-947 [NCIt concept]
- ERK1/2 Inhibitor UCT-01-097 [NCIt concept]
- ESR1 Peptides/GM-CSF/Montanide ISA Vaccine [NCIt concept]
- EZH1/2 Inhibitor HH2853 [NCIt concept]
- EZH2 Inhibitor [NCIt concept]
- East Indian Sandalwood Oil Mouth Rinse [NCIt concept]
- Ebvaciclib [NCIt concept]
- Eclutatug [NCIt concept]
- Ecromeximab [NCIt concept]
- Ecubectedin [NCIt concept]
- Edetate Calcium Disodium [NCIt concept]
- Edicotinib [NCIt concept]
- Edodekin alfa [NCIt concept]
- Edoxaban [NCIt concept]
- Edrecolomab [NCIt concept]
- Efanesoctocog Alfa [NCIt concept]
- Efaprinermin Alfa [NCIt concept]
- Efatutazone Dihydrochloride [NCIt concept]
- Efavirenz [NCIt concept]
- Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate [NCIt concept]
- Efbemalenograstim alfa [NCIt concept]
- Efdelikofusp Alfa [NCIt concept]
- Efgivanermin Alfa [NCIt concept]
- Efineptakin alfa [NCIt concept]
- Eflapegrastim [NCIt concept]
- Eflepedocokin Alfa [NCIt concept]
- Eflornithine [NCIt concept]
- Eflornithine Hydrochloride [NCIt concept]
- Eflornithine Hydrochloride Ointment [NCIt concept]
- Efmarodocokin Alfa [NCIt concept]
- Efocipegtrutide [NCIt concept]
- Efprezimod Alfa [NCIt concept]
- Eftilagimod Alpha [NCIt concept]
- Eftozanermin Alfa [NCIt concept]
- Eganelisib [NCIt concept]
- Egaptivon Pegol [NCIt concept]
- Eicosapentaenoic Acid [NCIt concept]
- Elacestrant [NCIt concept]
- Elacytarabine [NCIt concept]
- Elapegademase [NCIt concept]
- Elasomeran [NCIt concept]
- Elbasvir/Grazoprevir [NCIt concept]
- Elesclomol [NCIt concept]
- Elesclomol Sodium [NCIt concept]
- Elgemtumab [NCIt concept]
- Elimusertib [NCIt concept]
- Elisidepsin [NCIt concept]
- Elotuzumab [NCIt concept]
- Elraglusib [NCIt concept]
- Elranatamab [NCIt concept]
- Elritercept [NCIt concept]
- Eltanexor [NCIt concept]
- Eltivutabart [NCIt concept]
- Eltrapuldencel-T [NCIt concept]
- Eltrombopag [NCIt concept]
- Eltrombopag Olamine [NCIt concept]
- Eluvixtamab [NCIt concept]
- Elzovantinib [NCIt concept]
- Emactuzumab [NCIt concept]
- Emapalumab [NCIt concept]
- Emavusertib [NCIt concept]
- Emepepimut-S [NCIt concept]
- Emerfetamab [NCIt concept]
- Emibetuzumab [NCIt concept]
- Emicizumab [NCIt concept]
- Emiltatug Ledadotin [NCIt concept]
- Emirodatamab [NCIt concept]
- Emtricitabine [NCIt concept]
- Emunkitug [NCIt concept]
- Emvododstat [NCIt concept]
- Emzadirib [NCIt concept]
- Enadenotucirev [NCIt concept]
- Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A [NCIt concept]
- Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641 [NCIt concept]
- Enalapril Maleate [NCIt concept]
- Enapotamab Vedotin [NCIt concept]
- Enasidenib [NCIt concept]
- Enasidenib Mesylate [NCIt concept]
- Enavatuzumab [NCIt concept]
- Enbezotinib [NCIt concept]
- Encapsulated Rapamycin [NCIt concept]
- Encelimab [NCIt concept]
- Encequidar [NCIt concept]
- Encorafenib [NCIt concept]
- Endoxifen Hydrochloride [NCIt concept]
- Engineered Human Umbilical Vein Endothelial Cells AB-205 [NCIt concept]
- Engineered IL-12 Prodrug WTX-330 [NCIt concept]
- Engineered IL-12 Variant/Aluminum Hydroxide Complex ANK-101 [NCIt concept]
- Engineered IL-2 Prodrug WTX-124 [NCIt concept]
- Engineered Interferon ORB-011 [NCIt concept]
- Engineered Mobilized Peripheral Blood-derived Donor Graft OGFT-001 [NCIt concept]
- Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 [NCIt concept]
- Engineered Red Blood Cells Expressing 4-1BBL/IL-12 RTX-224 [NCIt concept]
- Engineered Red Blood Cells Expressing HPV16 E7/4-1BBL/IL-12 RTX-321 [NCIt concept]
- Engineered Toxin Body Targeting CD38 MT-0169 [NCIt concept]
- Engineered Toxin Body Targeting CTLA-4 MT-8421 [NCIt concept]
- Engineered Toxin Body Targeting HER2 MT-5111 [NCIt concept]
- Engineered Toxin Body Targeting PD-L1 MT-6402 [NCIt concept]
- Eniluracil [NCIt concept]
- Enitociclib [NCIt concept]
- Enoblituzumab [NCIt concept]
- Enobosarm [NCIt concept]
- Enoticumab [NCIt concept]
- Enoxaparin [NCIt concept]
- Enristomig [NCIt concept]
- Ensartinib [NCIt concept]
- Ensituximab [NCIt concept]
- Ensomafusp Alfa [NCIt concept]
- Enteric-Coated Zoledronic Acid Tablet MER-101 [NCIt concept]
- Enterococcus gallinarum Strain MRx0518 [NCIt concept]
- Entinostat [NCIt concept]
- Entolimod [NCIt concept]
- Entospletinib [NCIt concept]
- Envafolimab [NCIt concept]
- Environmental Tobacco Smoke [NCIt concept]
- Enzalutamide [NCIt concept]
- Enzastaurin [NCIt concept]
- Enzastaurin Hydrochloride [NCIt concept]
- Enzomenib [NCIt concept]
- Enzyme-inducing Antiepileptic Drug [NCIt concept]
- Epacadostat [NCIt concept]
- Epacmarstobart [NCIt concept]
- Epcoritamab [NCIt concept]
- EphA2-targeting Bicycle Toxin Conjugate BT5528 [NCIt concept]
- EphA2-targeting DOPC-encapsulated siRNA [NCIt concept]
- Epirubicin [NCIt concept]
- Epirubicin Hydrochloride [NCIt concept]
- Eplontersen [NCIt concept]
- Epoetin Alfa [NCIt concept]
- Epratuzumab [NCIt concept]
- Epratuzumab-cys-tesirine [NCIt concept]
- Eprodisate Disodium [NCIt concept]
- Equecabtagene Autoleucel [NCIt concept]
- Equine Thymocyte Immune Globulin [NCIt concept]
- Eragidomide [NCIt concept]
- Eramkafusp Alfa [NCIt concept]
- Erastin Analogue PRLX 93936 [NCIt concept]
- Erdafitinib [NCIt concept]
- Erenumab [NCIt concept]
- Ergocalciferol [NCIt concept]
- Eribulin Mesylate [NCIt concept]
- Eritoran [NCIt concept]
- Erlotinib [NCIt concept]
- Erlotinib Hydrochloride [NCIt concept]
- Ertumaxomab [NCIt concept]
- Eryaspase [NCIt concept]
- Erzotabart [NCIt concept]
- Escitalopram [NCIt concept]
- Escitalopram Oxalate [NCIt concept]
- Esomeprazole Magnesium [NCIt concept]
- Estradiol Vaginal Ring [NCIt concept]
- Estramustine Phosphate Sodium [NCIt concept]
- Estrogen Receptor Agonist GTx-758 [NCIt concept]
- Esuberaprost Sodium [NCIt concept]
- Etakafusp Alfa [NCIt concept]
- Etanercept [NCIt concept]
- Etanidazole [NCIt concept]
- Etaracizumab [NCIt concept]
- Etavopivat [NCIt concept]
- Etentamig [NCIt concept]
- Etevritamab [NCIt concept]
- Ethanol-containing Nasal Solution [NCIt concept]
- Ethinyl Estradiol [NCIt concept]
- Ethinyl Estradiol/Levonorgestrel [NCIt concept]
- Ethinyl Estradiol/Norethindrone [NCIt concept]
- Ethiodized Oil [NCIt concept]
- Etigilimab [NCIt concept]
- Etirinotecan Pegol [NCIt concept]
- Etodolac [NCIt concept]
- Etoposide [NCIt concept]
- Etoposide Phosphate [NCIt concept]
- Etrumadenant [NCIt concept]
- Ets-family Transcription Factor Inhibitor TK216 [NCIt concept]
- Eucerin [NCIt concept]
- Eutectic Mixture of Local Anesthetics [NCIt concept]
- Everolimus [NCIt concept]
- Everolimus/Exemestane Regimen [NCIt concept]
- Evexomostat [NCIt concept]
- Evofosfamide [NCIt concept]
- Evorpacept [NCIt concept]
- Ex Vivo-Expanded HER2-Specific T Cells [NCIt concept]
- Ex Vivo-expanded Autologous T Cells IMA101 [NCIt concept]
- Exagamglogene Autotemcel [NCIt concept]
- Exemestane [NCIt concept]
- Exicorilant [NCIt concept]
- Exisulind [NCIt concept]
- Exlinkibart [NCIt concept]
- Expanded Cord Blood Stem Cells Mixed with Engineered Human Endothelial Cells AB-110 [NCIt concept]
- Extended Release Bupivacaine Hydrochloride Resorbable Matrix Formulation [NCIt concept]
- Extended Release Flucytosine [NCIt concept]
- Extended Release Metformin Hydrochloride [NCIt concept]
- Extended-release Galantamine Hydrobromide [NCIt concept]
- Extended-release Microsphere Capsule-based Oxycodone [NCIt concept]
- Ezabenlimab [NCIt concept]
- Ezatiostat Hydrochloride [NCIt concept]
- Ezetimibe [NCIt concept]
- Ezetimibe/Simvastatin [NCIt concept]
- Ezobresib [NCIt concept]
- Ezurpimtrostat [NCIt concept]
- F-18 16 Alpha-Fluoroestradiol [NCIt concept]
- FACT Complex-targeting Curaxin CBL0137 [NCIt concept]
- FAK Inhibitor [NCIt concept]
- FAK Inhibitor VS-4718 [NCIt concept]
- FAP/4-1BB-targeting Fusion Protein RO7122290 [NCIt concept]
- FGF Receptor Antagonist HGS1036 [NCIt concept]
- FGFR Inhibitor ASP5878 [NCIt concept]
- FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999 [NCIt concept]
- FGFR1/2/3 Inhibitor TYRA-200 [NCIt concept]
- FGFR2 Inhibitor 3HP-2827 [NCIt concept]
- FGFR3 Inhibitor LOXO-435 [NCIt concept]
- FGFR3 Inhibitor TYRA-300 [NCIt concept]
- FGFR4 Antagonist INCB062079 [NCIt concept]
- FGFR4 Inhibitor H3B-6527 [NCIt concept]
- FLT3 Agonist-Fc Fusion Protein GS-3583 [NCIt concept]
- FLT3 Inhibitor BMF-500 [NCIt concept]
- FLT3 Inhibitor FF-10101 Succinate [NCIt concept]
- FLT3 Tyrosine Kinase Inhibitor TTT-3002 [NCIt concept]
- FLT3/ABL/Aurora Kinase Inhibitor KW-2449 [NCIt concept]
- FLT3/CDK4/6 Inhibitor FLX925 [NCIt concept]
- FLT3/KIT/CSF1R Inhibitor NMS-03592088 [NCIt concept]
- FOLFIRI Regimen [NCIt concept]
- FOLFIRI-Bevacizumab Regimen [NCIt concept]
- FOLFOX Regimen [NCIt concept]
- FOLR1-targeting Agent [NCIt concept]
- FPV Vaccine CV301 [NCIt concept]
- FPV-Brachyury-TRICOM Vaccine [NCIt concept]
- Factor VII-targeting Immunoconjugate Protein ICON-1 [NCIt concept]
- Fadraciclib [NCIt concept]
- Falbikitug [NCIt concept]
- Falimarev [NCIt concept]
- Famotidine [NCIt concept]
- Faricimab [NCIt concept]
- Farletuzumab [NCIt concept]
- Farletuzumab Ecteribulin [NCIt concept]
- Farnesyl Transferase Inhibitor KO-2806 [NCIt concept]
- Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells [NCIt concept]
- Fascin Inhibitor NP-G2-044 [NCIt concept]
- Favezelimab [NCIt concept]
- Favezelimab/Pembrolizumab Formulation [NCIt concept]
- Fc Fusion IL-7 Mimetic MDK-703 [NCIt concept]
- Fecal Microbiota Transplantation Capsule [NCIt concept]
- Fedratinib [NCIt concept]
- Fedratinib Hydrochloride [NCIt concept]
- Feladilimab [NCIt concept]
- Felcisetrag [NCIt concept]
- Felezonexor [NCIt concept]
- Fencabtagene Autoleucel [NCIt concept]
- Fenebrutinib [NCIt concept]
- Fenofibrate [NCIt concept]
- Fenofibric Acid [NCIt concept]
- Fenretinide [NCIt concept]
- Fenretinide Lipid Matrix [NCIt concept]
- Fentanyl [NCIt concept]
- Fentanyl Citrate [NCIt concept]
- Fentanyl Citrate Buccal Tablet [NCIt concept]
- Fentanyl Citrate Pectin-Based Nasal Spray [NCIt concept]
- Fentanyl Citrate-containing Nasal Spray [NCIt concept]
- Fermented Soybean Extract [NCIt concept]
- Fermented Soybean Protein Beverage [NCIt concept]
- Ferrous Sulfate [NCIt concept]
- Ferumoxides Non-Stoichiometric Magnetite [NCIt concept]
- Ferumoxtran-10 [NCIt concept]
- Ferumoxytol [NCIt concept]
- Fexagratinib [NCIt concept]
- Fezolinetant [NCIt concept]
- Fianlimab [NCIt concept]
- Fibrin Sealant [NCIt concept]
- Fibroblast Activation Protein Alpha-activated Doxorubicin Prodrug AVA6000 [NCIt concept]
- Fibroblast-activation Protein Inhibitor [NCIt concept]
- Ficerafusp Alfa [NCIt concept]
- Ficlatuzumab [NCIt concept]
- Fidaxomicin [NCIt concept]
- Figitumumab [NCIt concept]
- Filanesib [NCIt concept]
- Filgrastim [NCIt concept]
- Filgrastim-primed Peripheral Blood Progenitor Cells [NCIt concept]
- Fimaporfin [NCIt concept]
- Fimepinostat [NCIt concept]
- Finasteride [NCIt concept]
- Fingolimod [NCIt concept]
- Fingolimod Hydrochloride [NCIt concept]
- Firastotug [NCIt concept]
- Firicabtagene Autoleucel [NCIt concept]
- Firtecan Pegol [NCIt concept]
- Fish Oil [NCIt concept]
- Fisogatinib [NCIt concept]
- Flanvotumab [NCIt concept]
- Flaxseed [NCIt concept]
- Flaxseed Lignan [NCIt concept]
- Flexible Heteroarotinoid Sulfur Heteroarotinoid A2 [NCIt concept]
- Flibanserin [NCIt concept]
- Florbenguane F18 [NCIt concept]
- Florbetaben (18F) [NCIt concept]
- Flortaucipir F-18 [NCIt concept]
- Flotetuzumab [NCIt concept]
- Flotufolastat F-18 Gallium [NCIt concept]
- Floxuridine [NCIt concept]
- Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01 [NCIt concept]
- Flt3/MerTK Inhibitor MRX-2843 [NCIt concept]
- Fluciclatide F 18 [NCIt concept]
- Fluciclovine F18 [NCIt concept]
- Fluconazole [NCIt concept]
- Flucytosine [NCIt concept]
- Fludarabine Phosphate [NCIt concept]
- Fludeoxyglucose F-18 [NCIt concept]
- Fluocinolone Acetonide [NCIt concept]
- Fluocinonide Cream [NCIt concept]
- Fluorescein Sodium Injection [NCIt concept]
- Fluorescent Dye LS301 [NCIt concept]
- Fluorescent cRGDY PEG-Cy5.5 C Dots [NCIt concept]
- Fluorine F 18 3F-PHPG [NCIt concept]
- Fluorine F 18 4-Fluoro-1-naphthol [NCIt concept]
- Fluorine F 18 4-L-fluoroglutamine (2S,4R) [NCIt concept]
- Fluorine F 18 5-Fluoro-2-deoxycytidine [NCIt concept]
- Fluorine F 18 Ara-G [NCIt concept]
- Fluorine F 18 C-SNAT4 [NCIt concept]
- Fluorine F 18 CP18 Peptide [NCIt concept]
- Fluorine F 18 Clofarabine [NCIt concept]
- Fluorine F 18 DASA-23 [NCIt concept]
- Fluorine F 18 DCFBC [NCIt concept]
- Fluorine F 18 DPA-714 [NCIt concept]
- Fluorine F 18 Dasatinib [NCIt concept]
- Fluorine F 18 EF5 [NCIt concept]
- Fluorine F 18 FAPI-74 [NCIt concept]
- Fluorine F 18 FP-R01-MG-F2 [NCIt concept]
- Fluorine F 18 FTC-146 [NCIt concept]
- Fluorine F 18 Florbetapir [NCIt concept]
- Fluorine F 18 Florilglutamic Acid [NCIt concept]
- Fluorine F 18 Fluorobenzyl Triphenyl Phosphonium [NCIt concept]
- Fluorine F 18 Fluorocholine [NCIt concept]
- Fluorine F 18 Fluoroethylcholine [NCIt concept]
- Fluorine F 18 Fluorthanatrace [NCIt concept]
- Fluorine F 18 GEH121224 [NCIt concept]
- Fluorine F 18 NOS [NCIt concept]
- Fluorine F 18 PARP Inhibitor [NCIt concept]
- Fluorine F 18 PSMA-1007 [NCIt concept]
- Fluorine F 18 RGD-K5 [NCIt concept]
- Fluorine F 18 Tetrafluoroborate [NCIt concept]
- Fluorine F 18 W372 [NCIt concept]
- Fluorine F 18 WC-4-116 [NCIt concept]
- Fluorine F 18 alphaVbeta6-Binding Peptide [NCIt concept]
- Fluorine F 18 d-FMAU [NCIt concept]
- Fluorine F 18-AlF-cys-variant 3 pH Low Insertion Peptides [NCIt concept]
- Fluorine F 18-BMS-986229 [NCIt concept]
- Fluorine F 18-FETrp [NCIt concept]
- Fluorine F 18-VM4-037 [NCIt concept]
- Fluorine F 18-labeled 2-FACPC [NCIt concept]
- Fluorine F 18-labeled MeFAMP [NCIt concept]
- Fluorine F-18 6-Fluorodopamine [NCIt concept]
- Fluorine F-18 Fluoropaclitaxel [NCIt concept]
- Fluorine F-18 HX4 [NCIt concept]
- Fluorine F-18 ML-10 [NCIt concept]
- Fluorine F18 BMS-986192 [NCIt concept]
- Fluorodeoxygalactose F-18 [NCIt concept]
- Fluorodopa F 18 [NCIt concept]
- Fluorometholone Acetate Ophthalmic Suspension [NCIt concept]
- Fluoroquinolone Antibiotic [NCIt concept]
- Fluorothymidine F-18 [NCIt concept]
- Fluorouracil [NCIt concept]
- Fluoxetine [NCIt concept]
- Fluphenazine Hydrochloride [NCIt concept]
- Flutamide [NCIt concept]
- Flutemetamol F 18 [NCIt concept]
- Fluticasone Propionate [NCIt concept]
- Fluvastatin Sodium [NCIt concept]
- Fluvoxamine Maleate [NCIt concept]
- Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate [NCIt concept]
- Folate Binding Protein E39 Peptide Vaccine [NCIt concept]
- Folate Binding Protein J65 Peptide Vaccine [NCIt concept]
- Folate Receptor Targeted Epothilone BMS753493 [NCIt concept]
- Folate Receptor-Targeted Technetium Tc-99m EC20 [NCIt concept]
- Folate Receptor-Targeted Tubulysin Conjugate EC1456 [NCIt concept]
- Folate Receptor-Targeted Vinca Alkaloid EC0489 [NCIt concept]
- Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225 [NCIt concept]
- Folate-FITC [NCIt concept]
- Folate-receptor Alpha-targeting Ultrasmall Silica Nanoparticle-drug Conjugate ELU001 [NCIt concept]
- Folfirinox Regimen [NCIt concept]
- Folic Acid [NCIt concept]
- Fondaparinux Sodium [NCIt concept]
- Foretinib [NCIt concept]
- Forodesine Hydrochloride [NCIt concept]
- Fosaprepitant [NCIt concept]
- Fosaprepitant Dimeglumine [NCIt concept]
- Fosbretabulin Disodium [NCIt concept]
- Fosbretabulin Tromethamine [NCIt concept]
- Foscarnet [NCIt concept]
- Foscarnet Sodium [NCIt concept]
- Foscenvivint [NCIt concept]
- Fosciclopirox [NCIt concept]
- Fosgemcitabine Palabenamide [NCIt concept]
- Fosifloxuridine Nafalbenamide [NCIt concept]
- Fosmanogepix [NCIt concept]
- Fosnetupitant/Palonosetron Hydrochloride [NCIt concept]
- Fostamatinib [NCIt concept]
- Fostamatinib Disodium [NCIt concept]
- Freeze-dried Black Raspberry Bioadhesive Gel [NCIt concept]
- Frenlosirsen [NCIt concept]
- Fresolimumab [NCIt concept]
- Freund's Adjuvant [NCIt concept]
- Fructooligosaccharide [NCIt concept]
- Fructooligosaccharide Supplement [NCIt concept]
- Fruit and Vegetable Extract [NCIt concept]
- Fruquintinib [NCIt concept]
- Fucosylated Umbilical Cord Blood Regulatory T Cells [NCIt concept]
- Fulranumab [NCIt concept]
- Fulvestrant [NCIt concept]
- Fumagillin-Derived Polymer Conjugate XMT-1107 [NCIt concept]
- Futuximab [NCIt concept]
- G Protein-coupled Estrogen Receptor Agonist LNS8801 [NCIt concept]
- G-Quadruplex-selective Transcription Inhibitor QN-302 [NCIt concept]
- GCN2 Modulator HC-7366-K [NCIt concept]
- GD2 Lactone/GD3 Lactone-KLH Conjugate Bivalent Vaccine [NCIt concept]
- GD2-CAR-expressing Autologous T-lymphocytes [NCIt concept]
- GI-4000 Vaccine [NCIt concept]
- GITR-targeting Agent [NCIt concept]
- GITRL RNA-transfected Autologous Dendritic Cell Vaccine [NCIt concept]
- GM-CSF-encoding Oncolytic Adenovirus CGTG-102 [NCIt concept]
- GM-CSF-secreting Lethally Irradiated Tumor Cell Vaccine [NCIt concept]
- GM-K562 Cell Vaccine [NCIt concept]
- GM.CD40L Cell Vaccine [NCIt concept]
- GM2-KLH Vaccine [NCIt concept]
- GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine [NCIt concept]
- GNAQ/GNA11 Antagonist DYP688 [NCIt concept]
- GP2 Peptide/GM-CSF Vaccine [NCIt concept]
- GPC3-targeting Agent [NCIt concept]
- GPR35 Inhibitor CT3001 [NCIt concept]
- GPRC5D-targeting Agent [NCIt concept]
- GRPR-targeting Radioconjugate [NCIt concept]
- GSK-3 Inhibitor LY2090314 [NCIt concept]
- GSPT1 MGD MRT-2359 [NCIt concept]
- Gabapentin [NCIt concept]
- Gadobutrol [NCIt concept]
- Gadodiamide [NCIt concept]
- Gadofosveset Trisodium [NCIt concept]
- Gadolinium [NCIt concept]
- Gadolinium-Chelate [NCIt concept]
- Gadopentetate Dimeglumine [NCIt concept]
- Gadopiclenol [NCIt concept]
- Gadoquatrane [NCIt concept]
- Gadoterate Meglumine [NCIt concept]
- Gadoxetate Disodium [NCIt concept]
- Gag:267-274 Peptide Vaccine [NCIt concept]
- Galacto-oligosaccharide Prebiotic Supplement [NCIt concept]
- Galactomannan Derivative [NCIt concept]
- Galantamine Hydrobromide [NCIt concept]
- Galeterone [NCIt concept]
- Galinpepimut-S [NCIt concept]
- Galiximab [NCIt concept]
- Gallium Ga 68 Boclatixafortide [NCIt concept]
- Gallium Ga 68 Citrate [NCIt concept]
- Gallium Ga 68 FAP-2286 [NCIt concept]
- Gallium Ga 68 FAPi-46 [NCIt concept]
- Gallium Ga 68 Gozetotide [NCIt concept]
- Gallium Ga 68 NNS309 [NCIt concept]
- Gallium Ga 68 NODAGA-CBP8 [NCIt concept]
- Gallium Ga 68 P15-041 [NCIt concept]
- Gallium Ga 68 PSMA-R2 [NCIt concept]
- Gallium Ga 68 R8760 [NCIt concept]
- Gallium Ga 68 Satoreotide Tetraxetan [NCIt concept]
- Gallium Ga 68 Satoreotide Trizoxetan [NCIt concept]
- Gallium Ga 68-DOTA-5G [NCIt concept]
- Gallium Ga 68-DOTATATE [NCIt concept]
- Gallium Ga 68-Edotreotide [NCIt concept]
- Gallium Ga 68-HA-DOTA-TATE [NCIt concept]
- Gallium Ga 68-NeoB [NCIt concept]
- Gallium Ga 68-P16-093 [NCIt concept]
- Gallium Ga 68-PNT6555 [NCIt concept]
- Gallium Ga 68-VMT02 [NCIt concept]
- Gallium Ga 68-labeled MLN6907 [NCIt concept]
- Gallium Ga 68-labeled RM2 [NCIt concept]
- Gallium Ga 68-labeled alphaVbeta6 Binding Peptide RAD 301 [NCIt concept]
- Gallium Ga-labeled PSMA-11-Gadoxetate [NCIt concept]
- Gallium-based Bone Resorption Inhibitor AP-002 [NCIt concept]
- Galunisertib [NCIt concept]
- Gamitrinib [NCIt concept]
- Gamma-Secretase Inhibitor [NCIt concept]
- Gamma-Secretase Inhibitor RO4929097 [NCIt concept]
- Ganciclovir [NCIt concept]
- Gandotinib [NCIt concept]
- Ganetespib [NCIt concept]
- Ganitumab [NCIt concept]
- Garsorasib [NCIt concept]
- Gartisertib [NCIt concept]
- Gataparsen Sodium [NCIt concept]
- Gavocabtagene Autoleucel [NCIt concept]
- Gebasaxturev [NCIt concept]
- Gedatolisib [NCIt concept]
- Gefitinib [NCIt concept]
- Gemcitabine Elaidate [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
- Gemcitabine Prodrug LY2334737 [NCIt concept]
- Gemcitabine-Releasing Intravesical System [NCIt concept]
- Gemfibrozil [NCIt concept]
- Gemogenovatucel-T [NCIt concept]
- Gemtuzumab Ozogamicin [NCIt concept]
- Gene Therapy Agent [NCIt concept]
- Gene-edited Autologous Neoantigen-targeted NeoTCR-P1 T-cells [NCIt concept]
- Genetically Engineered Hematopoietic Stem Progenitor Cells [NCIt concept]
- Genetically Engineered NY-ESO-1-specific T Lymphocytes [NCIt concept]
- Genistein [NCIt concept]
- Gentamicin [NCIt concept]
- Gentamicin Sulfate [NCIt concept]
- Geranylgeranyltransferase I Inhibitor [NCIt concept]
- Gevokizumab [NCIt concept]
- Giloralimab [NCIt concept]
- Gilteritinib [NCIt concept]
- Gilteritinib Fumarate [NCIt concept]
- Gimatecan [NCIt concept]
- Gimistotug [NCIt concept]
- Ginger Extract [NCIt concept]
- Ginisortamab [NCIt concept]
- Giredestrant [NCIt concept]
- Girentuximab [NCIt concept]
- Givastomig [NCIt concept]
- Givosiran [NCIt concept]
- Glasdegib [NCIt concept]
- Glasdegib Maleate [NCIt concept]
- Glecaprevir/Pibrentasvir [NCIt concept]
- Glecirasib [NCIt concept]
- Glembatumumab Vedotin [NCIt concept]
- Glesatinib [NCIt concept]
- Glioblastoma Cancer Vaccine ERC1671 [NCIt concept]
- Glioblastoma Multiforme Multipeptide Vaccine IMA950 [NCIt concept]
- Glioma Lysate Vaccine GBM6-AD [NCIt concept]
- Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine [NCIt concept]
- Glofitamab [NCIt concept]
- Glucarpidase [NCIt concept]
- Glucocorticoid Receptor Antagonist ORIC-101 [NCIt concept]
- Glucosamine Sulfate/Chondroitin Sulfate Tablet [NCIt concept]
- Glufosfamide [NCIt concept]
- Glutamic Acid [NCIt concept]
- Glutaminase-1 Inhibitor IACS-6274 [NCIt concept]
- Glutamine [NCIt concept]
- Glutathione [NCIt concept]
- Glutathione Disulfide NOV-002 [NCIt concept]
- Glyburide [NCIt concept]
- Glycocyamine [NCIt concept]
- Glycosylated Recombinant Human Interleukin-7 [NCIt concept]
- Goat Milk [NCIt concept]
- Gocatamig [NCIt concept]
- Golcadomide [NCIt concept]
- Gold Sodium Thiomalate [NCIt concept]
- Golidocitinib [NCIt concept]
- Golimumab [NCIt concept]
- Golnerminogene Pradenovec [NCIt concept]
- Golotimod [NCIt concept]
- Golvatinib [NCIt concept]
- Gomiliximab [NCIt concept]
- Gonadotrophin Releasing Hormone [NCIt concept]
- Gonadotropin [NCIt concept]
- Gonadotropin Releasing Hormone Antagonist [NCIt concept]
- Gonadotropin-releasing Hormone Analog [NCIt concept]
- Gontivimab [NCIt concept]
- Gorilla-derived Adenovirus-expressing HPV-16/18 E6/E7 Vaccine [NCIt concept]
- Gorilla-derived Adenovirus-expressing HPV-6/11 Vaccine PRGN-2012 [NCIt concept]
- Goserelin [NCIt concept]
- Goserelin Acetate [NCIt concept]
- Gotistobart [NCIt concept]
- Gozetotide [NCIt concept]
- Granisetron Hydrochloride [NCIt concept]
- Granisetron Transdermal Patch [NCIt concept]
- Grape Seed Extract Supplement [NCIt concept]
- Grapiprant [NCIt concept]
- Green Tea [NCIt concept]
- Green Tea Extract [NCIt concept]
- Green Tea Lozenge [NCIt concept]
- Gresonitamab [NCIt concept]
- Gridegalutamide [NCIt concept]
- Gruticibart [NCIt concept]
- Guadecitabine [NCIt concept]
- Guadecitabine Sodium [NCIt concept]
- Guanabenz Acetate [NCIt concept]
- Gunagratinib [NCIt concept]
- Guretolimod [NCIt concept]
- Guselkumab [NCIt concept]
- H3.3K27M-specific Peptide Vaccine [NCIt concept]
- HAAH Lambda phage Vaccine SNS-301 [NCIt concept]
- HCV DNA Vaccine INO-8000 [NCIt concept]
- HDAC Inhibitor OBP-801 [NCIt concept]
- HDAC Inhibitor REC-2282 [NCIt concept]
- HDAC/EGFR/HER2 Inhibitor CUDC-101 [NCIt concept]
- HDAC6 Inhibitor KA2507 [NCIt concept]
- HDM2 Inhibitor MK-8242 [NCIt concept]
- HER-2/PD-L1-targeting CAR-T Cells [NCIt concept]
- HER-2/neu Intracellular Domain Protein [NCIt concept]
- HER-2/neu Peptide Vaccine [NCIt concept]
- HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901 [NCIt concept]
- HER2 Inhibitor [NCIt concept]
- HER2 Inhibitor DZD1516 [NCIt concept]
- HER2 Inhibitor ELVN-002 [NCIt concept]
- HER2 Inhibitor IAM1363 [NCIt concept]
- HER2 Inhibitor TAS0728 [NCIt concept]
- HER2 Inhibitor ZN-A-1041 [NCIt concept]
- HER2 Mutant-selective Inhibitor NVL-330 [NCIt concept]
- HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 [NCIt concept]
- HER2-targeting Agent [NCIt concept]
- HER2-targeting Antibody Fc Fragment FS102 [NCIt concept]
- HER2/neu Peptide Vaccine GLSI-100 [NCIt concept]
- HER2Bi-Armed Activated T Cells [NCIt concept]
- HER3-targeting Agent [NCIt concept]
- HIF-1alpha Inhibitor PX-478 [NCIt concept]
- HIF-2alpha Inhibitor [NCIt concept]
- HIF-2alpha Inhibitor PT2385 [NCIt concept]
- HIF2-alpha Inhibitor NKT2152 [NCIt concept]
- HIF2alpha Inhibitor DFF332 [NCIt concept]
- HLA-A*0201-restricted TRP2-gp100-EphA2-HER2 Multipeptide Vaccine [NCIt concept]
- HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine [NCIt concept]
- HLA-A2-restricted IL-13Ra2/EphA2/Survivin/Tetanus Toxoid T-helper Epitopes-Montanide 51 Vaccine [NCIt concept]
- HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201 [NCIt concept]
- HPPH [NCIt concept]
- HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 [NCIt concept]
- HPV 16 E7:12-20 Peptide Vaccine [NCIt concept]
- HPV 16 E7:86-93 Peptide Vaccine [NCIt concept]
- HPV 16/18 E6/E7 DNA Vaccine pBI-11 [NCIt concept]
- HPV E6/E7-encoding Arenavirus Vaccine HB-201 [NCIt concept]
- HPV-16 E6 Peptides Vaccine/Candida albicans Extract [NCIt concept]
- HPV-16 E7 TCR Expressing T-cells [NCIt concept]
- HPV-6-targeting Immunotherapeutic Vaccine INO-3106 [NCIt concept]
- HPV16 E6/7 mRNA Vaccine BNT113 [NCIt concept]
- HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101 [NCIt concept]
- HPV16 RG1 VLP Vaccine [NCIt concept]
- HPV16 Vaccine [NCIt concept]
- HPV6/11-targeted DNA Plasmid Vaccine INO-3107 [NCIt concept]
- HSD-1 Inhibitor SPI-62 [NCIt concept]
- HSP90 Inhibitor [NCIt concept]
- HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2 [NCIt concept]
- HSV-TK-Transduced Donor Lymphocytes [NCIt concept]
- Hafnium Oxide-containing Nanoparticles NBTXR3 [NCIt concept]
- Halofuginone Hydrobromide [NCIt concept]
- Haloperidol [NCIt concept]
- Haploidentical Natural Killer Cells K-NK002 [NCIt concept]
- Heat Shock Factor 1 Pathway Inhibitor NXP800 [NCIt concept]
- Heat Shock Protein Inhibitor [NCIt concept]
- Heat-Treated Varicella-Zoster Virus Vaccine V212 [NCIt concept]
- Hemostatic Agent [NCIt concept]
- Heparin [NCIt concept]
- Hepatitis A Vaccine [NCIt concept]
- Hepatitis B Antigen Vaccine [NCIt concept]
- Hepatitis B Vaccine [NCIt concept]
- Herb [NCIt concept]
- Hexaminolevulinate [NCIt concept]
- Hexaminolevulinate Hydrochloride [NCIt concept]
- High-Dose Methotrexate Regimen [NCIt concept]
- High-Selenium Brassica juncea [NCIt concept]
- High-titer RSV Immune Globulin RI-001 [NCIt concept]
- Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126 [NCIt concept]
- Histrelin [NCIt concept]
- Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine [NCIt concept]
- Hormone Antagonist [NCIt concept]
- Hormone Therapy Agent [NCIt concept]
- Hpk1 Inhibitor BGB-15025 [NCIt concept]
- Hpk1 Inhibitor BGB-26808 [NCIt concept]
- Hpk1 Inhibitor CFI-402411 [NCIt concept]
- Hpk1 Inhibitor FB849 [NCIt concept]
- Hpk1 Inhibitor GRC 54276 [NCIt concept]
- Hpk1 Inhibitor NDI-101150 [NCIt concept]
- Hpk1 Inhibitor PF-07265028 [NCIt concept]
- Hsp90 Antagonist KW-2478 [NCIt concept]
- Hsp90 Inhibitor BIIB021 [NCIt concept]
- Hsp90 Inhibitor BIIB028 [NCIt concept]
- Hsp90 Inhibitor DS-2248 [NCIt concept]
- Hsp90 Inhibitor LAM-003 [NCIt concept]
- Hsp90 Inhibitor SNX-5422 Mesylate [NCIt concept]
- Hsp90 Inhibitor XL888 [NCIt concept]
- Hsp90-targeted Photosensitizer HS-201 [NCIt concept]
- HuaChanSu [NCIt concept]
- Human Acellular Dermal Matrix [NCIt concept]
- Human Anti-CD30 CAR-expressing Autologous T-lymphocytes [NCIt concept]
- Human Embryonic Stem Cell-derived Midbrain Dopamine Neuron Cells MSK-DA01 [NCIt concept]
- Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104 [NCIt concept]
- Human Milk Oligosaccharides-based Formulation PBCLN-010 [NCIt concept]
- Human Monoclonal Antibody 216 [NCIt concept]
- Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 [NCIt concept]
- Human Papilloma Virus Vaccine [NCIt concept]
- Human Papillomavirus Tumor Antigen Vaccine [NCIt concept]
- Human Papillomavirus Vaccine V503 [NCIt concept]
- Hyaluronidase-zzxf/Pertuzumab/Trastuzumab [NCIt concept]
- Hydralazine Hydrochloride [NCIt concept]
- Hydrated Sodium Calcium Aluminosilicate [NCIt concept]
- Hydrocodone [NCIt concept]
- Hydrocortisone Sodium Succinate [NCIt concept]
- Hydrogel-based Resiquimod STM-416 [NCIt concept]
- Hydromorphone [NCIt concept]
- Hydroxocobalamin [NCIt concept]
- Hydroxychloroquine [NCIt concept]
- Hydroxychloroquine Sulfate [NCIt concept]
- Hydroxytyrosol [NCIt concept]
- Hydroxyurea [NCIt concept]
- Hyper-Sialylated IgG M254 [NCIt concept]
- Hyperpolarized Carbon 13 Alpha-ketoglutarate [NCIt concept]
- Hyperpolarized Carbon C 13 Pyruvate [NCIt concept]
- Hyperpolarized Carbon C 13/Nitrogen N 15-labeled Urea [NCIt concept]
- Hypertonic Saline [NCIt concept]
- Hypoxia-activated Prodrug TH-4000 [NCIt concept]
- IAP Inhibitor HGS1029 [NCIt concept]
- ICT-121 Dendritic Cell Vaccine [NCIt concept]
- IDH1(R132) Inhibitor IDH305 [NCIt concept]
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M [NCIt concept]
- IDO-1 Inhibitor LY3381916 [NCIt concept]
- IDO1 Inhibitor [NCIt concept]
- IDO1 Inhibitor KHK2455 [NCIt concept]
- IDO1 Inhibitor MK-7162 [NCIt concept]
- IDO1 Inhibitor PF-06840003 [NCIt concept]
- IDO1/TDO2 Inhibitor M4112 [NCIt concept]
- IGF-1R Antisense Oligodeoxynucleotide-treated Autologous Glioma Cells IGV-001 [NCIt concept]
- IGF-1R Inhibitor PL225B [NCIt concept]
- IGF-1R/IR Inhibitor KW-2450 [NCIt concept]
- IGF-methotrexate Conjugate [NCIt concept]
- IH636 Grape Seed Proanthocyanidin Extract [NCIt concept]
- IKZF2 Protein Degrader DKY709 [NCIt concept]
- IL-10 Immunomodulator MK-1966 [NCIt concept]
- IL-12-Fc Fusion Protein XmAb662 [NCIt concept]
- IL-12-expressing HSV-1 NSC 733972 [NCIt concept]
- IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000 [NCIt concept]
- IL-15 Superagonist SOT201 [NCIt concept]
- IL-15(N72D)/IL-15Ralpha-sFc Fusion Protein Complex FL115 [NCIt concept]
- IL-15/IL-15 Receptor alpha Heterodimer NIZ985 [NCIt concept]
- IL-2 Fusion Protein PTX-912 [NCIt concept]
- IL-2 Recombinant Fusion Protein ALT-801 [NCIt concept]
- IL-2 Superkine-Recombinant Human Albumin Fusion Protein MDNA11 [NCIt concept]
- IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1 [NCIt concept]
- IL-2/Anti-IL-2 Antibody Conjugate SLC-3010 [NCIt concept]
- IL-2/IL-12-based Fusion Protein CLN-617 [NCIt concept]
- IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine [NCIt concept]
- IL-34 Inhibitor [NCIt concept]
- IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells [NCIt concept]
- IMT-1012 Immunotherapeutic Vaccine [NCIt concept]
- IRAK4/Ikaros/Aiolos Protein Degrader KT-413 [NCIt concept]
- IRE1 RNase Inhibitor ORIN1001 [NCIt concept]
- IRS1/IRS2/STAT3 Inhibitor NT219 [NCIt concept]
- ITK Inhibitor [NCIt concept]
- Iadademstat [NCIt concept]
- Ibandronate Sodium [NCIt concept]
- Ibcasertib [NCIt concept]
- Ibentatug [NCIt concept]
- Iberdomide Hydrochloride [NCIt concept]
- Iboctadekin [NCIt concept]
- Ibrexafungerp [NCIt concept]
- Ibritumomab Tiuxetan [NCIt concept]
- Ibrutinib [NCIt concept]
- Ibudilast [NCIt concept]
- Ibuprofen [NCIt concept]
- Icatibant [NCIt concept]
- Icosapent Ethyl [NCIt concept]
- Icotinib Hydrochloride [NCIt concept]
- Icovamenib [NCIt concept]
- Icrucumab [NCIt concept]
- Idarubicin [NCIt concept]
- Idarubicin Hydrochloride [NCIt concept]
- Idasanutlin [NCIt concept]
- Idecabtagene Vicleucel [NCIt concept]
- Idelalisib [NCIt concept]
- Idronoxil [NCIt concept]
- Idronoxil Suppository NOX66 [NCIt concept]
- Idroxioleic Acid [NCIt concept]
- Iduronicrin Genleukocel-T [NCIt concept]
- Ieramilimab [NCIt concept]
- Ifabotuzumab [NCIt concept]
- Ifebemtinib [NCIt concept]
- Ifetroban [NCIt concept]
- Ifinatamab Deruxtecan [NCIt concept]
- Ifosfamide [NCIt concept]
- Ilantimod [NCIt concept]
- Ilginatinib [NCIt concept]
- Ilixadencel [NCIt concept]
- Ilorasertib [NCIt concept]
- Imaging Agent [NCIt concept]
- Imalumab [NCIt concept]
- Imaradenant [NCIt concept]
- Imatinib [NCIt concept]
- Imatinib Mesylate [NCIt concept]
- Imdevimab [NCIt concept]
- Imetelstat [NCIt concept]
- Imetelstat Sodium [NCIt concept]
- Imexon [NCIt concept]
- Imgatuzumab [NCIt concept]
- Imifoplatin [NCIt concept]
- Imipenem-Cilastatin-Relebactam [NCIt concept]
- Imipramine Blue [NCIt concept]
- Imipramine Hydrochloride [NCIt concept]
- Imiquimod [NCIt concept]
- Imisopasem Manganese [NCIt concept]
- Imlunestrant [NCIt concept]
- Immediate-release Bupropion [NCIt concept]
- Immediate-release Oxymorphone Hydrochloride Liquid Formulation [NCIt concept]
- Immune Checkpoint Inhibitor [NCIt concept]
- Immune Checkpoint Modulator [NCIt concept]
- Immunocytokine NHS-IL12 [NCIt concept]
- Immunocytokine NHS-IL2-LT [NCIt concept]
- Immunomodulatory Agent CC-11006 [NCIt concept]
- Immunomodulatory Imide Drug [NCIt concept]
- Immunotherapeutic Agent [NCIt concept]
- Immunotherapeutic Combination Product CMB305 [NCIt concept]
- Immunotherapy Regimen MKC-1106-MT [NCIt concept]
- Immunotoxin D2C7-(scdsFv)-PE38KDEL [NCIt concept]
- Imneskibart [NCIt concept]
- Imsidolimab [NCIt concept]
- Imvotamab [NCIt concept]
- Imzokitug [NCIt concept]
- Inactivated Poliovirus Vaccine [NCIt concept]
- Inalimarev [NCIt concept]
- Inavolisib [NCIt concept]
- Incomplete Freund's Adjuvant [NCIt concept]
- Incyclinide [NCIt concept]
- Indatuximab Ravtansine [NCIt concept]
- India Ink [NCIt concept]
- Indinavir Sulfate [NCIt concept]
- Indisulam [NCIt concept]
- Indium In 111 Anti-CD45 Monoclonal Antibody BC8 [NCIt concept]
- Indium In 111 CHX-A DTPA Trastuzumab [NCIt concept]
- Indium In 111 Capromab Pendetide [NCIt concept]
- Indium In 111 Daclizumab [NCIt concept]
- Indium In 111 FPI-2058 [NCIt concept]
- Indium In 111 FPI-2071 [NCIt concept]
- Indium In 111 Panitumumab [NCIt concept]
- Indium In 111 Rosopatamab Tetraxetan [NCIt concept]
- Indium In 111 Vofatamab [NCIt concept]
- Indium In 111-Autologous CMV-pp65-LAMP mRNA Loaded Dendritic Cells [NCIt concept]
- Indium In 111-DOTA-Basiliximab [NCIt concept]
- Indium In 111-DOTA-Daratumumab [NCIt concept]
- Indium In 111-DOTA-h11B6 [NCIt concept]
- Indium In 111-FPI-1547 [NCIt concept]
- Indium In 111-labeled Macroaggregated Albumin [NCIt concept]
- Indium In-111 Ibritumomab Tiuxetan [NCIt concept]
- Indium In-111 Pentetreotide [NCIt concept]
- Individualized MVA-based Vaccine TG4050 [NCIt concept]
- Indocyanine Green [NCIt concept]
- Indocyanine Green Solution [NCIt concept]
- Indole-3-Carbinol [NCIt concept]
- Indomethacin [NCIt concept]
- Indoximod [NCIt concept]
- Indoximod Prodrug NLG802 [NCIt concept]
- Inducible CD4+CD25+ Regulatory T Cells [NCIt concept]
- Indusatumab Vedotin [NCIt concept]
- Inebilizumab [NCIt concept]
- Inecalcitol [NCIt concept]
- Inezetamab [NCIt concept]
- Infigratinib [NCIt concept]
- Infigratinib Phosphate [NCIt concept]
- Infliximab [NCIt concept]
- Ingitamig [NCIt concept]
- Iniparib [NCIt concept]
- Inixaciclib [NCIt concept]
- Inlexisertib [NCIt concept]
- Innate Immunostimulator rBBX-01 [NCIt concept]
- Inodiftagene Vixteplasmid [NCIt concept]
- Inositol [NCIt concept]
- Inotersen [NCIt concept]
- Inotuzumab Ozogamicin [NCIt concept]
- Insulin Aspart [NCIt concept]
- Insulin Glargine [NCIt concept]
- Insulin, NPH [NCIt concept]
- Integrin Alpha V Beta 3-targeting Protein ACT50 [NCIt concept]
- Integrin alpha-2 Inhibitor E7820 [NCIt concept]
- Interferon Beta-1A [NCIt concept]
- Interferon Beta-secreting Mesenchymal Stem Cells [NCIt concept]
- Interleukin-12 Gene [NCIt concept]
- Interleukin-12-Fc Fusion Protein DF6002 [NCIt concept]
- Interleukin-15 Fusion Protein BJ-001 [NCIt concept]
- Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306 [NCIt concept]
- Interleukin-2 Gene [NCIt concept]
- Interleukin-2/Interleukin-15 Receptor Agonist NL-201 [NCIt concept]
- Internalized-arginylglycylaspartic Acid Cyclic Peptide [NCIt concept]
- Intetumumab [NCIt concept]
- Intismeran Autogene [NCIt concept]
- Intrathecal Deferoxamine [NCIt concept]
- Inupadenant [NCIt concept]
- Iobenguane [NCIt concept]
- Iobenguane I-123 [NCIt concept]
- Iobenguane I-124 [NCIt concept]
- Iobenguane I-131 [NCIt concept]
- Iodinated Contrast Agent [NCIt concept]
- Iodinated Polyethylene Glycol-based Hydrogel Tissue Marker [NCIt concept]
- Iodine I 123 Anti-CEA Recombinant Diabody T84.66 [NCIt concept]
- Iodine I 123 RISAD-P [NCIt concept]
- Iodine I 124 [NCIt concept]
- Iodine I 124 Icapamespib [NCIt concept]
- Iodine I 124 Iopofosine [NCIt concept]
- Iodine I 124 Monoclonal Antibody 3F8 [NCIt concept]
- Iodine I 124 Monoclonal Antibody M5A [NCIt concept]
- Iodine I 124 Omburtamab [NCIt concept]
- Iodine I 124 hJAA-F11 [NCIt concept]
- Iodine I 124-cRGDY-PEG-C Dots [NCIt concept]
- Iodine I 124-labeled Albumin [NCIt concept]
- Iodine I 124-labeled Anti-PSCA A11 Minibody [NCIt concept]
- Iodine I 124-labeled Hsp90 Inhibitor PUH71 [NCIt concept]
- Iodine I 125 RISAD-P [NCIt concept]
- Iodine I 131 Apamistamab [NCIt concept]
- Iodine I 131 Derlotuximab Biotin [NCIt concept]
- Iodine I 131 Iopofosine [NCIt concept]
- Iodine I 131 MIP-1095 [NCIt concept]
- Iodine I 131 Monoclonal Antibody 81C6 [NCIt concept]
- Iodine I 131 Monoclonal Antibody CC49-deltaCH2 [NCIt concept]
- Iodine I 131 Omburtamab [NCIt concept]
- Iodine I 131 SGMIB-Anti-HER2 CAM-H2 [NCIt concept]
- Iodine I 131 TM-601 [NCIt concept]
- Iodine I 131 Tositumomab [NCIt concept]
- Iodine I-123 [NCIt concept]
- Iodine I-123 ADAM [NCIt concept]
- Iodine I-123 MIP-1095 [NCIt concept]
- Iodine I-124 FIAU [NCIt concept]
- Iodine I-124 Girentuximab [NCIt concept]
- Iodine I-125 [NCIt concept]
- Iodine I-131 [NCIt concept]
- Iodixanol [NCIt concept]
- Iofolastat I123 [NCIt concept]
- Iopamidol [NCIt concept]
- Ioversol [NCIt concept]
- Ipafricept [NCIt concept]
- Ipamorelin [NCIt concept]
- Iparomlimab/Tuvonralimab [NCIt concept]
- Ipatasertib [NCIt concept]
- Ipilimumab [NCIt concept]
- Iratumumab [NCIt concept]
- Irinotecan [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Irinotecan Sucrosofate [NCIt concept]
- Irinotecan-Eluting Beads [NCIt concept]
- Irofulven [NCIt concept]
- Iron Chelating Agent SP-420 [NCIt concept]
- Iron Conjugated Polymers in Saline Suspension [NCIt concept]
- Irosustat [NCIt concept]
- Isatuximab [NCIt concept]
- Isavuconazole [NCIt concept]
- Isavuconazonium Sulfate [NCIt concept]
- Iso-fludelone [NCIt concept]
- Isosulfan Blue [NCIt concept]
- Isotretinoin [NCIt concept]
- Ispectamab Debotansine [NCIt concept]
- Ispinesib [NCIt concept]
- Istiratumab [NCIt concept]
- Istisociclib [NCIt concept]
- Itacitinib [NCIt concept]
- Itacitinib Adipate [NCIt concept]
- Itacnosertib [NCIt concept]
- Itraconazole [NCIt concept]
- Itraconazole Dispersion In Polymer Matrix [NCIt concept]
- Ivabradine [NCIt concept]
- Ivabradine Hydrochloride [NCIt concept]
- Ivicentamab [NCIt concept]
- Ivosidenib [NCIt concept]
- Ivospemin Hydrochloride [NCIt concept]
- Ivuxolimab [NCIt concept]
- Ixabepilone [NCIt concept]
- Ixazomib Citrate [NCIt concept]
- Izastobart [NCIt concept]
- Izorlisib [NCIt concept]
- Izuralimab [NCIt concept]
- JAK Inhibitor [NCIt concept]
- JAK1 Inhibitor INCB052793 [NCIt concept]
- JAK2 Inhibitor AZD1480 [NCIt concept]
- JAK2 Inhibitor BMS-911543 [NCIt concept]
- JAK2 Inhibitor XL019 [NCIt concept]
- JAK2V617F Inhibitor INCB160058 [NCIt concept]
- JNK1 Inhibitor BMS-986360 [NCIt concept]
- Jojoba Oil [NCIt concept]
- Juven [NCIt concept]
- KDM4 Inhibitor TACH101 [NCIt concept]
- KIF18A Inhibitor [NCIt concept]
- KIF18A Inhibitor VLS-1488 [NCIt concept]
- KIT-mutant Inhibitor IDRX-42 [NCIt concept]
- KLH/NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine [NCIt concept]
- KRAS G12C Inhibitor [NCIt concept]
- KRAS G12C Inhibitor BBO-8520 [NCIt concept]
- KRAS G12C Inhibitor BI 1823911 [NCIt concept]
- KRAS G12C Inhibitor FMC-376 [NCIt concept]
- KRAS G12C Inhibitor JNJ-74699157 [NCIt concept]
- KRAS G12C Inhibitor LY3499446 [NCIt concept]
- KRAS G12C Inhibitor MK-1084 [NCIt concept]
- KRAS G12C Inhibitor RMC-6291 [NCIt concept]
- KRAS G12D Degrader ASP3082 [NCIt concept]
- KRAS G12D Inhibitor [NCIt concept]
- KRAS G12D Inhibitor AZD0022 [NCIt concept]
- KRAS G12D Inhibitor INCB161734 [NCIt concept]
- KRAS G12D Inhibitor LY3962673 [NCIt concept]
- KRAS G12D Inhibitor QTX3046 [NCIt concept]
- KRAS G12D Inhibitor RMC-9805 [NCIt concept]
- KRAS G12D Inhibitor TSN1611 [NCIt concept]
- KRAS Inhibitor [NCIt concept]
- KRAS Inhibitor BI 3706674 [NCIt concept]
- KRAS Mutant Inhibitor QTX3034 [NCIt concept]
- KRN5500 [NCIt concept]
- KSP Inhibitor AZD4877 [NCIt concept]
- KSP Inhibitor SB-743921 [NCIt concept]
- Kanglaite [NCIt concept]
- Kava-based Supplement [NCIt concept]
- Kefir [NCIt concept]
- Ketamine [NCIt concept]
- Ketamine Hydrochloride [NCIt concept]
- Ketamine/Amitriptyline NP-H Cream [NCIt concept]
- Ketoconazole [NCIt concept]
- Ketoprofen [NCIt concept]
- Ketorolac [NCIt concept]
- Ketorolac Tromethamine [NCIt concept]
- Keyhole Limpet Hemocyanin [NCIt concept]
- L-4-chlorokynurenine [NCIt concept]
- L-Arginine/Korean Ginseng/Ginkgo biloba/Damiana-Based Supplement [NCIt concept]
- L-Lysine [NCIt concept]
- L-Selenomethionine [NCIt concept]
- L-lysine/L-arginine-containing Amino Acid [NCIt concept]
- L-methylfolate [NCIt concept]
- LAG-3-targeting Agent [NCIt concept]
- LAIR-2 Fusion Protein NC410 [NCIt concept]
- LILRB4-targeting Agent [NCIt concept]
- LMB-2 Immunotoxin [NCIt concept]
- LMP1/BARF1/EBNA1-specific Cytotoxic T-lymphocytes [NCIt concept]
- LMP7 Inhibitor M3258 [NCIt concept]
- LRP5 Antagonist BI 905681 [NCIt concept]
- LSD1 Inhibitor GSK2879552 [NCIt concept]
- Labetuzumab Govitecan [NCIt concept]
- Labyrinthin Peptide Vaccine LabVax 3(22)-23 [NCIt concept]
- Lacnotuzumab [NCIt concept]
- Lacosamide [NCIt concept]
- Lactobacillus brevis CD2 Lozenge [NCIt concept]
- Lactobacillus plantarum 299v/Lactobacillus acidophilus/Bifidobacterium lactis Probiotic Supplement [NCIt concept]
- Lactobacillus plantarum strain 299 [NCIt concept]
- Lactobacillus plantarum strain 299v [NCIt concept]
- Lactobacillus rhamnosus GG [NCIt concept]
- Lacutamab [NCIt concept]
- Ladiratuzumab Vedotin [NCIt concept]
- Lamivudine [NCIt concept]
- Landogrozumab [NCIt concept]
- Lanerkitug [NCIt concept]
- Lanreotide Acetate [NCIt concept]
- Lanreotide Long-Acting Aqueous Gel [NCIt concept]
- Lapatinib Ditosylate [NCIt concept]
- Lapatinib/Letrozole Regimen [NCIt concept]
- Lapine T-Lymphocyte Immune Globulin [NCIt concept]
- Laprituximab Emtansine [NCIt concept]
- Lapuleucel-T [NCIt concept]
- Laromustine [NCIt concept]
- Laronidase [NCIt concept]
- Larotaxel [NCIt concept]
- Larotrectinib Sulfate [NCIt concept]
- Lartesertib [NCIt concept]
- Lasofoxifene [NCIt concept]
- Latikafusp [NCIt concept]
- Lavender Oil [NCIt concept]
- Lawsonia inermis-based Supplement [NCIt concept]
- Laxative [NCIt concept]
- Lazertinib [NCIt concept]
- Lead Pb 203 VMT-a-NET [NCIt concept]
- Lead Pb 203-VMT01 [NCIt concept]
- Lead Pb 212 DOTAMTATE [NCIt concept]
- Lead Pb 212 TCMC-trastuzumab [NCIt concept]
- Lead Pb 212 VMT-a-NET [NCIt concept]
- Lead Pb 212-DOTAM-GRPR1 [NCIt concept]
- Lead Pb 212-VMT01 [NCIt concept]
- Lebrikizumab [NCIt concept]
- Ledipasvir [NCIt concept]
- Lefitolimod [NCIt concept]
- Leflunomide [NCIt concept]
- Lemzoparlimab [NCIt concept]
- Lenalidomide [NCIt concept]
- Lenalidomide Analog KPG-121 [NCIt concept]
- Lenti-D/ABCD1-transduced Autologous Hematopoietic Stem Cells [NCIt concept]
- Lentivirus Vector CCR5 shRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor Cells [NCIt concept]
- Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Progenitor Cells [NCIt concept]
- Lenumlostat [NCIt concept]
- Lenvatinib [NCIt concept]
- Lenvatinib Mesylate [NCIt concept]
- Lenzilumab [NCIt concept]
- Lerapolturev [NCIt concept]
- Leriglitazone [NCIt concept]
- Lerociclib [NCIt concept]
- Leronlimab [NCIt concept]
- Lestaurtinib [NCIt concept]
- Letaplimab [NCIt concept]
- Letetresgene Autoleucel [NCIt concept]
- Letolizumab [NCIt concept]
- Letrozole [NCIt concept]
- Letrozole/Palbociclib Regimen [NCIt concept]
- Leucovorin [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Leuprolide [NCIt concept]
- Leuprolide Acetate [NCIt concept]
- Leuprolide Acetate for Injectable Suspension TOL2506 [NCIt concept]
- Levamisole Hydrochloride [NCIt concept]
- Levocarnitine [NCIt concept]
- Levocetirizine Dihydrochloride [NCIt concept]
- Levofloxacin [NCIt concept]
- Levoketoconazole [NCIt concept]
- Levoleucovorin [NCIt concept]
- Levonorgestrel [NCIt concept]
- Levonorgestrel-Releasing Intrauterine System [NCIt concept]
- Levorphanol [NCIt concept]
- Levothyroxine [NCIt concept]
- Levothyroxine Sodium [NCIt concept]
- Lidocaine [NCIt concept]
- Lidocaine Hydrochloride [NCIt concept]
- Lidocaine Patch [NCIt concept]
- Lidocaine Topical [NCIt concept]
- Lidofenin [NCIt concept]
- Lifastuzumab Vedotin [NCIt concept]
- Lifileucel [NCIt concept]
- Lifirafenib [NCIt concept]
- Ligand Directed Degrader BMS-986460 [NCIt concept]
- Lilotomab [NCIt concept]
- Limantrafin [NCIt concept]
- Limonene, (+)- [NCIt concept]
- Linaclotide [NCIt concept]
- Linaclotide Acetate [NCIt concept]
- Linavonkibart [NCIt concept]
- Linezolid [NCIt concept]
- Linifanib [NCIt concept]
- Linoleyl Carbonate-Paclitaxel [NCIt concept]
- Linperlisib [NCIt concept]
- Linrodostat [NCIt concept]
- Linsitinib [NCIt concept]
- Lintuzumab [NCIt concept]
- Linvoseltamab [NCIt concept]
- Liothyronine Sodium [NCIt concept]
- Lipegfilgrastim [NCIt concept]
- Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1 [NCIt concept]
- Lipid Nanoparticle Encapsulated MYC-targeting mRNA-based Agent OTX-2002 [NCIt concept]
- Lipid Nanoparticle Encapsulated OX40L mRNA-2416 [NCIt concept]
- Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 JCXH-211 [NCIt concept]
- Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 STX-001 [NCIt concept]
- Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191 [NCIt concept]
- Lipid Nanoparticle Encapsulating Beta-catenin siRNA ALN-BCAT [NCIt concept]
- Lipid Nanoparticle Encapsulating mRNA Encoding Cas9 Protein and TTR-targeting Single Guide RNA NTLA-2001 [NCIt concept]
- Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752 [NCIt concept]
- Liposomal Alpha Galactosylceramide [NCIt concept]
- Liposomal Amphotericin B [NCIt concept]
- Liposomal Bupivacaine [NCIt concept]
- Liposomal Chk1 Inhibitor SMP-3124 SMP-3124LP [NCIt concept]
- Liposomal Cytarabine [NCIt concept]
- Liposomal Daunorubicin Citrate [NCIt concept]
- Liposomal Docetaxel [NCIt concept]
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 [NCIt concept]
- Liposomal MnSOD Plasmid [NCIt concept]
- Liposomal Topotecan FF-10850 [NCIt concept]
- Liposomal Vinorelbine Tartrate [NCIt concept]
- Liposomal iNKT Agonist PORT-2 [NCIt concept]
- Liposomal-based Cream Base [NCIt concept]
- Liposome-Encapsulated Doxorubicin Citrate [NCIt concept]
- Liposome-encapsulated Daunorubicin-Cytarabine [NCIt concept]
- Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94 [NCIt concept]
- Liposome-encapsulated miR-34 Mimic MRX34 [NCIt concept]
- Lirafugratinib [NCIt concept]
- Liraglutide [NCIt concept]
- Lirametostat [NCIt concept]
- Lirilumab [NCIt concept]
- Lisaftoclax [NCIt concept]
- Lisavanbulin [NCIt concept]
- Lisdexamfetamine Dimesylate [NCIt concept]
- Lisinopril [NCIt concept]
- Lisocabtagene Maraleucel [NCIt concept]
- Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142 [NCIt concept]
- Listeria monocytogenes-LLO-Prostate Cancer Neoantigens Vaccine ADXS-504 [NCIt concept]
- Lithium Carbonate [NCIt concept]
- Litronesib [NCIt concept]
- Live Freeze-Dried Lactic Acid Bacteria Probiotic [NCIt concept]
- Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207 [NCIt concept]
- Livmoniplimab [NCIt concept]
- Lm-tLLO-neoantigens Vaccine ADXS-NEO [NCIt concept]
- LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine OST31-164 [NCIt concept]
- Locnartecan [NCIt concept]
- Lodapolimab [NCIt concept]
- Lomustine [NCIt concept]
- Lonafarnib [NCIt concept]
- Loncastuximab Tesirine [NCIt concept]
- Long Peptide Vaccine 7 [NCIt concept]
- Long-acting Recombinant Erwinia asparaginase JZP-341 [NCIt concept]
- Long-acting Release Pasireotide [NCIt concept]
- Loperamide [NCIt concept]
- Lopinavir [NCIt concept]
- Lopinavir/Ritonavir [NCIt concept]
- Lorazepam [NCIt concept]
- Lorigerlimab [NCIt concept]
- Lorlatinib [NCIt concept]
- Lorpucitinib [NCIt concept]
- Lorukafusp alfa [NCIt concept]
- Lorvotuzumab Mertansine [NCIt concept]
- Losartan [NCIt concept]
- Losartan Potassium [NCIt concept]
- Losatuxizumab Vedotin [NCIt concept]
- Lovastatin [NCIt concept]
- Lovotibeglogene Autotemcel [NCIt concept]
- Low Molecular Weight Heparin [NCIt concept]
- Low-Dose Aspirin [NCIt concept]
- Low-dose Cytarabine Regimen [NCIt concept]
- Lubricant [NCIt concept]
- Lucanthone [NCIt concept]
- Lucatumumab [NCIt concept]
- Lucicebtide [NCIt concept]
- Lugol's Solution [NCIt concept]
- Luminespib [NCIt concept]
- Lunresertib [NCIt concept]
- Lurbinectedin [NCIt concept]
- Luspatercept [NCIt concept]
- Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1 [NCIt concept]
- Lutetium Lu 177 DOTA-N3-CTT1403 [NCIt concept]
- Lutetium Lu 177 DOTA-Tetulomab [NCIt concept]
- Lutetium Lu 177 Dotatate [NCIt concept]
- Lutetium Lu 177 FF58 [NCIt concept]
- Lutetium Lu 177 Ludotadipep [NCIt concept]
- Lutetium Lu 177 NNS309 [NCIt concept]
- Lutetium Lu 177 Rosopatamab Tetraxetan [NCIt concept]
- Lutetium Lu 177 Satoreotide Tetraxetan [NCIt concept]
- Lutetium Lu 177 Vipivotide Tetraxetan [NCIt concept]
- Lutetium Lu 177 Zalsenertant Tetraxetan [NCIt concept]
- Lutetium Lu 177-DOTA [NCIt concept]
- Lutetium Lu 177-DOTA-ABM-5G [NCIt concept]
- Lutetium Lu 177-DOTA-EB-TATE [NCIt concept]
- Lutetium Lu 177-DTPA-omburtamab [NCIt concept]
- Lutetium Lu 177-Edotreotide [NCIt concept]
- Lutetium Lu 177-FAP-2286 [NCIt concept]
- Lutetium Lu 177-NeoB [NCIt concept]
- Lutetium Lu 177-PNT6555 [NCIt concept]
- Lutetium Lu 177-PSMA-I&T [NCIt concept]
- Lutetium Lu-177 PSMA-R2 [NCIt concept]
- Luveltamab Tazevibulin [NCIt concept]
- Luvixasertib [NCIt concept]
- Luxdegalutamide [NCIt concept]
- Luxeptinib [NCIt concept]
- Lycopene [NCIt concept]
- Lymphoma TAA-specific Cytotoxic T Lymphocytes [NCIt concept]
- Lyophilized Black Raspberry Lozenge [NCIt concept]
- Lyophilized Inactivated Group A Streptococcus TARA-002 [NCIt concept]
- Lysine-specific Demethylase 1 Inhibitor INCB059872 [NCIt concept]
- Lyso-Thermosensitive Liposome Doxorubicin [NCIt concept]
- MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells [NCIt concept]
- MAGE-A3 Peptide Vaccine [NCIt concept]
- MAGE-A3 Reactive T Cell Receptor-transduced Autologous T Cells [NCIt concept]
- MAGE-A3-specific Immunotherapeutic GSK 2132231A [NCIt concept]
- MAGE-A3/12-specific TCR Gene-transduced Autologous PBLs [NCIt concept]
- MAGE-A4-specific T-cell Engager CDR404 [NCIt concept]
- MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 [NCIt concept]
- MALT1 Inhibitor [NCIt concept]
- MALT1 Inhibitor ABBV-525 [NCIt concept]
- MALT1 Inhibitor MPT-0118 [NCIt concept]
- MART-1 Antigen [NCIt concept]
- MART-1 Reactive CD8+ T-lymphocytes [NCIt concept]
- MART-1:26-35(27L) Peptide Vaccine [NCIt concept]
- MART-1:27-35 Peptide Vaccine [NCIt concept]
- MAT2A Inhibitor [NCIt concept]
- MAT2A Inhibitor AG-270 [NCIt concept]
- MAT2A Inhibitor IDE397 [NCIt concept]
- MCL-1 Inhibitor ABBV-467 [NCIt concept]
- MCL1 Inhibitor GS-9716 [NCIt concept]
- MCPyV TAg-specific Polyclonal Autologous CD8-positive T Cells [NCIt concept]
- MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000 [NCIt concept]
- MDM2 Antagonist ASTX295 [NCIt concept]
- MDM2 Antagonist RO5045337 [NCIt concept]
- MDM2 Degrader KT-253 [NCIt concept]
- MDM2 Inhibitor [NCIt concept]
- MDM2 Inhibitor SA53-OS [NCIt concept]
- MDS Neoantigen-specific Autologous T-lymphocytes [NCIt concept]
- MEK 1/2 Inhibitor AS703988/MSC2015103B [NCIt concept]
- MEK Inhibitor AZD8330 [NCIt concept]
- MEK Inhibitor GDC-0623 [NCIt concept]
- MEK Inhibitor IMM-1-104 [NCIt concept]
- MEK Inhibitor IMM-6-415 [NCIt concept]
- MEK Inhibitor PF-07799544 [NCIt concept]
- MEK Inhibitor REC-4881 [NCIt concept]
- MEK-1/MEKK-1 Inhibitor E6201 [NCIt concept]
- MEK/RAF Molecular Glue IK-595 [NCIt concept]
- MEK1/2 Inhibitor ABM-168 [NCIt concept]
- MELITAC 12.1 Peptide Vaccine [NCIt concept]
- MELK Inhibitor OTS167 [NCIt concept]
- MET Tyrosine Kinase Inhibitor EMD 1204831 [NCIt concept]
- MET Tyrosine Kinase Inhibitor PF-04217903 [NCIt concept]
- MET Tyrosine Kinase Inhibitor SAR125844 [NCIt concept]
- METTL-3 Inhibitor STC-15 [NCIt concept]
- MKC-1 [NCIt concept]
- MKNK1 Inhibitor BAY 1143269 [NCIt concept]
- MOF Compound RiMO-301 [NCIt concept]
- MOv19 CAR-CD3zeta-4-1BB-expressing Allogeneic T-lymphocytes [NCIt concept]
- MPS1 Inhibitor [NCIt concept]
- MPS1 Kinase Inhibitor NMS-01940153E [NCIt concept]
- MSCV-MGMT(P140K) Vaccine [NCIt concept]
- MSLN-targeting Agent [NCIt concept]
- MTF-1 Inhibitor APTO-253 HCl [NCIt concept]
- MUC-1 Peptide Vaccine [NCIt concept]
- MUC-1-targeting Agent [NCIt concept]
- MUC1 Peptide-Poly-ICLC Vaccine [NCIt concept]
- MUC1-targeted Peptide GO-203-2C [NCIt concept]
- MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP [NCIt concept]
- MVA-BN-Brachyury-TRICOM Vaccine [NCIt concept]
- MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ [NCIt concept]
- MYC-targeting siRNA DCR-MYC [NCIt concept]
- Maackia amurensis Seed Lectin [NCIt concept]
- Macimorelin [NCIt concept]
- Macitentan [NCIt concept]
- Macrocycle-bridged STING Agonist E7766 [NCIt concept]
- Magic Mouthwash [NCIt concept]
- Magnesium Chloride-based Lotion [NCIt concept]
- Magnesium Glycinate [NCIt concept]
- Magnesium Oxide [NCIt concept]
- Magnesium Sulfate [NCIt concept]
- Magnesium-based Bone Void Filler [NCIt concept]
- Maitake Mushroom Extract [NCIt concept]
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Mammaglobin-A DNA Vaccine [NCIt concept]
- Manganese/L-alanine/Vitamin D3-containing Contrast Agent Formulation [NCIt concept]
- Mannitol [NCIt concept]
- Mannose-Binding Lectin [NCIt concept]
- Manufactured Autologous Anti-BCMA CAR-T Cells [NCIt concept]
- Manuka Honey [NCIt concept]
- Manuka Honey Breast Pads [NCIt concept]
- Mapatumumab [NCIt concept]
- Maplirpacept [NCIt concept]
- Maraba Oncolytic Virus Expressing Mutant HPV E6/E7 [NCIt concept]
- Maraviroc [NCIt concept]
- Margetuximab [NCIt concept]
- Maribavir [NCIt concept]
- Marizomib [NCIt concept]
- Masitinib Mesylate [NCIt concept]
- Masofaniten [NCIt concept]
- Masoprocol [NCIt concept]
- Mavelertinib [NCIt concept]
- Maveropepimut-S [NCIt concept]
- Mavorixafor [NCIt concept]
- Mcl-1 Inhibitor MIK665 [NCIt concept]
- Mebendazole [NCIt concept]
- Mechlorethamine Hydrochloride [NCIt concept]
- Meclizine [NCIt concept]
- Meclofenamate Sodium [NCIt concept]
- Medroxyprogesterone [NCIt concept]
- Medroxyprogesterone Acetate [NCIt concept]
- Mefloquine [NCIt concept]
- Megestrol [NCIt concept]
- Megestrol Acetate [NCIt concept]
- Melanocortin-4 Receptor Agonist LB54640 [NCIt concept]
- Melanoma Helper Peptide Vaccine [NCIt concept]
- Melia azadirachta Flower Extract [NCIt concept]
- Meloxicam [NCIt concept]
- Melphalan [NCIt concept]
- Melphalan Flufenamide [NCIt concept]
- Melphalan Hydrochloride [NCIt concept]
- Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex [NCIt concept]
- Memantine [NCIt concept]
- Memantine Hydrochloride [NCIt concept]
- Membrane-bound IL-15-expressing Tumor-infiltrating Lymphocytes OBX-115 [NCIt concept]
- Membrane-bound Interleukin-21-Expanded Haploidentical Natural Killer Cells [NCIt concept]
- Menadione Topical Lotion [NCIt concept]
- Mepolizumab [NCIt concept]
- Mercaptopurine [NCIt concept]
- Merestinib [NCIt concept]
- Mesalamine [NCIt concept]
- Mesenchymal Stem Cell [NCIt concept]
- Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA [NCIt concept]
- Mesmulogene Ancovacivec [NCIt concept]
- Mesna [NCIt concept]
- Mesothelin-specific Chimeric Antigen Receptor-engineered Peripheral Blood Lymphocytes [NCIt concept]
- Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536 [NCIt concept]
- Metarrestin [NCIt concept]
- Metformin [NCIt concept]
- Metformin Hydrochloride [NCIt concept]
- Metformin Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet [NCIt concept]
- Methadone [NCIt concept]
- Methadone Hydrochloride [NCIt concept]
- Methimazole [NCIt concept]
- Methionine Aminopeptidase 2 Inhibitor M8891 [NCIt concept]
- Methionine C 11 [NCIt concept]
- Methotrexate [NCIt concept]
- Methotrexate Sodium [NCIt concept]
- Methoxsalen [NCIt concept]
- Methoxyamine [NCIt concept]
- Methoxyamine Hydrochloride [NCIt concept]
- Methyl Bacteriopurpurinimide [NCIt concept]
- Methyl-5-Aminolevulinate Hydrochloride Cream [NCIt concept]
- Methylene Blue [NCIt concept]
- Methylene Blue Oral Rinse [NCIt concept]
- Methylnaltrexone [NCIt concept]
- Methylphenidate [NCIt concept]
- Methylphenidate Hydrochloride [NCIt concept]
- Methylprednisolone [NCIt concept]
- Methylprednisolone Sodium Succinate [NCIt concept]
- Methylselenocysteine [NCIt concept]
- Metoclopramide [NCIt concept]
- Metoprolol [NCIt concept]
- Metoprolol Succinate [NCIt concept]
- Metoprolol Tartrate [NCIt concept]
- Mevociclib [NCIt concept]
- Mexiletine [NCIt concept]
- Mexiletine Hydrochloride [NCIt concept]
- Mezagitamab [NCIt concept]
- Mezigdomide [NCIt concept]
- Mibefradil Dihydrochloride [NCIt concept]
- Micafungin [NCIt concept]
- Micafungin Sodium [NCIt concept]
- Micellar Nanoparticle-encapsulated Epirubicin [NCIt concept]
- Michelia alba Leaf Oil [NCIt concept]
- Micro Needle Array-Doxorubicin [NCIt concept]
- MicroRNA-10b Antagomir-Iron Oxide/Dextran-based Nanoparticle TTX-MC138 [NCIt concept]
- Microbiome GEN-001 [NCIt concept]
- Microbiome SER-155 [NCIt concept]
- Microbiome SER-401 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2040 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2401 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2463 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO4010 [NCIt concept]
- Microbiota-based Formulation RBX7455 [NCIt concept]
- Microparticle MDP/Bacterial DNA-containing MIS416 [NCIt concept]
- Micvotabart Pelidotin [NCIt concept]
- Midazolam [NCIt concept]
- Midazolam Hydrochloride [NCIt concept]
- Midostaurin [NCIt concept]
- Mifamurtide [NCIt concept]
- Mifepristone [NCIt concept]
- Milademetan Tosylate [NCIt concept]
- Milatuzumab [NCIt concept]
- Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110 [NCIt concept]
- Mild Soap Skin Cleanser [NCIt concept]
- Minocycline Hydrochloride [NCIt concept]
- Minocycline-EDTA [NCIt concept]
- Mipasetamab Uzoptirine [NCIt concept]
- Mipicoledine [NCIt concept]
- Mipletamig [NCIt concept]
- Mipsagargin [NCIt concept]
- Miptenalimab [NCIt concept]
- Mirdametinib [NCIt concept]
- Miridesap [NCIt concept]
- Mirtazapine [NCIt concept]
- Mirvetuximab Soravtansine [NCIt concept]
- Mirzotamab Clezutoclax [NCIt concept]
- Misetionamide [NCIt concept]
- Mitapivat [NCIt concept]
- Mitazalimab [NCIt concept]
- Mitochondria-targeted Antioxidant MIT-001 [NCIt concept]
- Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101 [NCIt concept]
- Mitogen-Activated Protein Kinase Kinase Inhibitor [NCIt concept]
- Mitomycin [NCIt concept]
- Mitotane [NCIt concept]
- Mitoxantrone [NCIt concept]
- Mitoxantrone Hydrochloride [NCIt concept]
- Mivavotinib [NCIt concept]
- Mivebresib [NCIt concept]
- MnSOD Mimetic BMX-001 [NCIt concept]
- Mobocertinib [NCIt concept]
- Mobocertinib Succinate [NCIt concept]
- Mocetinostat [NCIt concept]
- Modafinil [NCIt concept]
- Modakafusp Alfa [NCIt concept]
- Modified Interleukin-2 DF6215 [NCIt concept]
- Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine [NCIt concept]
- Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208 [NCIt concept]
- Modified Vaccinia Virus Ankara Expressing Flt3L/OX40L MQ710 [NCIt concept]
- Modified Vaccinia Virus Ankara Vaccine Expressing p53 [NCIt concept]
- Modified-release Calcifediol Capsule [NCIt concept]
- Modotuximab [NCIt concept]
- Mogamulizumab [NCIt concept]
- Molibresib [NCIt concept]
- Molibresib Besylate [NCIt concept]
- Momelotinib [NCIt concept]
- Mometasone Furoate [NCIt concept]
- Monoclonal Antibody [NCIt concept]
- Monoclonal Antibody 3F8 [NCIt concept]
- Monoclonal Antibody AbGn-7 [NCIt concept]
- Monoclonal Antibody CEP-37250/KHK2804 [NCIt concept]
- Monoclonal Antibody Mik-Beta-1 [NCIt concept]
- Monoclonal Microbial EDP1503 [NCIt concept]
- Monosialotetrahexosylganglioside [NCIt concept]
- Monosodium Glutamate [NCIt concept]
- Montanide ISA 51 VG [NCIt concept]
- Montanide ISA 720 [NCIt concept]
- Montanide ISA-51 VG/KLH/NY-ESO-1/MART-1 Peptide Vaccine [NCIt concept]
- Montanide ISA-51/Survivin Peptide Vaccine [NCIt concept]
- Montelukast [NCIt concept]
- Montelukast Sodium [NCIt concept]
- Morphine [NCIt concept]
- Morphine Sulfate [NCIt concept]
- Morphine Sulfate Sustained-Release Tablet [NCIt concept]
- Mosunetuzumab [NCIt concept]
- Motacabtagene Lurevgedleucel [NCIt concept]
- Motesanib Diphosphate [NCIt concept]
- Motexafin Gadolinium [NCIt concept]
- Motexafin Lutetium [NCIt concept]
- Motixafortide [NCIt concept]
- Motolimod [NCIt concept]
- Mouse Renal Adenocarcinoma Cell-Encapsulated Agarose-Agarose Macrobeads [NCIt concept]
- Moxetumomab Pasudotox [NCIt concept]
- Moxifloxacin [NCIt concept]
- Moxifloxacin Hydrochloride [NCIt concept]
- Mozafancogene Autotemcel [NCIt concept]
- Mozistobart Zoratolimod [NCIt concept]
- Mps1 Inhibitor BAY 1217389 [NCIt concept]
- Mucoadhesive Oral Wound Rinse [NCIt concept]
- Mucoadhesive Paclitaxel Formulation [NCIt concept]
- Mucoadhesive Polymer Hydrogel Vehicle [NCIt concept]
- Mulnitorsen [NCIt concept]
- Multi-antigen-directed Autologous T-cells NEXI-002 [NCIt concept]
- Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 [NCIt concept]
- Multi-epitope Folate Receptor Alpha Peptide Vaccine [NCIt concept]
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine H2NVAC [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine TPIV100 [NCIt concept]
- Multi-epitope Melanoma Peptide Vaccine [NCIt concept]
- Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107 [NCIt concept]
- Multi-kinase Inhibitor LNK01002 [NCIt concept]
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine [NCIt concept]
- Multikinase Inhibitor AT9283 [NCIt concept]
- Multikinase Inhibitor SAR103168 [NCIt concept]
- Multipeptide Vaccine S-588210 [NCIt concept]
- Multivitamin [NCIt concept]
- Mupadolimab [NCIt concept]
- Muparfostat [NCIt concept]
- Murizatoclax [NCIt concept]
- Muromonab-CD3 [NCIt concept]
- Muscadine Grape Extract [NCIt concept]
- Muscadine Grape Skin Extract [NCIt concept]
- Mutant p53 Activator COTI-2 [NCIt concept]
- Mutant-selective PI3K-alpha H1047R Inhibitor LOXO-783 [NCIt concept]
- Mutant-selective PI3K-alpha H1047R Inhibitor OKI-219 [NCIt concept]
- Mutant-selective PI3K-alpha H1047X Inhibitor STX-478 [NCIt concept]
- Muzastotug [NCIt concept]
- Mycobacterial Cell Wall-DNA Complex [NCIt concept]
- Mycophenolate Mofetil [NCIt concept]
- Mycophenolic Acid [NCIt concept]
- Myelin-binding Imaging Agent [NCIt concept]
- Myeloid Cell Leukemia 1 Inhibitor PRT1419 [NCIt concept]
- Myrciaria dubia Prebiotic Supplement [NCIt concept]
- N-Acetylcysteine Amide [NCIt concept]
- N-dihydrogalactochitosan [NCIt concept]
- N-oleyl-phosphatidylethanolamine/Epigallocatechin Gallate Supplement [NCIt concept]
- NA17.A2 Peptide Vaccine [NCIt concept]
- NAMPT Inhibitor OT-82 [NCIt concept]
- NEDD8 Activating Enzyme E1 Inhibitor TAS4464 [NCIt concept]
- NFE2L2/KEAP1/CUL3 Mutant-targeting Agent MGY825 [NCIt concept]
- NGFR-transduced Autologous T Lymphocytes [NCIt concept]
- NHS-POx-based Hemostatic Sealant Patch [NCIt concept]
- NIR Fluorochrome VM110 [NCIt concept]
- NK Cell-enriched Donor Lymphocytes [NCIt concept]
- NKp46/CD16-based CD123-targeted NK Cell Engager SAR443579 [NCIt concept]
- NKp46/CD16/CD20/IL-2-variant-specific NK Cell Engager IPH6501 [NCIt concept]
- NLRP3 Agonist BMS-986299 [NCIt concept]
- NLRP3 Inhibitor DFV890 [NCIt concept]
- NSCLC-specific Marrow Infiltrating Lymphocytes [NCIt concept]
- NSD2 Inhibitor KTX-1001 [NCIt concept]
- NY-ESO-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1 Protein Vaccine Plus Montanide ISA-51 VG [NCIt concept]
- NY-ESO-1 Reactive TCR Retroviral Vector Transduced Autologous PBL [NCIt concept]
- NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- NY-ESO-1-expressing Artificial Adjuvant Vector Cells ASP0739 [NCIt concept]
- NY-ESO-1/GLA-SE Vaccine ID-G305 [NCIt concept]
- NY-ESO-1/LAGE-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1/MAGE-A4/PRAME/Survivin/SSX2-specific Autologous Cytotoxic T Lymphocytes [NCIt concept]
- Nab-paclitaxel [NCIt concept]
- Nab-paclitaxel/Danburstotug Complex AP160 [NCIt concept]
- Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 [NCIt concept]
- Nabiximols [NCIt concept]
- Nadofaragene Firadenovec [NCIt concept]
- Nafcillin [NCIt concept]
- Nagrestipen [NCIt concept]
- Naltrexone Hydrochloride [NCIt concept]
- Naltrexone Hydrochloride/Bupropion Hydrochloride [NCIt concept]
- Nanatinostat [NCIt concept]
- Nanoparticle Albumin-Bound Docetaxel [NCIt concept]
- Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404 [NCIt concept]
- Nanoparticle Complex [NCIt concept]
- Nanoparticle Formulation CPI-300 [NCIt concept]
- Nanoparticle Paclitaxel Ointment SOR007 [NCIt concept]
- Nanoparticle-based Paclitaxel Suspension [NCIt concept]
- Nanoplexed Poly I:C BO-112 [NCIt concept]
- Nanoscale Coordination Polymer Nanoparticles CPI-100 [NCIt concept]
- Nanosomal Docetaxel Lipid Suspension [NCIt concept]
- Nanrilkefusp Alfa [NCIt concept]
- Napabucasin [NCIt concept]
- Naphthalimide Analogue UNBS5162 [NCIt concept]
- Naporafenib [NCIt concept]
- Naproxen [NCIt concept]
- Naproxen Sodium [NCIt concept]
- Naratuximab Emtansine [NCIt concept]
- Narazaciclib [NCIt concept]
- Narnatumab [NCIt concept]
- Narsoplimab [NCIt concept]
- Nasal Saline Irrigation Solution [NCIt concept]
- Nasaruplase Gamma [NCIt concept]
- Natalizumab [NCIt concept]
- Natural Killer Cells ZRx101 [NCIt concept]
- Navarixin [NCIt concept]
- Navicixizumab [NCIt concept]
- Navitoclax [NCIt concept]
- Navoximod [NCIt concept]
- Navtemadlin [NCIt concept]
- Naxitamab [NCIt concept]
- Near Infrared Imaging Agent HS-196 [NCIt concept]
- Near Infrared Imaging Agent IS-001 [NCIt concept]
- Near-Infrared Fluorescence Imaging Probe [NCIt concept]
- Necitumumab [NCIt concept]
- Nectin-4-directed TLR8 Agonist SBT6290 [NCIt concept]
- Necuparanib [NCIt concept]
- Nedometinib [NCIt concept]
- Neem Mouthrinse [NCIt concept]
- Neihulizumab [NCIt concept]
- Nelarabine [NCIt concept]
- Nelfinavir [NCIt concept]
- Nelfinavir Mesylate [NCIt concept]
- Nelipepimut-S Plus GM-CSF Vaccine [NCIt concept]
- Nelistotug [NCIt concept]
- Nelitolimod [NCIt concept]
- Nelmastobart [NCIt concept]
- Nemtabrutinib [NCIt concept]
- Nemvaleukin Alfa [NCIt concept]
- Nendratareotide Uzatansine [NCIt concept]
- Neoantigen DNA-Based Pancreatic Cancer Vaccine [NCIt concept]
- Neoantigen Heat Shock Protein Vaccine rHSC-DIPGVax [NCIt concept]
- Neoantigen Peptide [NCIt concept]
- Neoantigen Peptide Vaccine [NCIt concept]
- Neoantigen Vaccine GEN-009 [NCIt concept]
- Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 [NCIt concept]
- Neoantigen-based Glioblastoma Vaccine [NCIt concept]
- Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine [NCIt concept]
- Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 [NCIt concept]
- Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 [NCIt concept]
- Neoantigen-loaded Autologous Dendritic Cell Vaccine [NCIt concept]
- Neostigmine [NCIt concept]
- Neratinib [NCIt concept]
- Neratinib Maleate [NCIt concept]
- Netazepide [NCIt concept]
- Netupitant [NCIt concept]
- Netupitant/Palonosetron Hydrochloride [NCIt concept]
- Neural Stem Cells-expressing CRAd-S-pk7 [NCIt concept]
- Nezastomig [NCIt concept]
- Nezulcitinib [NCIt concept]
- Niacin [NCIt concept]
- Niacinamide [NCIt concept]
- Nibrozetone [NCIt concept]
- Niclosamide [NCIt concept]
- Nicotinamide Riboside [NCIt concept]
- Nicotine [NCIt concept]
- Nicotine Lozenge [NCIt concept]
- Nicotine Oral Pouch [NCIt concept]
- Nicotine Patch [NCIt concept]
- Nicotine Replacement Agent [NCIt concept]
- Nidanilimab [NCIt concept]
- Nilotinib [NCIt concept]
- Nilotinib Hydrochloride Monohydrate [NCIt concept]
- Nilutamide [NCIt concept]
- Nimesulide-Hyaluronic Acid Conjugate CA102N [NCIt concept]
- Nimotuzumab [NCIt concept]
- Nintedanib [NCIt concept]
- Nipocalimab [NCIt concept]
- Niraparib [NCIt concept]
- Nirogacestat [NCIt concept]
- Nirsevimab [NCIt concept]
- Nisevokitug [NCIt concept]
- Nitrogen Mustard Prodrug PR-104 [NCIt concept]
- Nitroglycerin [NCIt concept]
- Nitrous Oxide [NCIt concept]
- Nivatrotamab [NCIt concept]
- Nivolumab [NCIt concept]
- Nivolumab/Relatlimab-rmbw [NCIt concept]
- Nogapendekin Alfa [NCIt concept]
- Nogapendekin Alfa Inbakicept [NCIt concept]
- Nomacopan [NCIt concept]
- Non-Fucosylated Umbilical Cord Blood Regulatory T-cells [NCIt concept]
- Non-enzyme Inducing Antiepileptic Drug [NCIt concept]
- Noraramtide [NCIt concept]
- Norepinephrine, DL- [NCIt concept]
- Norgestimate [NCIt concept]
- Norgestrel [NCIt concept]
- Noscapine Hydrochloride [NCIt concept]
- Notch Signaling Inhibitor PF-06650808 [NCIt concept]
- Notch Signaling Pathway Inhibitor MK0752 [NCIt concept]
- Nucleoside Analog DFP-10917 [NCIt concept]
- Nucleotide Analogue GS 9219 [NCIt concept]
- Numidargistat [NCIt concept]
- Nutraceutical TBL-12 [NCIt concept]
- Nutritional Supplement Drink [NCIt concept]
- Nuvisertib [NCIt concept]
- O6-Benzylguanine [NCIt concept]
- Obatoclax Mesylate [NCIt concept]
- Obecabtagene Autoleucel [NCIt concept]
- Obexelimab [NCIt concept]
- Obinutuzumab [NCIt concept]
- Oblimersen Sodium [NCIt concept]
- Obrindatamab [NCIt concept]
- Obrixtamig [NCIt concept]
- Ocaratuzumab [NCIt concept]
- Ociperlimab [NCIt concept]
- Octreotide [NCIt concept]
- Octreotide Acetate [NCIt concept]
- Octreotide Depot Formulation CAM2029 [NCIt concept]
- Octreotide Long-acting Release Regimen [NCIt concept]
- Octreotide Pamoate [NCIt concept]
- Odetiglucan [NCIt concept]
- Odronextamab [NCIt concept]
- Ofatumumab [NCIt concept]
- Ofranergene Obadenovec [NCIt concept]
- Ointment OQL011 [NCIt concept]
- Olanzapine [NCIt concept]
- Olaparib [NCIt concept]
- Olaratumab [NCIt concept]
- Oleandrin [NCIt concept]
- Oleclumab [NCIt concept]
- Olendalizumab [NCIt concept]
- Oleogel-S10 [NCIt concept]
- Oligofructose-Enriched Inulin [NCIt concept]
- Oligomeric Procyanidin Complex [NCIt concept]
- Olinciguat [NCIt concept]
- Olintatug Tesirine [NCIt concept]
- Olive Oil [NCIt concept]
- Olmutinib [NCIt concept]
- Olomorasib [NCIt concept]
- Olorofim [NCIt concept]
- Olutasidenib [NCIt concept]
- Olverembatinib [NCIt concept]
- Olvimulogene Nanivacirepvec [NCIt concept]
- Omacetaxine [NCIt concept]
- Omacetaxine Mepesuccinate [NCIt concept]
- Omaveloxolone [NCIt concept]
- Ombitasvir [NCIt concept]
- Ombrabulin [NCIt concept]
- Omega-3 Fatty Acid [NCIt concept]
- Omega-3-Acid Ethyl Esters [NCIt concept]
- Omeprazole [NCIt concept]
- Omidubicel [NCIt concept]
- Omipalisib [NCIt concept]
- Ompenaclid [NCIt concept]
- Onalespib [NCIt concept]
- Onalespib Lactate [NCIt concept]
- Onapristone [NCIt concept]
- Onartuzumab [NCIt concept]
- Onatasertib [NCIt concept]
- Oncolytic Adenovirus AdAPT-001 [NCIt concept]
- Oncolytic Adenovirus CAdVEC [NCIt concept]
- Oncolytic Adenovirus Expressing Interferon Beta/CD40 Ligand MEM-288 [NCIt concept]
- Oncolytic Adenovirus ICVB-1042 [NCIt concept]
- Oncolytic Bacterium [NCIt concept]
- Oncolytic HSV-1 C134 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody MVR-C5252 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-2 and IL-12 KB707 [NCIt concept]
- Oncolytic HSV-1 JNJ-87704916 [NCIt concept]
- Oncolytic HSV-1 NV1020 [NCIt concept]
- Oncolytic HSV-1 rQNestin34.5v.2 [NCIt concept]
- Oncolytic HSV-1 rRp450 [NCIt concept]
- Oncolytic HSV1716 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody-like Molecule and GM-CSF RP2 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody/CD40L/4-1BBL RP3 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 ONCR-177 [NCIt concept]
- Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein [NCIt concept]
- Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter [NCIt concept]
- Oncolytic Newcastle Disease Virus MEDI5395 [NCIt concept]
- Oncolytic Newcastle Disease Virus Strain PV701 [NCIt concept]
- Oncolytic Type 2 Herpes Simplex Virus Expressing Anti-PD-L1/CD3 Bispecific Antibody BS-006 [NCIt concept]
- Oncolytic Type 2 Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor OH2 [NCIt concept]
- Oncolytic VSV-GP BI 1821736 [NCIt concept]
- Oncolytic Vaccinia Virus Expressing Leptin/IL-2 Fusion Protein ASP1012 [NCIt concept]
- Oncolytic Vaccinia Virus PF-07263689 [NCIt concept]
- Oncolytic Virus ASP9801 [NCIt concept]
- Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody [NCIt concept]
- Ondansetron [NCIt concept]
- Ondansetron Hydrochloride [NCIt concept]
- Ontorpacept [NCIt concept]
- Ontuxizumab [NCIt concept]
- Onvansertib [NCIt concept]
- Onvatilimab [NCIt concept]
- Opaganib [NCIt concept]
- Opebacan [NCIt concept]
- Opelconazole [NCIt concept]
- Opevesostat [NCIt concept]
- Ophthalmic Solution [NCIt concept]
- Opiate Antagonist [NCIt concept]
- Oplunofusp [NCIt concept]
- Opnurasib [NCIt concept]
- Opolimogene Capmilisbac [NCIt concept]
- Oportuzumab Monatox [NCIt concept]
- Oprelvekin [NCIt concept]
- Oprozomib [NCIt concept]
- Opugotamig Olatansine [NCIt concept]
- Oral Aminolevulinic Acid Hydrochloride [NCIt concept]
- Oral Hsp90 Inhibitor IPI-493 [NCIt concept]
- Oral Irinotecan Hydrochloride Formulation VAL-413 [NCIt concept]
- Oral Microencapsulated Diindolylmethane [NCIt concept]
- Oral Sodium Phenylbutyrate [NCIt concept]
- Oral Topotecan Hydrochloride [NCIt concept]
- Orantinib [NCIt concept]
- Oraxol [NCIt concept]
- Ordesekimab [NCIt concept]
- Oregovomab [NCIt concept]
- Orelabrutinib [NCIt concept]
- Orilanolimab [NCIt concept]
- Orludodstat [NCIt concept]
- Orteronel [NCIt concept]
- Orvacabtagene Autoleucel [NCIt concept]
- Osanetant [NCIt concept]
- Oseltamivir [NCIt concept]
- Oseltamivir Phosphate [NCIt concept]
- Osemitamab [NCIt concept]
- Osilodrostat [NCIt concept]
- Osimertinib [NCIt concept]
- Osimertinib Mesylate [NCIt concept]
- Osivelotor [NCIt concept]
- Osugacestat [NCIt concept]
- Other Investigational Agent [NCIt concept]
- Otlertuzumab [NCIt concept]
- Ovarian Cancer Peptide Vaccine [NCIt concept]
- Oxacillin [NCIt concept]
- Oxaliplatin [NCIt concept]
- Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome [NCIt concept]
- Oxcarbazepine [NCIt concept]
- Oxidative Phosphorylation Inhibitor IACS-010759 [NCIt concept]
- Oxybutynin Chloride [NCIt concept]
- Oxycodone [NCIt concept]
- Oxycodone Hydrochloride [NCIt concept]
- Oxygen 15-labeled Carbon Monoxide [NCIt concept]
- Oxygen 15-labeled Oxygen [NCIt concept]
- Oxymorphone [NCIt concept]
- Oxyquinoline Sulfate/Sodium Lauryl Sulfate Vaginal Gel [NCIt concept]
- Ozekibart [NCIt concept]
- Ozuriftamab Vedotin [NCIt concept]
- P-cadherin Inhibitor PCA062 [NCIt concept]
- P-cadherin-targeting Agent PF-06671008 [NCIt concept]
- P-p68 Inhibitor RX-5902 [NCIt concept]
- PADRE 965.10 [NCIt concept]
- PADRE-CMV Fusion Peptide Vaccine [NCIt concept]
- PAI-1 Inhibitor ACT001 [NCIt concept]
- PAK4 Inhibitor PF-03758309 [NCIt concept]
- PARG Inhibitor ETX-19477 [NCIt concept]
- PARG Inhibitor IDE161 [NCIt concept]
- PARP Inhibitor CEP-9722 [NCIt concept]
- PARP Inhibitor E7016 [NCIt concept]
- PARP Inhibitor NMS-03305293 [NCIt concept]
- PARP/Microtubule Polymerization Inhibitor AMXI-5001 [NCIt concept]
- PARP/Tankyrase Inhibitor 2X-121 [NCIt concept]
- PARP1 Inhibitor GS-0201 [NCIt concept]
- PARP1 Inhibitor IMP1734 [NCIt concept]
- PARP1 Inhibitor SNV1521 [NCIt concept]
- PBTL CD19CAR-28/CD137/zeta [NCIt concept]
- PCNA Inhibitor AOH1996 [NCIt concept]
- PD-1 Ligand Inhibitor [NCIt concept]
- PD-1 Targeted IL-15 Mutein Fusion Protein PF-07209960 [NCIt concept]
- PD-1-positive B-cell Peptide Antigen/MVF IMU-201/Montanide Vaccine [NCIt concept]
- PD-L1 Inhibitor [NCIt concept]
- PD-L1 Inhibitor AN4005 [NCIt concept]
- PD-L1 Inhibitor INCB086550 [NCIt concept]
- PD-L1 Inhibitor INCB099280 [NCIt concept]
- PD-L1 Inhibitor INCB099318 [NCIt concept]
- PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480 [NCIt concept]
- PD-L1/IDO Peptide Vaccine IO102-103 [NCIt concept]
- PD-L1/PD-L2/VISTA Antagonist CA-170 [NCIt concept]
- PD-L2 Inhibitor [NCIt concept]
- PD1 Inhibitor [NCIt concept]
- PDGFR alpha/KIT Mutant-specific Inhibitor NB003 [NCIt concept]
- PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1 [NCIt concept]
- PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector IMNN-001 [NCIt concept]
- PEOX-based Polymer Encapsulated Paclitaxel FID-007 [NCIt concept]
- PEP-3-KLH Conjugate Vaccine [NCIt concept]
- PEP-CMV Vaccine [NCIt concept]
- PERK Inhibitor HC-5404-FU [NCIt concept]
- PERK Inhibitor NMS-03597812 [NCIt concept]
- PGLA/PEG Copolymer-Based Paclitaxel [NCIt concept]
- PH20 Hyaluronidase-expressing Adenovirus VCN-01 [NCIt concept]
- PI3K Alpha Inhibitor [NCIt concept]
- PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate [NCIt concept]
- PI3K Inhibitor BGT226 [NCIt concept]
- PI3K Inhibitor GSK1059615 [NCIt concept]
- PI3K Inhibitor ZSTK474 [NCIt concept]
- PI3K p110beta/delta Inhibitor CVL237 [NCIt concept]
- PI3K-alpha Inhibitor TOS-358 [NCIt concept]
- PI3K-beta Inhibitor GSK2636771 [NCIt concept]
- PI3K-beta Inhibitor SAR260301 [NCIt concept]
- PI3K-delta Inhibitor AMG 319 [NCIt concept]
- PI3K-gamma Inhibitor ZX-4081 [NCIt concept]
- PI3K/mTOR Inhibitor CLL442 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor DS-7423 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor PF-04691502 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor VS-5584 [NCIt concept]
- PI3Kalpha Inhibitor AZD8835 [NCIt concept]
- PI3Kbeta Inhibitor AZD8186 [NCIt concept]
- PI3Kdelta Inhibitor GS-9901 [NCIt concept]
- PI3Kdelta/gamma Inhibitor ZX-101A [NCIt concept]
- PIM Kinase Inhibitor LGH447 [NCIt concept]
- PIM Kinase Inhibitor SGI-1776 [NCIt concept]
- PKC-beta Inhibitor MS-553 [NCIt concept]
- PKMYT1 Inhibitor [NCIt concept]
- PLED-based MnSOD Mimetic [NCIt concept]
- PLK1 Inhibitor TAK-960 [NCIt concept]
- PLK4 Inhibitor [NCIt concept]
- PLK4 Inhibitor RP-1664 [NCIt concept]
- PLZ4-coated Paclitaxel-loaded Micelle Formulation [NCIt concept]
- PPAR Alpha Antagonist TPST-1120 [NCIt concept]
- PPAR Gamma Inhibitor [NCIt concept]
- PPAR Gamma Inhibitor FX-909 [NCIt concept]
- PPE-Expressing Replication-Defective HSV-1 Vector NP2 [NCIt concept]
- PR1 Leukemia Peptide Vaccine [NCIt concept]
- PRAME-targeting TCR-engineered NK Cells [NCIt concept]
- PRC2 Inhibitor ORIC-944 [NCIt concept]
- PRMT1 Inhibitor [NCIt concept]
- PRMT1 Inhibitor GSK3368715 [NCIt concept]
- PRMT5 Inhibitor AMG 193 [NCIt concept]
- PRMT5 Inhibitor AZD3470 [NCIt concept]
- PRMT5 Inhibitor PRT811 [NCIt concept]
- PRMT5 Inhibitor SKL27969 [NCIt concept]
- PRMT5-MTA Inhibitor MRTX1719 [NCIt concept]
- PSA Prostate Cancer Vaccine [NCIt concept]
- PSA/IL-2/GM-CSF Vaccine [NCIt concept]
- PSA/PSMA DNA Plasmid INO-5150 [NCIt concept]
- PSA/PSMA/PSCA-encoding DNA Plasmid Vaccine PF-06755990 [NCIt concept]
- PSA:154-163(155L) Peptide Vaccine [NCIt concept]
- PSMA-targeted Docetaxel Nanoparticles BIND-014 [NCIt concept]
- PSMA-targeted Tubulysin B-containing Conjugate EC1169 [NCIt concept]
- PSMA-targeting Agent [NCIt concept]
- PSMA-targeting Agent-Technetium Tc99m EC0652 [NCIt concept]
- PSMA-targeting Fluorescent Imaging Agent IS-002 [NCIt concept]
- PSMA-targeting Fluorescent Imaging Agent MDX1201-A488 [NCIt concept]
- PSMA-targeting T-cell Redirecting Agent JNJ-80038114 [NCIt concept]
- PSMA/CD3 Tri-specific T-cell Activating Construct HPN424 [NCIt concept]
- PSMA/TARP Peptide Vaccine [NCIt concept]
- PVA Microporous Hydrospheres/Doxorubicin Hydrochloride [NCIt concept]
- Pacanalotamab [NCIt concept]
- Paclitaxel [NCIt concept]
- Paclitaxel Injection Concentrate for Nanodispersion [NCIt concept]
- Paclitaxel Poliglumex [NCIt concept]
- Paclitaxel Trevatide [NCIt concept]
- Paclitaxel-loaded Tumor Penetrating Microparticles [NCIt concept]
- Pacmilimab [NCIt concept]
- Pacritinib [NCIt concept]
- Padeliporfin [NCIt concept]
- Padnarsertib [NCIt concept]
- Pafolacianine [NCIt concept]
- Pafolacianine Sodium [NCIt concept]
- Palazestrant [NCIt concept]
- Palbociclib [NCIt concept]
- Palbociclib Isethionate [NCIt concept]
- Palifermin [NCIt concept]
- Palifosfamide [NCIt concept]
- Palifosfamide Tromethamine [NCIt concept]
- Palladium Pd-103 [NCIt concept]
- Palmidrol [NCIt concept]
- Palonosetron [NCIt concept]
- Palonosetron Hydrochloride [NCIt concept]
- Paltimatrectinib [NCIt concept]
- Paltusotine [NCIt concept]
- Palupiprant [NCIt concept]
- Pamidronate Disodium [NCIt concept]
- Pamiparib [NCIt concept]
- Pamrevlumab [NCIt concept]
- Pamvatamig [NCIt concept]
- Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514 [NCIt concept]
- Pan-AKT Inhibitor ARQ751 [NCIt concept]
- Pan-AKT Inhibitor LY2503029 [NCIt concept]
- Pan-AKT Kinase Inhibitor GSK690693 [NCIt concept]
- Pan-DDR DNA Decoy-cholesterol Conjugate VIO-01 [NCIt concept]
- Pan-ErbB Inhibitor [NCIt concept]
- Pan-FGFR Inhibitor LY2874455 [NCIt concept]
- Pan-KRAS Inhibitor BI 1701963 [NCIt concept]
- Pan-KRAS Inhibitor PF-07934040 [NCIt concept]
- Pan-KRAS Inhibitor YL-17231 [NCIt concept]
- Pan-LOX Inhibitor PXS-5505 [NCIt concept]
- Pan-Mutant-IDH1 Inhibitor Bay-1436032 [NCIt concept]
- Pan-RAF Inhibitor LY3009120 [NCIt concept]
- Pan-RAF/MEK Molecular Glue NST-628 [NCIt concept]
- Pan-TEAD Inhibitor ISM6331 [NCIt concept]
- Pan-TRK Inhibitor ONO-7579 [NCIt concept]
- Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981 [NCIt concept]
- Pan-mutant-selective PI3K-alpha Inhibitor RLY-2608 [NCIt concept]
- Pan-mutant-selective PI3K-alpha Inhibitor RLY-5836 [NCIt concept]
- Pan-variant KIT Inhibitor THE-630 [NCIt concept]
- Pancrelipase [NCIt concept]
- Panitumumab [NCIt concept]
- Panitumumab-IRDye800 [NCIt concept]
- Panobinostat [NCIt concept]
- Panobinostat Lactate [NCIt concept]
- Panobinostat Nanoparticle Formulation MTX110 [NCIt concept]
- Panulisib [NCIt concept]
- Papaverine [NCIt concept]
- Papaverine Hydrochloride [NCIt concept]
- Paricalcitol [NCIt concept]
- Paritaprevir [NCIt concept]
- Parsaclisib [NCIt concept]
- Parsatuzumab [NCIt concept]
- Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 [NCIt concept]
- Partially HLA-matched AdV/CMV/EBV-specific Allogeneic T-Lymphocytes [NCIt concept]
- Partially HLA-matched AdV/CMV/EBV/BKV-specific Allogeneic T-lymphocytes [NCIt concept]
- Partially HLA-matched Adenovirus-specific T Lymphocytes [NCIt concept]
- Pasireotide [NCIt concept]
- Patent Blue V Dye [NCIt concept]
- Patidegib [NCIt concept]
- Patidegib Topical Gel [NCIt concept]
- Patient-derived WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes [NCIt concept]
- Patritumab [NCIt concept]
- Patritumab Deruxtecan [NCIt concept]
- Patupilone [NCIt concept]
- Pavunalimab [NCIt concept]
- Pavurutamab [NCIt concept]
- Paxalisib [NCIt concept]
- Pazopanib Hydrochloride [NCIt concept]
- Pediatric Nutritional Supplement Drink [NCIt concept]
- Pegargiminase [NCIt concept]
- Pegaspargase [NCIt concept]
- Pegcetacoplan [NCIt concept]
- Pegdinetanib [NCIt concept]
- Pegenzileukin [NCIt concept]
- Pegfilgrastim [NCIt concept]
- Peginterferon Alfa-2a [NCIt concept]
- Peginterferon Alfa-2b [NCIt concept]
- Peginterferon Alfa-2b Regimen [NCIt concept]
- Pegloprastide [NCIt concept]
- Pegloticase [NCIt concept]
- Pegsitacianine [NCIt concept]
- Pegtomarginase [NCIt concept]
- Pegulicianine Acetate [NCIt concept]
- Pegvisomant [NCIt concept]
- Pegvorhyaluronidase Alfa [NCIt concept]
- Pegylated CD25/CD122-selective Interleukin-2 Mutein STK-012 [NCIt concept]
- Pegylated Deoxycytidine Analogue DFP-14927 [NCIt concept]
- Pegylated Interferon Alfa [NCIt concept]
- Pegylated Liposomal Doxorubicin Hydrochloride [NCIt concept]
- Pegylated Liposomal Irinotecan [NCIt concept]
- Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010 [NCIt concept]
- Pegylated Orthogonal IL-2 STK-009 [NCIt concept]
- Pegylated SN-38 Conjugate PLX038 [NCIt concept]
- Pegylated TOP1 Inhibitor PEEL-224 [NCIt concept]
- Pegylated Topoisomerase Inhibitor [NCIt concept]
- Pegzilarginase [NCIt concept]
- Pelabresib [NCIt concept]
- Pelabresib Anhydrous [NCIt concept]
- Pelareorep [NCIt concept]
- Pelcitoclax [NCIt concept]
- Pelitinib [NCIt concept]
- Peluntamig [NCIt concept]
- Pembrolizumab [NCIt concept]
- Pemetrexed [NCIt concept]
- Pemetrexed Disodium [NCIt concept]
- Pemlimogene Merolisbac [NCIt concept]
- Pemrametostat [NCIt concept]
- Penpulimab [NCIt concept]
- Pentamidine [NCIt concept]
- Pentavalent KLH Conjugate Vaccine [NCIt concept]
- Pentetate Calcium [NCIt concept]
- Pentosan Polysulfate Sodium [NCIt concept]
- Pentostatin [NCIt concept]
- Pentoxifylline [NCIt concept]
- Pepinemab [NCIt concept]
- Peposertib [NCIt concept]
- Peppermint Oil [NCIt concept]
- Peppermint Oil-containing Enteric-coated Microspheres [NCIt concept]
- Peramivir [NCIt concept]
- Perampanel [NCIt concept]
- Perenostobart [NCIt concept]
- Perflenapent Emulsion [NCIt concept]
- Perflubutane Microbubble [NCIt concept]
- Perflutren [NCIt concept]
- Perflutren Lipid Microspheres [NCIt concept]
- Perifosine [NCIt concept]
- Perillyl Alcohol [NCIt concept]
- Peripheral Blood Stem Cell [NCIt concept]
- Personalized Neoantigen Cancer Vaccine VB10.NEO [NCIt concept]
- Personalized Neoantigen DNA Vaccine GNOS-PV01 [NCIt concept]
- Personalized Neoantigen DNA Vaccine GNOS-PVO2 [NCIt concept]
- Personalized Neoantigen Follicular Lymphoma Vaccine [NCIt concept]
- Personalized Neoantigen Ovarian Cancer Vaccine [NCIt concept]
- Personalized Neoantigen Upper Gastrointestinal Tract Cancer Vaccine [NCIt concept]
- Personalized Peptide Cancer Vaccine NEO-PV-01 [NCIt concept]
- Personalized Polyepitope Plasmid DNA Breast Cancer Vaccine [NCIt concept]
- Personalized Synthetic Long Peptide Breast Cancer Vaccine [NCIt concept]
- Personalized Synthetic Long Peptide Vaccine [NCIt concept]
- Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC [NCIt concept]
- Pertuzumab [NCIt concept]
- Pertuzumab Zuvotolimod [NCIt concept]
- Petosemtamab [NCIt concept]
- Petrolatum [NCIt concept]
- Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment [NCIt concept]
- Pevonedistat [NCIt concept]
- Pexastimogene Devacirepvec [NCIt concept]
- Pexidartinib [NCIt concept]
- Pexidartinib Hydrochloride [NCIt concept]
- Pexmetinib [NCIt concept]
- Pharmacological Ascorbate [NCIt concept]
- Phellodendron amurense Bark Extract [NCIt concept]
- Phenelzine Sulfate [NCIt concept]
- Phenethyl Isothiocyanate [NCIt concept]
- Phenformin [NCIt concept]
- Phenformin Hydrochloride [NCIt concept]
- Phentolamine Mesylate [NCIt concept]
- Phosphatidylcholine-Bound Silybin [NCIt concept]
- Phosphatidylinositide 3-Kinase Inhibitor [NCIt concept]
- Photodynamic Compound TLD-1433 [NCIt concept]
- Phytochlorin Sodium-Polyvinylpyrrolidone Complex [NCIt concept]
- Picoplatin [NCIt concept]
- Pictilisib Bismesylate [NCIt concept]
- Pidilizumab [NCIt concept]
- Pifusertib [NCIt concept]
- Pilaralisib [NCIt concept]
- Pilocarpine Hydrochloride [NCIt concept]
- Pimasertib [NCIt concept]
- Pimasertib Hydrochloride [NCIt concept]
- Pimicotinib [NCIt concept]
- Pimitespib [NCIt concept]
- Pimivalimab [NCIt concept]
- Pimozide [NCIt concept]
- Pinatuzumab Vedotin [NCIt concept]
- Pinometostat [NCIt concept]
- Pioglitazone [NCIt concept]
- Pioglitazone Hydrochloride [NCIt concept]
- Piper methysticum [NCIt concept]
- Piperacillin [NCIt concept]
- Piperacillin-Tazobactam [NCIt concept]
- Piperine Extract (Standardized) [NCIt concept]
- Pirotinib [NCIt concept]
- Pirtobrutinib [NCIt concept]
- Pivekimab Sunirine [NCIt concept]
- Pixantrone [NCIt concept]
- Pixantrone Dimaleate [NCIt concept]
- Pixatimod [NCIt concept]
- Placebo [NCIt concept]
- Pladienolide Derivative E7107 [NCIt concept]
- Plamotamab [NCIt concept]
- Platelet-rich Plasma [NCIt concept]
- Platelets Product [NCIt concept]
- Platinum Compound [NCIt concept]
- Platinum Doublet [NCIt concept]
- Plecanatide [NCIt concept]
- Plectin-1 Targeting Agent PTP-01 [NCIt concept]
- Plerixafor [NCIt concept]
- Plicamycin [NCIt concept]
- Plinabulin [NCIt concept]
- Plitidepsin [NCIt concept]
- Plixorafenib [NCIt concept]
- Plk1 Inhibitor BI 2536 [NCIt concept]
- Plocabulin [NCIt concept]
- Plogosertib [NCIt concept]
- Plozalizumab [NCIt concept]
- Pneumococcal 13-valent Conjugate Vaccine [NCIt concept]
- Pneumococcal 20-Valent Conjugate Vaccine [NCIt concept]
- Pneumococcal 7-Valent Conjugate Vaccine [NCIt concept]
- Pneumococcal Conjugate Vaccine [NCIt concept]
- Pneumococcal Polyvalent Vaccine [NCIt concept]
- Pocenbrodib [NCIt concept]
- Podentamig [NCIt concept]
- Pol Theta Inhibitor ART4215 [NCIt concept]
- Polatuzumab Vedotin [NCIt concept]
- Poliglusam [NCIt concept]
- Poly (ADP-Ribose) Polymerase Inhibitor [NCIt concept]
- Poly ICLC [NCIt concept]
- Polyamine Transport Inhibitor AMXT-1501 Dicaprate [NCIt concept]
- Polycarbophil/Carbomer/Glycerin/Palm Oil Glyceride/Mineral Oil-containing Vaginal Moisturizer [NCIt concept]
- Polyethylene Glycol [NCIt concept]
- Polyethylene Glycol Hydrogel [NCIt concept]
- Polyethylene Glycol Polymer Surgical Sealant [NCIt concept]
- Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318 [NCIt concept]
- Polymer-conjugated IL-15 Receptor Agonist NKTR-255 [NCIt concept]
- Polymeric Camptothecin Prodrug XMT-1001 [NCIt concept]
- Polymeric Nanoparticle-conjugated Camptothecin DAN-222 [NCIt concept]
- Polymyxin B [NCIt concept]
- Polymyxin-B Immobilized Fiber PMX-20R [NCIt concept]
- Polyphenol [NCIt concept]
- Polysaccharide-K [NCIt concept]
- Polysiloxane/Gadolinium Chelates-based Nanoparticles [NCIt concept]
- Polyvalent Antigen-KLH Conjugate Vaccine [NCIt concept]
- Polyvalent Melanoma Vaccine [NCIt concept]
- Polyvinyl Alcohol [NCIt concept]
- Polzastobart [NCIt concept]
- Pomalidomide [NCIt concept]
- Pomegranate Juice [NCIt concept]
- Pomegranate Liquid Extract [NCIt concept]
- Pomegranate-Extract Pill [NCIt concept]
- Ponatinib Hydrochloride [NCIt concept]
- Ponesimod [NCIt concept]
- Ponsegromab [NCIt concept]
- Pooled Mutant KRAS-Targeted Long Peptide Vaccine [NCIt concept]
- Porcupine Inhibitor CGX1321 [NCIt concept]
- Porcupine Inhibitor ETC-1922159 [NCIt concept]
- Porcupine Inhibitor WNT974 [NCIt concept]
- Porfimer Sodium [NCIt concept]
- Porustobart [NCIt concept]
- Posaconazole [NCIt concept]
- Poseltinib [NCIt concept]
- Posoleucel [NCIt concept]
- Potassium Iodide [NCIt concept]
- Povidone-Iodine [NCIt concept]
- Poziotinib [NCIt concept]
- Poziotinib Hydrochloride [NCIt concept]
- Pracinostat [NCIt concept]
- Pradusinstobart [NCIt concept]
- Pralatrexate [NCIt concept]
- Pralsetinib [NCIt concept]
- Pramlintide [NCIt concept]
- Prasterone [NCIt concept]
- Prasugrel [NCIt concept]
- Pravastatin [NCIt concept]
- Pravastatin Sodium [NCIt concept]
- Prebiotic-based Vaginal Gel [NCIt concept]
- Prednisolone [NCIt concept]
- Prednisolone Acetate [NCIt concept]
- Prednisone [NCIt concept]
- Pregabalin [NCIt concept]
- Presatovir [NCIt concept]
- Prexasertib [NCIt concept]
- Prexigebersen [NCIt concept]
- Prime Cancer Vaccine MVA-BN-CV301 [NCIt concept]
- Pritelivir [NCIt concept]
- Prizloncabtagene Autoleucel [NCIt concept]
- Probiotic [NCIt concept]
- Probiotic Acidophilus [NCIt concept]
- Procarbazine [NCIt concept]
- Procarbazine Hydrochloride [NCIt concept]
- Procaspase Activating Compound-1 VO-100 [NCIt concept]
- Prochlorperazine [NCIt concept]
- Proflavine Hemisulfate [NCIt concept]
- Progesterone Antagonist [NCIt concept]
- Proglumide [NCIt concept]
- Prohibitin-Targeting Peptide 1 [NCIt concept]
- Propofol [NCIt concept]
- Propranolol Hydrochloride [NCIt concept]
- Prostate Health Cocktail Dietary Supplement [NCIt concept]
- Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 [NCIt concept]
- Protease Inhibitor Formulation LB1148 [NCIt concept]
- Protease-activated Anti-EGFR/Anti-CD3 Bispecific Antibody Prodrug CX-904 [NCIt concept]
- Protease-activated Interferon Alpha-2b Prodrug CX-801 [NCIt concept]
- Protein Arginine Methyltransferase 5 Inhibitor PF-06939999 [NCIt concept]
- Protein Arginine Methyltransferase 5 Inhibitor PRT543 [NCIt concept]
- Protein Kinase C Inhibitor [NCIt concept]
- Protein Kinase Inhibitor [NCIt concept]
- Protein Stabilized Liposomal Docetaxel Nanoparticles [NCIt concept]
- Protein-engineered Interleukin-2 XTX202 [NCIt concept]
- Proton Pump Inhibitor [NCIt concept]
- Psilocybine [NCIt concept]
- Pterostilbene [NCIt concept]
- Pudexacianinium Chloride [NCIt concept]
- Pulrodemstat [NCIt concept]
- Purple Grape Juice [NCIt concept]
- Pyrazoloacridine [NCIt concept]
- Pyridoxine Hydrochloride [NCIt concept]
- Pyrimethamine [NCIt concept]
- Pyrotinib [NCIt concept]
- Pyruvate Kinase M2 Isoform Activator TP-1454 [NCIt concept]
- Pyruvate Kinase-R Activator AG-946 [NCIt concept]
- Pyrvinium Pamoate [NCIt concept]
- QS21 [NCIt concept]
- Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine [NCIt concept]
- Quadrivalent Inactivated Influenza Vaccine [NCIt concept]
- Quaratusugene Ozeplasmid [NCIt concept]
- Quarfloxin [NCIt concept]
- Quavonlimab [NCIt concept]
- Quemliclustat [NCIt concept]
- Quercetin [NCIt concept]
- Quercetin/Rye Flower Pollen/Bromelain/Papain Supplement [NCIt concept]
- Quinacrine Hydrochloride [NCIt concept]
- Quinolonyl-oxazolidinone Antibiotic DNV3837 [NCIt concept]
- Quisinostat [NCIt concept]
- Quizartinib [NCIt concept]
- Quizartinib Dihydrochloride [NCIt concept]
- R-(-)-Gossypol Acetic Acid [NCIt concept]
- R-CHOP Regimen [NCIt concept]
- R-CVP Regimen [NCIt concept]
- RAF Inhibitor BDTX-4933 [NCIt concept]
- RAF Inhibitor DCC-3084 [NCIt concept]
- RAF Kinase Inhibitor XL281 [NCIt concept]
- RARalpha Agonist IRX5183 [NCIt concept]
- RAS Inhibitor RMC-6236 [NCIt concept]
- RAS Peptide Cancer Vaccine TG01 [NCIt concept]
- RET Inhibitor EP0031 [NCIt concept]
- RET Inhibitor LOXO-260 [NCIt concept]
- RFT5-dgA Immunotoxin IMTOX25 [NCIt concept]
- RGD-modified COX-2 Promoter-controlled Conditionally Replicative Adenovirus RGDCRAdCox2F [NCIt concept]
- RIP1 Inhibitor GDC-8264 [NCIt concept]
- RIPK1 Inhibitor GSK3145095 [NCIt concept]
- RNA Electroporated CD19CAR-CD3zeta-4-1BB-expressing Autologous T-lymphocytes [NCIt concept]
- RNA Transcription Modulator AU-409 [NCIt concept]
- RNA-lipoplex Cancer Vaccine BNT116 [NCIt concept]
- RNR Inhibitor BBI-825 [NCIt concept]
- RNR Inhibitor COH29 [NCIt concept]
- RNR Subunits Interaction Inhibitor TAS1553 [NCIt concept]
- RNase-Fc Fusion Protein RSLV-132 [NCIt concept]
- ROR1-targeting Agent [NCIt concept]
- RSK1-4 Inhibitor PMD-026 [NCIt concept]
- RSVPreF3/AS01E RSV Vaccine [NCIt concept]
- RXR-alpha Inhibitor [NCIt concept]
- RXR-alpha Variant-targeting Agent NM6603 [NCIt concept]
- Rabies Vaccine [NCIt concept]
- Rabusertib [NCIt concept]
- Racemetyrosine [NCIt concept]
- Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus [NCIt concept]
- Radgocitabine [NCIt concept]
- Radioactive Iodine [NCIt concept]
- Radioactive Sodium Iodide [NCIt concept]
- Radioisotope [NCIt concept]
- Radiopharmaceutical Compound [NCIt concept]
- Radium Ra 223 Dichloride [NCIt concept]
- Raf Kinase Inhibitor [NCIt concept]
- Ragifilimab [NCIt concept]
- Ralaniten Acetate [NCIt concept]
- Ralimetinib Mesylate [NCIt concept]
- Raloxifene [NCIt concept]
- Raloxifene Hydrochloride [NCIt concept]
- Raltegravir Potassium [NCIt concept]
- Raltitrexed [NCIt concept]
- Raludotatug Deruxtecan [NCIt concept]
- Ralzapastotug [NCIt concept]
- Ramipril [NCIt concept]
- Ramucirumab [NCIt concept]
- Ranibizumab [NCIt concept]
- Ranolazine [NCIt concept]
- Ranosidenib [NCIt concept]
- Rapamycin-Polarized Th1/Tc1 Autologous T Lymphocytes [NCIt concept]
- Rapcabtagene Autoleucel [NCIt concept]
- Ras Inhibitor LUNA18 [NCIt concept]
- Ras Inhibitor RSC-1255 [NCIt concept]
- Rasburicase [NCIt concept]
- Rasdegafusp Alfa [NCIt concept]
- Ravoxertinib [NCIt concept]
- Ravulizumab [NCIt concept]
- Rebastinib [NCIt concept]
- Rebastinib Tosylate [NCIt concept]
- Rebimastat [NCIt concept]
- Receptor Tyrosine Kinase Inhibitor R1530 [NCIt concept]
- Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand [NCIt concept]
- Recombinant Albumin-binding IL-12 SON-1010 [NCIt concept]
- Recombinant Anti-WT1 Immunotherapeutic GSK2302024A [NCIt concept]
- Recombinant Attenuated Salmonella typhimurium Expressing IL-2 [NCIt concept]
- Recombinant Bacterial Minicells VAX014 [NCIt concept]
- Recombinant EphB4-HSA Fusion Protein [NCIt concept]
- Recombinant Fowlpox GM-CSF Vaccine Adjuvant [NCIt concept]
- Recombinant Fowlpox-B7.1 Vaccine [NCIt concept]
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine [NCIt concept]
- Recombinant Fowlpox-Prostate Specific Antigen Vaccine [NCIt concept]
- Recombinant Fowlpox-TRICOM Vaccine [NCIt concept]
- Recombinant Human Apolipoprotein(a) Kringle V MG1102 [NCIt concept]
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine [NCIt concept]
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine [NCIt concept]
- Recombinant Human Hyaluronidase [NCIt concept]
- Recombinant Human Interleukin-15 [NCIt concept]
- Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Recombinant Human Papillomavirus Bivalent Vaccine [NCIt concept]
- Recombinant Human Papillomavirus Nonavalent Vaccine [NCIt concept]
- Recombinant Interferon Alfa [NCIt concept]
- Recombinant Interferon Alfa-2a [NCIt concept]
- Recombinant Interferon Alfa-2b [NCIt concept]
- Recombinant Interferon Alpha 2b-like Protein [NCIt concept]
- Recombinant Interferon Beta [NCIt concept]
- Recombinant Interferon Gamma [NCIt concept]
- Recombinant Interleukin-2 [NCIt concept]
- Recombinant Interleukin-6 [NCIt concept]
- Recombinant Interleukin-7 [NCIt concept]
- Recombinant Luteinizing Hormone [NCIt concept]
- Recombinant MAGE-3.1 Antigen [NCIt concept]
- Recombinant Modified Vaccinia Ankara-5T4 Vaccine [NCIt concept]
- Recombinant Newcastle Disease Virus-encoding Interleukin-12 MEDI9253 [NCIt concept]
- Recombinant Newcastle Disease Virus-encoding Interleukin-12 V938 [NCIt concept]
- Recombinant Oxytocin [NCIt concept]
- Recombinant Parathyroid Hormone [NCIt concept]
- Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 [NCIt concept]
- Recombinant Super-compound Interferon [NCIt concept]
- Recombinant Thyrotropin Alfa [NCIt concept]
- Recombinant Tumor Necrosis Factor Family Protein [NCIt concept]
- Recombinant Vaccinia PSA Vaccine [NCIt concept]
- Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine [NCIt concept]
- Recombinant Vaccinia-MUC-1 Vaccine [NCIt concept]
- Recombinant Vaccinia-TRICOM Vaccine [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta and Tyrosinase Related Protein 1 [NCIt concept]
- Refametinib [NCIt concept]
- Regorafenib [NCIt concept]
- Regorafenib Anhydrous [NCIt concept]
- Relacorilant [NCIt concept]
- Related Donor Adenovirus-specific Cytotoxic T Cells [NCIt concept]
- Relatlimab [NCIt concept]
- Relugolix [NCIt concept]
- Remdesivir [NCIt concept]
- Remestemcel-L [NCIt concept]
- Remetinostat [NCIt concept]
- Renal Cell Carcinoma Peptides Vaccine IMA901 [NCIt concept]
- Renvistobart [NCIt concept]
- Reozalimab [NCIt concept]
- Repaglinide [NCIt concept]
- Reparixin [NCIt concept]
- Repotrectinib [NCIt concept]
- Resigratinib [NCIt concept]
- Resiquimod [NCIt concept]
- Resiquimod Hydrogel-based Sustained-release formulation [NCIt concept]
- Resiquimod Pegol [NCIt concept]
- Resiquimod Topical Gel [NCIt concept]
- Resistant Starch [NCIt concept]
- Resveratrol [NCIt concept]
- Retaspimycin Hydrochloride [NCIt concept]
- Reteplase [NCIt concept]
- Retifanlimab [NCIt concept]
- Retinoid 9cUAB30 [NCIt concept]
- Retinoid X Receptor Agonist IRX4204 [NCIt concept]
- Retrovector Encoding Mutant Anti-Cyclin G1 [NCIt concept]
- Revdofilimab [NCIt concept]
- Revumenib [NCIt concept]
- Rexinoid NRX 194204 [NCIt concept]
- Rezafungin [NCIt concept]
- Rezorstobart [NCIt concept]
- Rhenium Re 188 [NCIt concept]
- Ribavirin [NCIt concept]
- Ribaxamase [NCIt concept]
- Ribociclib [NCIt concept]
- Ribonuclease QBI-139 [NCIt concept]
- Ricolinostat [NCIt concept]
- Ridaforolimus [NCIt concept]
- Ridinilazole [NCIt concept]
- Rifampin [NCIt concept]
- Rifaximin [NCIt concept]
- Rigosertib [NCIt concept]
- Rigosertib Sodium [NCIt concept]
- Rilematovir [NCIt concept]
- Rilimogene Galvacirepvec [NCIt concept]
- Rilimogene Galvacirepvec/Rilimogene Glafolivec [NCIt concept]
- Rilimogene Glafolivec [NCIt concept]
- Rilogrotug [NCIt concept]
- Rilotumumab [NCIt concept]
- Riluzole [NCIt concept]
- Rilvegostomig [NCIt concept]
- Rimiducid [NCIt concept]
- Rindopepimut [NCIt concept]
- Rineterkib [NCIt concept]
- Rintatolimod [NCIt concept]
- Rintodestrant [NCIt concept]
- Ripretinib [NCIt concept]
- Risedronate Sodium [NCIt concept]
- Ritlecitinib [NCIt concept]
- Ritonavir [NCIt concept]
- Rituximab [NCIt concept]
- Rituximab and Hyaluronidase Human [NCIt concept]
- Rivaroxaban [NCIt concept]
- Riviciclib [NCIt concept]
- Rivipansel [NCIt concept]
- Rivoceranib [NCIt concept]
- Rivoceranib Mesylate [NCIt concept]
- Rivogenlecleucel [NCIt concept]
- Robatumumab [NCIt concept]
- Roblitinib [NCIt concept]
- Rocakinogene Sifuplasmid [NCIt concept]
- Rocapuldencel-T [NCIt concept]
- Rocbrutinib [NCIt concept]
- Rociletinib [NCIt concept]
- Rocuronium [NCIt concept]
- Rocuronium Bromide [NCIt concept]
- Roducitabine [NCIt concept]
- Roflumilast [NCIt concept]
- Rogaratinib [NCIt concept]
- Romidepsin [NCIt concept]
- Romiplostim [NCIt concept]
- Romyelocel-L [NCIt concept]
- Roniciclib [NCIt concept]
- Ropeginterferon Alfa-2B [NCIt concept]
- Ropidoxuridine [NCIt concept]
- Ropivacaine Hydrochloride [NCIt concept]
- Ropocamptide [NCIt concept]
- Rose Bengal Solution PV-10 [NCIt concept]
- Rose Geranium in Sesame Oil Nasal Spray [NCIt concept]
- Rosiglitazone [NCIt concept]
- Rosiglitazone Maleate [NCIt concept]
- Rosmantuzumab [NCIt concept]
- Rosuvastatin [NCIt concept]
- Rosuvastatin Calcium [NCIt concept]
- Rovalpituzumab Tesirine [NCIt concept]
- Roxadustat [NCIt concept]
- Roxithromycin [NCIt concept]
- Rubidium Chloride Rb-82 [NCIt concept]
- Rucaparib Camsylate [NCIt concept]
- Rucaparib Phosphate [NCIt concept]
- Rucosopasem Manganese [NCIt concept]
- Rupitasertib [NCIt concept]
- Rusfertide [NCIt concept]
- Ruthenium Ru-106 [NCIt concept]
- Ruthenium-based Small Molecule Therapeutic BOLD-100 [NCIt concept]
- Ruxolitinib [NCIt concept]
- Ruxolitinib Phosphate [NCIt concept]
- Ruxolitinib Phosphate Cream [NCIt concept]
- S-Adenosyl-L-Methionine Disulfate P-Toluene-Sulfonate [NCIt concept]
- S-equol [NCIt concept]
- S-warfarin [NCIt concept]
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes [NCIt concept]
- SARS-CoV-2 Spike Protein Plasmid DNA Vaccine CORVax [NCIt concept]
- SB-AS15 Adjuvant [NCIt concept]
- SERD ZN-c5 [NCIt concept]
- SGLT2 Inhibitor [NCIt concept]
- SHP2 Inhibitor BBP-398 [NCIt concept]
- SHP2 Inhibitor ERAS-601 [NCIt concept]
- SHP2 Inhibitor HBI-2376 [NCIt concept]
- SHP2 Inhibitor JAB-3312 [NCIt concept]
- SHP2 Inhibitor PF-07284892 [NCIt concept]
- SHP2 Inhibitor RLY-1971 [NCIt concept]
- SIRP-alpha-Fc Fusion Protein HCB101 [NCIt concept]
- SIRPa-4-1BBL Fusion Protein DSP107 [NCIt concept]
- SIRPa-Fc-CD40L Fusion Protein SL-172154 [NCIt concept]
- SIRPa-targeting Agent [NCIt concept]
- SMARCA2 Degrader PRT3789 [NCIt concept]
- SMARCA2 Degrader PRT7732 [NCIt concept]
- SMARCA2 Inhibitor [NCIt concept]
- SMARCA4 Inhibitor [NCIt concept]
- SNS01-T Nanoparticles [NCIt concept]
- SOS1 Inhibitor MRTX0902 [NCIt concept]
- SRC/YES1 Kinase Inhibitor NXP900 [NCIt concept]
- SS1(dsFv)-PE38 Immunotoxin [NCIt concept]
- STAT Inhibitor OPB-111077 [NCIt concept]
- STAT3 Degrader KT-333 [NCIt concept]
- STAT3 Inhibitor [NCIt concept]
- STAT3 Inhibitor C-188-9 [NCIt concept]
- STAT3 Inhibitor DSP-0337 [NCIt concept]
- STAT3 Inhibitor OPB-31121 [NCIt concept]
- STAT3 Inhibitor OPB-51602 [NCIt concept]
- STAT3 Inhibitor VVD-130850 [NCIt concept]
- STAT3 Inhibitor WP1066 [NCIt concept]
- STING Agonist [NCIt concept]
- STING Agonist BI 1387446 [NCIt concept]
- STING Agonist BI 1703880 [NCIt concept]
- STING Agonist BMS-986301 [NCIt concept]
- STING Agonist CRD3874 [NCIt concept]
- STING Agonist GSK3745417 [NCIt concept]
- STING Agonist IMSA101 [NCIt concept]
- STING Agonist MK-2118 [NCIt concept]
- STING Agonist PF-07820435 [NCIt concept]
- STING Agonist SB 11285 [NCIt concept]
- STING Agonist SNX281 [NCIt concept]
- STING Agonist-containing PTGFRN-expressing Exosomes CDK002 [NCIt concept]
- STING-expressing E. coli SYNB1891 [NCIt concept]
- SVN53-67/M57-KLH Peptide Vaccine [NCIt concept]
- Sabatolimab [NCIt concept]
- Sabizabulin [NCIt concept]
- Sacituzumab Govitecan [NCIt concept]
- Sacituzumab Tirumotecan [NCIt concept]
- Safimaltib [NCIt concept]
- Safingol [NCIt concept]
- Safusidenib [NCIt concept]
- Sagopilone [NCIt concept]
- Saline [NCIt concept]
- Salirasib [NCIt concept]
- Salsalate [NCIt concept]
- Salt-inducible Kinase Inhibitor GRN-300 [NCIt concept]
- Salvia hispanica Seed [NCIt concept]
- Sam68 Modulator CWP232291 [NCIt concept]
- Samalizumab [NCIt concept]
- Samarium Sm 153-DOTMP [NCIt concept]
- Samarium Sm-153 Lexidronam Pentasodium [NCIt concept]
- Samatatug Zovodotin [NCIt concept]
- Samotolisib [NCIt concept]
- Samrotamab Vedotin [NCIt concept]
- Sapablursen [NCIt concept]
- Sapacitabine [NCIt concept]
- Sapanisertib [NCIt concept]
- Saponin-Cholesterol-Phospholipid Adjuvant [NCIt concept]
- Saponin-based Immunoadjuvant OBI-821 [NCIt concept]
- SarCNU [NCIt concept]
- Saracatinib [NCIt concept]
- Sargramostim [NCIt concept]
- Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine [NCIt concept]
- Sarilumab [NCIt concept]
- Saruparib [NCIt concept]
- Sasanlimab [NCIt concept]
- Satraplatin [NCIt concept]
- Satricabtagene Autoleucel [NCIt concept]
- Sec61 Inhibitor KZR-261 [NCIt concept]
- Seclidemstat [NCIt concept]
- Secoisolariciresinol [NCIt concept]
- Secretin [NCIt concept]
- Secretin Human [NCIt concept]
- Selective Androgen Receptor Modulator LY2452473 [NCIt concept]
- Selective Estrogen Receptor Covalent Antagonist [NCIt concept]
- Selective Estrogen Receptor Degrader AZD9496 [NCIt concept]
- Selective Estrogen Receptor Degrader LSZ102 [NCIt concept]
- Selective Estrogen Receptor Degrader SRN-927 [NCIt concept]
- Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352 [NCIt concept]
- Selenium [NCIt concept]
- Seliciclib [NCIt concept]
- Selicrelumab [NCIt concept]
- Selinexor [NCIt concept]
- Selitrectinib [NCIt concept]
- Selonsertib [NCIt concept]
- Selpercatinib [NCIt concept]
- Selumetinib [NCIt concept]
- Selumetinib Sulfate [NCIt concept]
- Semaglutide [NCIt concept]
- Semaxanib [NCIt concept]
- Semuloparin [NCIt concept]
- Sendegobresib [NCIt concept]
- Seneca Valley Virus-001 [NCIt concept]
- Sepantronium Bromide [NCIt concept]
- Serabelisib [NCIt concept]
- Seribantumab [NCIt concept]
- Serine/Threonine Kinase Inhibitor CBP501 [NCIt concept]
- Serplulimab [NCIt concept]
- Sertraline [NCIt concept]
- Sertraline Hydrochloride [NCIt concept]
- Serum-derived Bovine Immunoglobulin Protein Isolate [NCIt concept]
- Seviteronel [NCIt concept]
- Shark Cartilage Extract AE-941 [NCIt concept]
- Sialyl Tn-KLH Vaccine [NCIt concept]
- Signal Transduction Inhibitor [NCIt concept]
- Silatecan AR-67 [NCIt concept]
- Sildenafil [NCIt concept]
- Sildenafil Citrate [NCIt concept]
- Silibinin [NCIt concept]
- Silicon Phthalocyanine 4 [NCIt concept]
- Silicone-based Film Forming Topical Gel [NCIt concept]
- Silmitasertib Sodium [NCIt concept]
- Siltuximab [NCIt concept]
- Simethicone [NCIt concept]
- Simlukafusp Alfa [NCIt concept]
- Simotaxel [NCIt concept]
- Simtuzumab [NCIt concept]
- Simurosertib [NCIt concept]
- Simvastatin [NCIt concept]
- Sinecatechins [NCIt concept]
- Sintilimab [NCIt concept]
- Sipavibart [NCIt concept]
- Sipuleucel-T [NCIt concept]
- Siremadlin [NCIt concept]
- Sirexatamab [NCIt concept]
- Sirolimus [NCIt concept]
- Sirolimus Albumin-bound Nanoparticles [NCIt concept]
- Sirolimus Topical Gel PTX-022 [NCIt concept]
- Sirpiglenastat [NCIt concept]
- Sirtratumab Vedotin [NCIt concept]
- Sisunatovir [NCIt concept]
- Sitagliptin [NCIt concept]
- Sitagliptin Phosphate [NCIt concept]
- Sizavaleucel [NCIt concept]
- Skin Care Product [NCIt concept]
- Smac Mimetic BGB-24714 [NCIt concept]
- Smac Mimetic GDC-0152 [NCIt concept]
- Smac Mimetic LCL161 [NCIt concept]
- Smokeless Tobacco [NCIt concept]
- Smoothened Antagonist BMS-833923 [NCIt concept]
- Smoothened Antagonist LEQ506 [NCIt concept]
- Smoothened Antagonist TAK-441 [NCIt concept]
- Snuff Tobacco [NCIt concept]
- Sodium Bicarbonate [NCIt concept]
- Sodium Bicarbonate Solution [NCIt concept]
- Sodium Dichloroacetate [NCIt concept]
- Sodium Ferric Gluconate Complex [NCIt concept]
- Sodium Fluoride F-18 [NCIt concept]
- Sodium Hyaluronate Topical Hydrogel [NCIt concept]
- Sodium Hypochlorite [NCIt concept]
- Sodium Iodide I-131 [NCIt concept]
- Sodium Metaarsenite [NCIt concept]
- Sodium Phenylbutyrate [NCIt concept]
- Sodium Selenite [NCIt concept]
- Sodium Stibogluconate [NCIt concept]
- Sodium Thiosulfate [NCIt concept]
- Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108 [NCIt concept]
- Sofituzumab Vedotin [NCIt concept]
- Sofosbuvir [NCIt concept]
- Solifenacin Succinate [NCIt concept]
- Somatostatin Receptor Agonist [NCIt concept]
- Somatropin [NCIt concept]
- Sonidegib [NCIt concept]
- Sonolisib [NCIt concept]
- Sonrotoclax [NCIt concept]
- Sontuzumab [NCIt concept]
- Soquelitinib [NCIt concept]
- Sorafenib [NCIt concept]
- Sorafenib Tosylate [NCIt concept]
- Sotatercept [NCIt concept]
- Sotevtamab [NCIt concept]
- Sotigalimab [NCIt concept]
- Sotorasib [NCIt concept]
- Sotrastaurin Acetate [NCIt concept]
- Sovateltide [NCIt concept]
- Sovilnesib [NCIt concept]
- Sovipostobart [NCIt concept]
- Soy Isoflavones [NCIt concept]
- Soy Protein Isolate [NCIt concept]
- Spanlecortemlocel [NCIt concept]
- Spartalizumab [NCIt concept]
- Spebrutinib [NCIt concept]
- Spherical Nucleic Acid Nanoparticle NU-0129 [NCIt concept]
- Spironolactone [NCIt concept]
- Splicing Inhibitor H3B-8800 [NCIt concept]
- Spunoleucel [NCIt concept]
- Squeezed Red Blood Cells Expressing HPV16 Epitopes SQZ-AAC-HPV [NCIt concept]
- Src/tubulin Inhibitor KX2-361 [NCIt concept]
- Stabilized Sulphur Hexafluoride Microbubble-Based Contrast Agent [NCIt concept]
- Sterile Distilled Water [NCIt concept]
- Strontium Chloride Sr-89 [NCIt concept]
- Subasumstat [NCIt concept]
- Submicron Particle Paclitaxel Sterile Suspension [NCIt concept]
- Substance P-Saporin [NCIt concept]
- Succimer [NCIt concept]
- Sudocetaxel Zendusortide [NCIt concept]
- Sugammadex [NCIt concept]
- Sugemalimab [NCIt concept]
- Sulanemadlin [NCIt concept]
- Sulfasalazine [NCIt concept]
- Sulfatinib [NCIt concept]
- Sulforaphane [NCIt concept]
- Sulfur Hexafluoride [NCIt concept]
- Sulfur Hexafluoride Lipid Microspheres [NCIt concept]
- Sulindac [NCIt concept]
- Sunitinib [NCIt concept]
- Sunitinib Malate [NCIt concept]
- Sunscreen [NCIt concept]
- Sunvozertinib [NCIt concept]
- Supersaturated Calcium Phosphate Rinse [NCIt concept]
- Supra-pharmacologic Dexamethasone Sodium Phosphate AVM0703 [NCIt concept]
- Suramin [NCIt concept]
- Suratadenoturev [NCIt concept]
- Surovatamig [NCIt concept]
- Survivin Antigen [NCIt concept]
- Survivin mRNA Antagonist EZN-3042 [NCIt concept]
- Survivin-expressing CVD908ssb-TXSVN Vaccine [NCIt concept]
- Surzebiclimab [NCIt concept]
- Sustained-Exposure Dexamethasone Formulation OTO-104 [NCIt concept]
- Sustained-release Lipid Inhaled Cisplatin [NCIt concept]
- Sustained-release Mitomycin C Hydrogel Formulation UGN-101 [NCIt concept]
- Sustained-release Mitomycin C Hydrogel Formulation UGN-102 [NCIt concept]
- Sutetinib Maleate [NCIt concept]
- Sutimlimab [NCIt concept]
- Synbiotic Supplement [NCIt concept]
- Synthetic Alkaloid PM00104 [NCIt concept]
- Synthetic Brain Tumor Peptides-Pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Poly ICLC Vaccine [NCIt concept]
- Synthetic Hypericin [NCIt concept]
- Synthetic Long E6/E7 Peptides Vaccine HPV-01 [NCIt concept]
- Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b [NCIt concept]
- Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1 [NCIt concept]
- Synthetic Peptides E-PRA And E-PSM Vaccine [NCIt concept]
- Synthetic Plumbagin PCUR-101 [NCIt concept]
- Synthetic hTERT DNA Vaccine INO-1400 [NCIt concept]
- Synthetic hTERT DNA Vaccine INO-1401 [NCIt concept]
- T-cell Engaging Antibody [NCIt concept]
- T-cell Engaging Bispecific Antibody [NCIt concept]
- T-cell Membrane-anchored Tumor-targeted IL-12-modified Tumor Infiltrating Lymphocytes [NCIt concept]
- T-cell Receptor-engineered T-cells [NCIt concept]
- T-type Calcium Channel Blocker ABT-639 [NCIt concept]
- T4N5 Liposomal Lotion [NCIt concept]
- TACC3 Protein-Protein Interaction Inhibitor AO-252 [NCIt concept]
- TAEK-VAC-HerBy Vaccine [NCIt concept]
- TAFIa Inhibitor DS-1040b [NCIt concept]
- TAM/c-Met Inhibitor RXDX-106 [NCIt concept]
- TCR alpha/beta/CD19-depleted Allogeneic Hematopoietic Progenitor Cells [NCIt concept]
- TCR-specific, alpha Fetoprotein-enhanced Autologous T Lymphocytes [NCIt concept]
- TEAD Inhibitor [NCIt concept]
- TEAD Inhibitor BGC515 [NCIt concept]
- TEAD Inhibitor IK-930 [NCIt concept]
- TEAD Inhibitor SW-682 [NCIt concept]
- TEAD Inhibitor VT3989 [NCIt concept]
- TGF-beta Receptor 1 Inhibitor PF-06952229 [NCIt concept]
- TGF-beta-Resistant LMP-Specific Cytotoxic T-Lymphocytes [NCIt concept]
- TGF-beta-targeting Agent [NCIt concept]
- TGFbeta Inhibitor LY3200882 [NCIt concept]
- TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein BMS-986416 [NCIt concept]
- TIL 1383I T Cell Receptor-Transduced Autologous T Cells [NCIt concept]
- TLR 2/6/9 Agonist PUL-042 [NCIt concept]
- TLR Agonist Decoy20 [NCIt concept]
- TLR4 Agonist G100 [NCIt concept]
- TLR7 Agonist ANA773 Tosylate [NCIt concept]
- TLR7 Agonist LHC165 [NCIt concept]
- TLR7 agonist BNT411 [NCIt concept]
- TLR8 Agonist DN1508052 [NCIt concept]
- TLR9 Agonist DUK-CPG-001 [NCIt concept]
- TLR9 Agonist EMD 1201081 [NCIt concept]
- TLR9 Agonist IMO-2055 [NCIt concept]
- TMPRSS6 RNAi SLN124 [NCIt concept]
- TNFalpha/IL-2-encoding Oncolytic Adenovirus TILT-123 [NCIt concept]
- TPO Receptor Agonist ONO-7746 [NCIt concept]
- TRAC Locus Integrated Anti-CD19 19(T2)28z1xx CAR-T Cells [NCIt concept]
- TRK Inhibitor [NCIt concept]
- TROP2-targeting Agent [NCIt concept]
- TRP2 mRNA-electroporated Autologous Langerhans-type Dendritic Cell Vaccine [NCIt concept]
- TSP-1 Activator VT1021 [NCIt concept]
- TSP-1 Mimetic ABT-510 [NCIt concept]
- TTK/PLK1 Inhibitor BAL0891 [NCIt concept]
- Tabalumab [NCIt concept]
- Tabelecleucel [NCIt concept]
- Tacaciclib [NCIt concept]
- Tacrolimus [NCIt concept]
- Tadalafil [NCIt concept]
- Tafamidis Meglumine [NCIt concept]
- Tafasitamab [NCIt concept]
- Tagraxofusp-erzs [NCIt concept]
- Talabostat [NCIt concept]
- Talacotuzumab [NCIt concept]
- Talactoferrin Alfa [NCIt concept]
- Taladegib [NCIt concept]
- Talaporfin Sodium [NCIt concept]
- Talazoparib [NCIt concept]
- Talazoparib Tosylate [NCIt concept]
- Talfirastide [NCIt concept]
- Talimogene Laherparepvec [NCIt concept]
- Talotrexin Ammonium [NCIt concept]
- Talquetamab [NCIt concept]
- Tamibarotene [NCIt concept]
- Taminadenant [NCIt concept]
- Tamoxifen [NCIt concept]
- Tamoxifen Citrate [NCIt concept]
- Tamrintamab Pamozirine [NCIt concept]
- Tandutinib [NCIt concept]
- Tanespimycin [NCIt concept]
- Tanezumab [NCIt concept]
- Taniraleucel [NCIt concept]
- Tapentadol Hydrochloride [NCIt concept]
- Tapotoclax [NCIt concept]
- Tarextumab [NCIt concept]
- Targeted Alpha Therapy Agent [NCIt concept]
- Tariquidar [NCIt concept]
- Tarlatamab [NCIt concept]
- Tarloxotinib Bromide [NCIt concept]
- Tasadenoturev [NCIt concept]
- Tasadenoturev-infected Allogeneic Bone Marrow-derived Mesenchymal Stem Cells [NCIt concept]
- Taselisib [NCIt concept]
- Tasisulam Sodium [NCIt concept]
- Tasquinimod [NCIt concept]
- Tavokinogene Telseplasmid [NCIt concept]
- Tavolimab [NCIt concept]
- Taxane Analogue TPI 287 [NCIt concept]
- Tazarotene [NCIt concept]
- Tazemetostat [NCIt concept]
- Tazemetostat Hydrobromide [NCIt concept]
- Tazobactam [NCIt concept]
- Tebentafusp [NCIt concept]
- Tebotelimab [NCIt concept]
- Tecaginlimab [NCIt concept]
- Technetium TC-99m [NCIt concept]
- Technetium Tc 94m Sestamibi [NCIt concept]
- Technetium Tc 99 Hydrazinonicotinamide-Tricine-linked Interleukin-2 [NCIt concept]
- Technetium Tc 99m Trofolastat [NCIt concept]
- Technetium Tc 99m-labeled Tilmanocept [NCIt concept]
- Technetium Tc-99m Albumin Aggregated [NCIt concept]
- Technetium Tc-99m DTPA [NCIt concept]
- Technetium Tc-99m Ethylenedicysteine-Deoxyglucose [NCIt concept]
- Technetium Tc-99m Mebrofenin [NCIt concept]
- Technetium Tc-99m Medronate [NCIt concept]
- Technetium Tc-99m Sulfur Colloid [NCIt concept]
- Teclistamab [NCIt concept]
- Tecotabart [NCIt concept]
- Tecotabart Vedotin [NCIt concept]
- Tecovirimat [NCIt concept]
- Tegafur-gimeracil-oteracil Potassium [NCIt concept]
- Tegavivint [NCIt concept]
- Teglarinad Chloride [NCIt concept]
- Tegtociclib [NCIt concept]
- Telaglenastat [NCIt concept]
- Telaglenastat Hydrochloride [NCIt concept]
- Telaprevir [NCIt concept]
- Telapristone Acetate [NCIt concept]
- Telatinib Mesylate [NCIt concept]
- Telavancin [NCIt concept]
- Telavancin Hydrochloride [NCIt concept]
- Telisotuzumab [NCIt concept]
- Telisotuzumab Vedotin [NCIt concept]
- Telmisartan [NCIt concept]
- Telotristat Ethyl [NCIt concept]
- Telotristat Etiprate [NCIt concept]
- Telratolimod [NCIt concept]
- Temoporfin [NCIt concept]
- Temozolomide [NCIt concept]
- Temozolomide Perillyl Alcohol Conjugate NEO212 [NCIt concept]
- Temsirolimus [NCIt concept]
- Temuterkib [NCIt concept]
- Tenalisib [NCIt concept]
- Teniposide [NCIt concept]
- Tenofovir [NCIt concept]
- Tenofovir Alafenamide [NCIt concept]
- Tenofovir Anhydrous [NCIt concept]
- Tenofovir Disoproxil Fumarate [NCIt concept]
- Tepoditamab [NCIt concept]
- Tepotinib [NCIt concept]
- Tepotinib Hydrochloride [NCIt concept]
- Teprotumumab [NCIt concept]
- Terameprocol [NCIt concept]
- Tergenpumatucel-L [NCIt concept]
- Tesetaxel [NCIt concept]
- Tesevatinib [NCIt concept]
- Tesidolumab [NCIt concept]
- Testosterone Cypionate [NCIt concept]
- Testosterone Enanthate [NCIt concept]
- Testosterone Gel [NCIt concept]
- Testosterone Nasal Gel [NCIt concept]
- Testosterone Vaginal Cream [NCIt concept]
- Tetanus Peptide Melanoma Vaccine [NCIt concept]
- Tetanus Toxoid Helper Peptide [NCIt concept]
- Tetanus Toxoid Vaccine [NCIt concept]
- Tetanus and Diphtheria Toxoids Adsorbed [NCIt concept]
- Tetanus-CMV Fusion Peptide Vaccine [NCIt concept]
- Tetracycline Hydrochloride [NCIt concept]
- Tetradecanoylphorbol Acetate [NCIt concept]
- Tetrahydrouridine [NCIt concept]
- Tetrathiomolybdate [NCIt concept]
- Tetravalent RNA-lipoplex Cancer Vaccine BNT111 [NCIt concept]
- Tetrodotoxin [NCIt concept]
- Tezemlimogene Daxadenorepvec [NCIt concept]
- Thalidomide [NCIt concept]
- Theophylline [NCIt concept]
- Therapeutic Allogeneic Cytotoxic T-Lymphocytes [NCIt concept]
- Therapeutic Allogeneic Hematopoietic Stem Cells [NCIt concept]
- Therapeutic Allogeneic Lymphocytes [NCIt concept]
- Therapeutic Autologous Dendritic Cells [NCIt concept]
- Therapeutic Autologous Lymphocytes [NCIt concept]
- Therapeutic Autologous Platelet-rich Plasma [NCIt concept]
- Therapeutic Bacterial Strain CJRB-101 [NCIt concept]
- Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 [NCIt concept]
- Therapeutic Cancer Vaccine ATP128 [NCIt concept]
- Therapeutic Cancer Vaccine ATP150 [NCIt concept]
- Therapeutic Cancer Vaccine ATP152 [NCIt concept]
- Therapeutic Effector T-Lymphocytes [NCIt concept]
- Therapeutic Epinephrine [NCIt concept]
- Therapeutic Estradiol [NCIt concept]
- Therapeutic Ex Vivo-expanded Allogeneic gamma delta T-cells [NCIt concept]
- Therapeutic Exchange Plasma [NCIt concept]
- Therapeutic Hormone [NCIt concept]
- Therapeutic Hydrocortisone [NCIt concept]
- Therapeutic Immune Globulin [NCIt concept]
- Therapeutic Insulin [NCIt concept]
- Therapeutic Melatonin [NCIt concept]
- Therapeutic Testosterone [NCIt concept]
- Therapeutic Tumor Infiltrating Lymphocytes [NCIt concept]
- Thiarabine [NCIt concept]
- Thioguanine [NCIt concept]
- Thioredoxin-1 Inhibitor PX-12 [NCIt concept]
- Thioridazine Hydrochloride [NCIt concept]
- Thiotepa [NCIt concept]
- Thioureidobutyronitrile [NCIt concept]
- Thorium Th 227 Anetumab Corixetan [NCIt concept]
- Thorium Th 227 Pelgifatamab Corixetan [NCIt concept]
- Thorium Th 227 Trastuzumab Corixetan [NCIt concept]
- Thrombomodulin Alfa [NCIt concept]
- Thyrointegrin AlphaVBeta3 Antagonist fb-PMT [NCIt concept]
- Ticagrelor [NCIt concept]
- Tidutamab [NCIt concept]
- Tifcemalimab [NCIt concept]
- Tigatuzumab [NCIt concept]
- Tigozertinib [NCIt concept]
- Tilatamig Samrotecan [NCIt concept]
- Tilogotamab [NCIt concept]
- Tilsotolimod [NCIt concept]
- Tilsotolimod Sodium [NCIt concept]
- Tin Sn 117m Pentetate [NCIt concept]
- Tinengotinib [NCIt concept]
- Tinlorafenib [NCIt concept]
- Tinodasertib [NCIt concept]
- Tinostamustine [NCIt concept]
- Tinurilimab [NCIt concept]
- Tinzaparin Sodium [NCIt concept]
- Tipapkinogene Sovacivec [NCIt concept]
- Tipifarnib [NCIt concept]
- Tirabrutinib [NCIt concept]
- Tiragolumab [NCIt concept]
- Tirapazamine [NCIt concept]
- Tirbanibulin [NCIt concept]
- Tisagenlecleucel [NCIt concept]
- Tislelizumab [NCIt concept]
- Tisotumab Vedotin [NCIt concept]
- Tissue Polypeptide Specific Antigen [NCIt concept]
- Titanium Dioxide/Zinc Oxide Sunscreen [NCIt concept]
- Tivantinib [NCIt concept]
- Tivozanib [NCIt concept]
- Tivozanib Hydrochloride [NCIt concept]
- Tivumecirnon [NCIt concept]
- Tizanidine Hydrochloride [NCIt concept]
- Tobemstomig [NCIt concept]
- Tocilizumab [NCIt concept]
- Tocladesine [NCIt concept]
- Tolbutamide [NCIt concept]
- Tolcapone [NCIt concept]
- Tolinapant [NCIt concept]
- Toll-like Receptor 7/8 Agonist EIK1001 [NCIt concept]
- Tolvaptan [NCIt concept]
- Tomaralimab [NCIt concept]
- Tomivosertib [NCIt concept]
- Toothpaste [NCIt concept]
- Topical Calcitriol [NCIt concept]
- Topical Fibrinogen-depleted Human Standardized Platelet Lysate CAM-101 [NCIt concept]
- Topical Fluorouracil [NCIt concept]
- Topical Gel HT-001 [NCIt concept]
- Topical Keratin [NCIt concept]
- Topical Keratinocyte Growth Factor Hair Serum [NCIt concept]
- Topical Menthol Cream [NCIt concept]
- Topical Phenylephrine Solution [NCIt concept]
- Topical Piperidine Nitroxide MTS-01 [NCIt concept]
- Topical Preparation [NCIt concept]
- Topical VBP-926 Solution [NCIt concept]
- Topoisomerase I Inhibitor Genz-644282 [NCIt concept]
- Topoisomerase I Inhibitor LMP400 [NCIt concept]
- Topoisomerase I Inhibitor LMP776 [NCIt concept]
- Topoisomerase I inhibitor-containing Antibody-drug Conjugate [NCIt concept]
- Topoisomerase I/II Inhibitor NEV-801 [NCIt concept]
- Topoisomerase-1 Inhibitor LMP744 [NCIt concept]
- Topoisomerase-I Inhibitor [NCIt concept]
- Topoisomerase-II-beta Inhibitor Racemic XK469 [NCIt concept]
- Topotecan [NCIt concept]
- Topotecan Hydrochloride [NCIt concept]
- Topotecan Hydrochloride Liposomes [NCIt concept]
- Topotecan Sustained-release Episcleral Plaque [NCIt concept]
- Toremifene Citrate [NCIt concept]
- Toripalimab [NCIt concept]
- Tosedostat [NCIt concept]
- Tositumomab [NCIt concept]
- Tositumomab and Iodine I 131 Tositumomab [NCIt concept]
- Total Tumor RNA-loaded Dendritic Cell Vaccine [NCIt concept]
- Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells [NCIt concept]
- Totrombopag [NCIt concept]
- Tovetumab [NCIt concept]
- Tovorafenib [NCIt concept]
- Tozadenant [NCIt concept]
- Tozasertib Lactate [NCIt concept]
- Tozinameran [NCIt concept]
- Tozuleristide [NCIt concept]
- Trabectedin [NCIt concept]
- Trabedersen [NCIt concept]
- Trametinib [NCIt concept]
- Trametinib Dimethyl Sulfoxide [NCIt concept]
- Trans Sodium Crocetinate [NCIt concept]
- Transcription Factor Protein SON-DP [NCIt concept]
- Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01 [NCIt concept]
- Transgenic Lymphocyte Immunization Vaccine [NCIt concept]
- Tranylcypromine [NCIt concept]
- Trastuzumab [NCIt concept]
- Trastuzumab Botidotin [NCIt concept]
- Trastuzumab Deruxtecan [NCIt concept]
- Trastuzumab Duocarmazine [NCIt concept]
- Trastuzumab Emtansine [NCIt concept]
- Trastuzumab Imbotolimod [NCIt concept]
- Trastuzumab Vedotin [NCIt concept]
- Trastuzumab/Hyaluronidase-oysk [NCIt concept]
- Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 [NCIt concept]
- Trebananib [NCIt concept]
- Treg Inhibitor GIM-531 [NCIt concept]
- Tremelimumab [NCIt concept]
- Tremtelectogene Empogeditemcel [NCIt concept]
- Treosulfan [NCIt concept]
- Tretinoin [NCIt concept]
- Triamcinolone [NCIt concept]
- Triapine [NCIt concept]
- Triciribine Phosphate [NCIt concept]
- Trientine Hydrochloride [NCIt concept]
- Trifarotene [NCIt concept]
- Trifluridine [NCIt concept]
- Trifluridine and Tipiracil Hydrochloride [NCIt concept]
- Trilaciclib [NCIt concept]
- Trimethoprim-Sulfamethoxazole [NCIt concept]
- Triptolide Analog [NCIt concept]
- Triptorelin [NCIt concept]
- Triptorelin Pamoate [NCIt concept]
- Tris-acryl Gelatin Microspheres [NCIt concept]
- Trivalent Influenza Vaccine [NCIt concept]
- TrkA Inhibitor VMD-928 [NCIt concept]
- Tropisetron [NCIt concept]
- Troriluzole [NCIt concept]
- Trotabresib [NCIt concept]
- Troxacitabine [NCIt concept]
- Tubulin Inhibitor ALB 109564 Dihydrochloride [NCIt concept]
- Tubulin Polymerization Inhibitor AB8939 [NCIt concept]
- Tucatinib [NCIt concept]
- Tucidinostat [NCIt concept]
- Tulmimetostat [NCIt concept]
- Tumor Antigen-specific Antibody [NCIt concept]
- Tumor-Cells Apoptosis Factor Hormone-Peptide [NCIt concept]
- Tuparstobart [NCIt concept]
- Tusamitamab Ravtansine [NCIt concept]
- Tuspetinib [NCIt concept]
- Tuvusertib [NCIt concept]
- Tuxobertinib [NCIt concept]
- Type II JAK2 Inhibitor AJ1-11095 [NCIt concept]
- Tyrosinase Peptide [NCIt concept]
- Tyrosine Kinase Inhibitor [NCIt concept]
- Tyrosine Kinase Inhibitor XL228 [NCIt concept]
- UAE Inhibitor TAK-243 [NCIt concept]
- UGT1A1 Inhibitor [NCIt concept]
- USP1 Inhibitor ISM3091 [NCIt concept]
- USP1 Inhibitor TNG348 [NCIt concept]
- USP1 inhibitor KSQ-4279 [NCIt concept]
- USP14/UCHL5 Inhibitor VLX1570 [NCIt concept]
- UV1 Telomerase Peptide Vaccine [NCIt concept]
- Ubamatamab [NCIt concept]
- Ubidecarenone Nanodispersion BPM31510n [NCIt concept]
- Ublituximab [NCIt concept]
- Ucalolictide [NCIt concept]
- Ulevostinag [NCIt concept]
- Uliledlimab [NCIt concept]
- Ulimorelin Hydrochloride [NCIt concept]
- Ulixertinib [NCIt concept]
- Ulocuplumab [NCIt concept]
- Umbilical Cord Blood-Derived Mesenchymal Stem Cells [NCIt concept]
- Umbilical Cord Blood-derived CD16-expressing Natural Killer Cells AB-101 [NCIt concept]
- Umbralisib [NCIt concept]
- Umbralisib Tosylate [NCIt concept]
- Unesbulin [NCIt concept]
- Uniformly-labeled [13C]fructose [NCIt concept]
- Uniformly-labeled [13C]glucose [NCIt concept]
- Uniformly-labeled [13C]glutamine [NCIt concept]
- Uniformly-labeled [13C]lactate [NCIt concept]
- Universal Donor Expanded TGF-beta-imprinted NK Cells [NCIt concept]
- Upamostat [NCIt concept]
- Upinitatug [NCIt concept]
- Upinitatug Rilsodotin [NCIt concept]
- Uprevstobart [NCIt concept]
- Uproleselan [NCIt concept]
- Uprosertib [NCIt concept]
- Urabrelimab [NCIt concept]
- Urea C-13 [NCIt concept]
- Urea/Lactic Acid-Based Cream [NCIt concept]
- Urelumab [NCIt concept]
- Uridine [NCIt concept]
- Urokinase-Derived Peptide A6 [NCIt concept]
- Urolithin A Supplement [NCIt concept]
- Ursodiol [NCIt concept]
- Ursolic Acid [NCIt concept]
- Ustekinumab [NCIt concept]
- Utatrectinib [NCIt concept]
- Utidelone [NCIt concept]
- Utomilumab [NCIt concept]
- Uzansertib [NCIt concept]
- Uzatresgene Autoleucel [NCIt concept]
- VCL-CB01 Vaccine [NCIt concept]
- VEGF-targeting Agent [NCIt concept]
- VEGF/HGF-targeting DARPin MP0250 [NCIt concept]
- VEGFR-targeting Agent [NCIt concept]
- VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 [NCIt concept]
- VEGFR2 Tyrosine Kinase Inhibitor PF-00337210 [NCIt concept]
- VISTA-targeting Agent [NCIt concept]
- VSV-GP BI 1831169 [NCIt concept]
- VSV-GP-based Cancer Vaccine VSV-GP128 [NCIt concept]
- VSV-GP-based Cancer Vaccine VSV-GP154 [NCIt concept]
- VT30 Topical Gel [NCIt concept]
- Vaccine [NCIt concept]
- Vaccinia Virus DD-CDSR [NCIt concept]
- Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules [NCIt concept]
- Vadastuximab Talirine [NCIt concept]
- Vadimezan [NCIt concept]
- Vaginal Moisturizer [NCIt concept]
- Valacyclovir [NCIt concept]
- Valemetostat [NCIt concept]
- Valemetostat Tosylate [NCIt concept]
- Valerian [NCIt concept]
- Valganciclovir [NCIt concept]
- Valproic Acid [NCIt concept]
- Valproic Acid-Expanded Umbilical Cord Blood-derived CD34-positive Cells [NCIt concept]
- Valrubicin [NCIt concept]
- Valspodar [NCIt concept]
- Vancomycin [NCIt concept]
- Vandetanib [NCIt concept]
- Vandortuzumab Vedotin [NCIt concept]
- Vantictumab [NCIt concept]
- Vanucizumab [NCIt concept]
- Varegacestat [NCIt concept]
- Varenicline [NCIt concept]
- Varenicline Tartrate [NCIt concept]
- Varicella-Zoster Virus Strain Oka/Merck Live Antigen [NCIt concept]
- Varlilumab [NCIt concept]
- Varlitinib [NCIt concept]
- Vascular Disrupting Agent BNC105P [NCIt concept]
- Vatalanib [NCIt concept]
- Vebreltinib [NCIt concept]
- Vecabrutinib [NCIt concept]
- Vecuronium [NCIt concept]
- Vedolizumab [NCIt concept]
- Veledimex [NCIt concept]
- Veliparib [NCIt concept]
- Velpatasvir [NCIt concept]
- Veltuzumab [NCIt concept]
- Vemurafenib [NCIt concept]
- Venadaparib [NCIt concept]
- Venetoclax [NCIt concept]
- Venlafaxine [NCIt concept]
- Venlafaxine Hydrochloride [NCIt concept]
- Venlafaxine Hydrochloride Extended Release [NCIt concept]
- Vepafestinib [NCIt concept]
- Vepdegestrant [NCIt concept]
- Vepoloxamer [NCIt concept]
- Vepsitamab [NCIt concept]
- Verapamil [NCIt concept]
- Verapamil Hydrochloride [NCIt concept]
- Vericiguat [NCIt concept]
- Verpasep Caltespen [NCIt concept]
- Verubulin Hydrochloride [NCIt concept]
- Verzistobart [NCIt concept]
- Vesencumab [NCIt concept]
- Vesicular Stomatitis Virus-based Therapeutic Agent [NCIt concept]
- Vevoctadekin [NCIt concept]
- Vibecotamab [NCIt concept]
- Vibostolimab [NCIt concept]
- Vibostolimab/Pembrolizumab MK-7684A [NCIt concept]
- Vidoflufolastat (18F) [NCIt concept]
- Vidutolimod [NCIt concept]
- Vilamakitug [NCIt concept]
- Vilaprisan [NCIt concept]
- Vimseltinib [NCIt concept]
- Vinblastine [NCIt concept]
- Vinblastine Sulfate [NCIt concept]
- Vincristine [NCIt concept]
- Vincristine Liposomal [NCIt concept]
- Vincristine Sulfate [NCIt concept]
- Vincristine Sulfate Liposome [NCIt concept]
- Vinflunine [NCIt concept]
- Vinorelbine [NCIt concept]
- Vinorelbine Tartrate [NCIt concept]
- Vinorelbine Tartrate Emulsion [NCIt concept]
- Vintafolide [NCIt concept]
- Viral Vector [NCIt concept]
- Viral Vector-based Cancer Vaccine VAC85135 [NCIt concept]
- Virgin Coconut Oil Mouth Rinse [NCIt concept]
- Visilizumab [NCIt concept]
- Vislarafusp Alfa [NCIt concept]
- Vismodegib [NCIt concept]
- Vistusertib [NCIt concept]
- Vitamin A Compound [NCIt concept]
- Vitamin B Complex [NCIt concept]
- Vitamin B6 [NCIt concept]
- Vitamin E Compound [NCIt concept]
- Vitamin K [NCIt concept]
- Vitespen [NCIt concept]
- Vixtimotamab [NCIt concept]
- Vobramitamab Duocarmazine [NCIt concept]
- Vocimagene Amiretrorepvec [NCIt concept]
- Vociprotafib [NCIt concept]
- Vodobatinib [NCIt concept]
- Vodudeutentan Sodium [NCIt concept]
- Vofatamab [NCIt concept]
- Volagidemab [NCIt concept]
- Volasertib [NCIt concept]
- Volrustomig [NCIt concept]
- Vonlerolizumab [NCIt concept]
- Vopikitug [NCIt concept]
- Vopratelimab [NCIt concept]
- Vorasidenib [NCIt concept]
- Voriconazole [NCIt concept]
- Vorinostat [NCIt concept]
- Vorolanib [NCIt concept]
- Vorsetzumab Mafodotin [NCIt concept]
- Voruciclib [NCIt concept]
- Vosaroxin [NCIt concept]
- Vosilasarm [NCIt concept]
- Voxalatamab [NCIt concept]
- Voxelotor [NCIt concept]
- Voxilaprevir [NCIt concept]
- Voxtalisib [NCIt concept]
- Vudalimab [NCIt concept]
- Vusolimogene Oderparepvec [NCIt concept]
- WRN Inhibitor HRO761 [NCIt concept]
- WRN Inhibitor RO7589831 [NCIt concept]
- WT1 124-138 Peptide Vaccine [NCIt concept]
- WT1 126-134 Peptide Vaccine [NCIt concept]
- WT1 235-243 Peptide Vaccine [NCIt concept]
- WT1 247-261 Peptide Vaccine [NCIt concept]
- WT1 Analog Peptide Vaccine [NCIt concept]
- WT1 Peptide Vaccine WT2725 [NCIt concept]
- WT1 Peptide-loaded Allogeneic Dendritic Cell Vaccine [NCIt concept]
- WT1 Protein-derived Peptide Vaccine DSP-7888 [NCIt concept]
- WT1-A10/AS01B Immunotherapeutic GSK2130579A [NCIt concept]
- WT1-Sensitized Allogeneic T-Lymphocytes [NCIt concept]
- WT1-loaded Artificial Adjuvant Vector Cell Immunotherapeutic ASP7517 [NCIt concept]
- WT1-targeted IL-2-based Fusion Protein CUE-102 [NCIt concept]
- WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes [NCIt concept]
- WT1/PRAME/Survivin-specific T-cells MANA-312 [NCIt concept]
- WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401 [NCIt concept]
- W_pro1 Cancer Vaccine [NCIt concept]
- Warfarin [NCIt concept]
- Warfarin Sodium [NCIt concept]
- Water O-15 [NCIt concept]
- Watercress [NCIt concept]
- Wee1 Inhibitor [NCIt concept]
- Wee1 Inhibitor APR-1051 [NCIt concept]
- Wee1 Kinase Inhibitor Debio 0123 [NCIt concept]
- Wee1 Kinase Inhibitor IMP7068 [NCIt concept]
- Wee1/Myt1 Inhibitor SGR-3515 [NCIt concept]
- Werner Syndrome Helicase Inhibitor [NCIt concept]
- White Button Mushroom Extract [NCIt concept]
- White Grape Juice [NCIt concept]
- White Wine [NCIt concept]
- Wistar Rabies Virus Strain PM-1503-3M Vaccine [NCIt concept]
- Wnt Signaling Inhibitor APL-5125 [NCIt concept]
- Wnt Signaling Inhibitor SM04755 [NCIt concept]
- Wnt Signaling Pathway Inhibitor [NCIt concept]
- Wnt Signaling Pathway Inhibitor SM08502 [NCIt concept]
- XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 [NCIt concept]
- XELOX Regimen [NCIt concept]
- XIAP Antisense Oligonucleotide AEG35156 [NCIt concept]
- XPO1 Inhibitor [NCIt concept]
- Xaliproden Hydrochloride [NCIt concept]
- Xaluritamig [NCIt concept]
- Xentuzumab [NCIt concept]
- Xevinapant [NCIt concept]
- Xirestomig [NCIt concept]
- Xylitol [NCIt concept]
- YAP/TEAD Interaction Inhibitor IAG933 [NCIt concept]
- YAP1 Antisense Oligonucleotide ION537 [NCIt concept]
- Yeast-derived Beta-glucan Supplement [NCIt concept]
- Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12 [NCIt concept]
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 [NCIt concept]
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 [NCIt concept]
- Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101 [NCIt concept]
- Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 [NCIt concept]
- Yttrium Y 90 Basiliximab [NCIt concept]
- Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Yttrium Y 90 Daclizumab [NCIt concept]
- Yttrium Y 90 Glass Microspheres [NCIt concept]
- Yttrium Y 90 Resin Microspheres [NCIt concept]
- Yttrium Y 90-Edotreotide [NCIt concept]
- Yttrium Y-90 Clivatuzumab Tetraxetan [NCIt concept]
- Yttrium Y-90 Epratuzumab Tetraxetan [NCIt concept]
- Yttrium Y-90 Ibritumomab Tiuxetan [NCIt concept]
- Yttrium-90 Polycarbonate Brachytherapy Plaque [NCIt concept]
- Zafirlukast [NCIt concept]
- Zalifrelimab [NCIt concept]
- Zalutumumab [NCIt concept]
- Zamtocabtagene Autoleucel [NCIt concept]
- Zanamivir [NCIt concept]
- Zandelisib [NCIt concept]
- Zanidatamab [NCIt concept]
- Zanolimumab [NCIt concept]
- Zanthoxylum Fructus/Zingiberis Siccatum Rhizoma/Ginseng Radix-based Supplement TU-100 [NCIt concept]
- Zanubrutinib [NCIt concept]
- Zanzalintinib [NCIt concept]
- Zedenoleucel [NCIt concept]
- Zegocractin [NCIt concept]
- Zelavespib [NCIt concept]
- Zelebrudomide [NCIt concept]
- Zelenectide Pevedotin [NCIt concept]
- Zeluvalimab [NCIt concept]
- Zemirciclib [NCIt concept]
- Zenocutuzumab [NCIt concept]
- Zeteletinib [NCIt concept]
- Zevorcabtagene Autoleucel [NCIt concept]
- Zibotentan [NCIt concept]
- Zidesamtinib [NCIt concept]
- Zidovudine [NCIt concept]
- Zifcasiran [NCIt concept]
- Ziftomenib [NCIt concept]
- Zigakibart [NCIt concept]
- Zileuton [NCIt concept]
- Zilovertamab [NCIt concept]
- Zilovertamab Vedotin [NCIt concept]
- Zilucoplan [NCIt concept]
- Zilurgisertib [NCIt concept]
- Zimberelimab [NCIt concept]
- Zinc Gluconate [NCIt concept]
- Zinc Picolinate [NCIt concept]
- Zinc Sulfate [NCIt concept]
- Zinpentraxin Alfa [NCIt concept]
- Zipalertinib [NCIt concept]
- Zirconium Zr 89 Anti-TAA Monoclonal Antibody BAY3630942 [NCIt concept]
- Zirconium Zr 89 Crefmirlimab Berdoxam [NCIt concept]
- Zirconium Zr 89 DFO-Daratumumab [NCIt concept]
- Zirconium Zr 89 DFO-MSTP2109A [NCIt concept]
- Zirconium Zr 89 DFO-Pertuzumab [NCIt concept]
- Zirconium Zr 89 Desferrioxamine B Monoclonal Antibody huJ591 [NCIt concept]
- Zirconium Zr 89 Df-IAB2M [NCIt concept]
- Zirconium Zr 89 Girentuximab [NCIt concept]
- Zirconium Zr 89 Panitumumab [NCIt concept]
- Zirconium Zr 89 Trastuzumab [NCIt concept]
- Zirconium Zr 89-DFO-REGN3504 [NCIt concept]
- Zirconium Zr 89-DFO-SC16.56 [NCIt concept]
- Zirconium Zr 89-DFO-YS5 [NCIt concept]
- Zirconium Zr 89-DFO-emapalumab [NCIt concept]
- Zirconium Zr 89-DFO-fianlimab [NCIt concept]
- Zirconium Zr 89-TAK-164 [NCIt concept]
- Zirconium Zr 89-labeled Anti-CA19-9 Monoclonal Antibody 5B1 [NCIt concept]
- Zirconium Zr 89-labeled Atezolizumab [NCIt concept]
- Zirconium Zr 89-ss-Pertuzumab [NCIt concept]
- Ziv-Aflibercept [NCIt concept]
- Zolbetuximab [NCIt concept]
- Zoledronate Disodium [NCIt concept]
- Zoledronic Acid [NCIt concept]
- Zoligratinib [NCIt concept]
- Zongertinib [NCIt concept]
- Zoptarelin Doxorubicin [NCIt concept]
- Zorifertinib [NCIt concept]
- Zoster Vaccine Recombinant, Adjuvanted [NCIt concept]
- Zotatifin [NCIt concept]
- Zotiraciclib Citrate [NCIt concept]
- Zotizalkib [NCIt concept]
- Zurletrectinib [NCIt concept]
- Zymosan [NCIt concept]
- [18F]L-FAC [NCIt concept]
- [18F]L-FMAC [NCIt concept]
- [Leu15] Gastrin-17 [NCIt concept]
- c-Met Inhibitor [NCIt concept]
- c-Met Inhibitor ABN401 [NCIt concept]
- c-Met Inhibitor AMG 208 [NCIt concept]
- c-Met Inhibitor AMG 337 [NCIt concept]
- c-Met Inhibitor ANS014004 [NCIt concept]
- c-Met Inhibitor JNJ-38877605 [NCIt concept]
- c-Met Inhibitor MK8033 [NCIt concept]
- c-Met-targeting Tri-specific Natural Killer Cell Engager ABBV-303 [NCIt concept]
- c-Met/FLT3/TRK/CDK8/19 Inhibitor TSN084 [NCIt concept]
- c-Myb mRNA Degrader REM-422 [NCIt concept]
- c-Myb mRNA Degrader RGT-61159 [NCIt concept]
- cEt KRAS Antisense Oligonucleotide AZD4785 [NCIt concept]
- cFMS Tyrosine Kinase Inhibitor ARRY-382 [NCIt concept]
- cMet CAR-mRNA Electroporated Autologous T Lymphocytes [NCIt concept]
- dHER2 Vaccine+AS15 Adjuvant [NCIt concept]
- dUTPase/DPD Inhibitor TAS-114 [NCIt concept]
- eIF4E Antisense Oligonucleotide ISIS 183750 [NCIt concept]
- eVLP CMV gB-pp65 Plus GM-CSF VBI-1901 [NCIt concept]
- gp100 Antigen [NCIt concept]
- gp100:209-217(210M) Peptide Vaccine [NCIt concept]
- gp100:280-288(288V) Peptide Vaccine [NCIt concept]
- hTERT Vaccine V934/V935 [NCIt concept]
- hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1 [NCIt concept]
- hTERT-encoding DNA Vaccine INVAC-1 [NCIt concept]
- hTERT/Survivin/CMV Multipeptide Vaccine [NCIt concept]
- iC9-GD2-CD28-OX40-expressing T Lymphocytes [NCIt concept]
- iNKT Cell Agonist ABX196 [NCIt concept]
- iNOS Dimerization Inhibitor FK-330 [NCIt concept]
- iPSC-derived Allogeneic Anti-CD19 1XX-CAR T-cells FT819 [NCIt concept]
- iPSC-derived Allogeneic Anti-HER2 CAR T-cells FT825 [NCIt concept]
- iPSC-derived Anti-BCMA CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT576 [NCIt concept]
- iPSC-derived Anti-CD19 CAR/CD16/IL-15RF/ADR-expressing CD38-eliminated NK Cells FT522 [NCIt concept]
- iPSC-derived CD16-expressing Natural Killer Cells FT516 [NCIt concept]
- iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596 [NCIt concept]
- iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538 [NCIt concept]
- iPSC-derived MSCs CYP-001 [NCIt concept]
- iPSC-derived Natural Killer Cells FT500 [NCIt concept]
- mRNA COVID-19 Vaccine [NCIt concept]
- mRNA-based Personalized Cancer Vaccine NCI-4650 [NCIt concept]
- mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902 [NCIt concept]
- mRNA-derived IDO/PD-L1-targeted Vaccine mRNA-4359 [NCIt concept]
- mRNA-derived KRAS-targeted Vaccine V941 [NCIt concept]
- mRNA-encoded Anti-CD3/Anti-CLDN6 Bispecific Antibody BNT142 [NCIt concept]
- mTOR Inhibitor [NCIt concept]
- mTOR Kinase Inhibitor AZD8055 [NCIt concept]
- mTOR Kinase Inhibitor CERC-006 [NCIt concept]
- mTORC1 Kinase Inhibitor RMC-5552 [NCIt concept]
- mTORC1/mTORC2 Inhibitor Palomid 529 [NCIt concept]
- mTORC1/mTORC2 Inhibitor XL388 [NCIt concept]
- p38 MAPK Inhibitor LY3007113 [NCIt concept]
- p53 Mutant Reactivator APR-548 [NCIt concept]
- p53 Y220C Mutant Reactivator PC14586 [NCIt concept]
- p53 Y220C Reactivator JAB-30355 [NCIt concept]
- p53-HDM2 Interaction Inhibitor MI-773 [NCIt concept]
- p53/HDM2 Interaction Inhibitor CGM097 [NCIt concept]
- p97 Inhibitor CB-5339 [NCIt concept]
- p97 Inhibitor CB-5339 Tosylate [NCIt concept]
- pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0 [NCIt concept]
- pH Low Insertion Peptide-exatecan Conjugate CBX-12 [NCIt concept]
- pH-Low Insertion Peptide-Indocyanine Green [NCIt concept]
- pNGVL3-hICD Vaccine [NCIt concept]
- pNGVL3-hICD Vaccine AST-301 [NCIt concept]
- pNGVL4a-CRT-E6E7L2 DNA Vaccine [NCIt concept]
- pNGVL4a-CRT/E7(detox) DNA Vaccine [NCIt concept]
- pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine [NCIt concept]
- pTVG-HP Plasmid DNA Vaccine [NCIt concept]
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine [NCIt concept]
- pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine [NCIt concept]
- pan FGFR Inhibitor PRN1371 [NCIt concept]
- pan-HER Kinase Inhibitor AC480 [NCIt concept]
- pan-PI3K/mTOR Inhibitor SF1126 [NCIt concept]
- pan-PIM Kinase Inhibitor AZD1208 [NCIt concept]
- pan-PIM Kinase Inhibitor GDC-0570 [NCIt concept]
- pan-PIM Kinase Inhibitor NVP-LGB-321 [NCIt concept]
- pan-RAF Inhibitor JZP815 [NCIt concept]
- siG12D LODER [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients